>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 1; Drug: Control Apo 0.5 然
bRgRsmbRgbRibRsbLsbRhbRiRsmbLgbRgbRibLibLsRsbRibRsRsmbRibRiRsmbRibRgbR
ibLibRhbRibRgbRhbLibLgRsbRibRibLgbRibRhbRibLibRibRsbRibRibRobLebRcbRib
RibLcbLcLsmbRibRcbRibLgbRgbRgbRsbRgbRgRsmbRgbRibRhbRibRsbLgbLsbLgbLgLs
bLgbRibLibLibLibRsbLgbRibRsbLsbLibLibRgbRsbLibLsbRgRsmbLgbRgbRgbRgbRsb
RibRgbRsbLgbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 2; Drug: Control Apo 0.5 然
bLgRsbLgbLgbLgbLgLsbLgbRsbLgbLsbLgLsbLgbLsbLgbLgbLgbRsLsbLgbLgLsbLgLsb
LgLsbLsbLsbLgbLgbLgbLsbRsbLsRobRcbRibRibRgbLibRgbRibRsbLcbLcbRsbLcbRgb
RhLsbRgbLcbLiLsbRcRsmbRcbLgbRcbLibRoLsbLibRoLsbRibLibRiLsbRhLsbRibRibR
hbRibLjbRcbRiLsbLibLcbRibLcbLsbRcbRcbRoLsbRibRoLsbRibLgbLobRgbRibRibRo
bLibLsbLibRibRcbLcbRjbRhbLgbRcbRsbRibLiLsbLibRobLsLsmbLobRibLibRsbLgbR
sbLoRsbRibRobRobRgbLsbRgbLsbRobLibRcbLjbRcbLibRcbLjbRcbLibLcbLobRgbRsb
RibRsbRobLibLhbLobRgbRibLgbRhbRibRobLsLsmbLcbLgbLobRgbLcbLebRsbLgbLibR
sbRcbRgbRgLsLsmbRgbLsbLhbRibRhbRsbRoLsbRibLsbLgLsbRobRcbLiLsbRobLjbLob
LobRgbLcbLjbRibLsbLobLjbLsbLsbRgbRibRobLjLsmbRibLgbRsbRobRibLgbRobRsRc
bRoLsbLibRobRgbLjbRjbRobLibRobLibLibRsbRcbRcbLibRcbLibRibRgbRiLsbRsbRg
bRhbRsbLobLibLobLsbLobRobLsbRobLcbRgbLsbRsbLibRobRhbLsbRgbRsbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 3; Drug: Control Apo 0.5 然
bLibLiLsbLgLsbLsbRobLsLsmbLsbRobLibRoLsbRgbLsbRobLsbRsbLcbRgbLhbLcbRgb
LgbLhbRgLsbLibLgLsbRgbLoLsmbRsbLsbLobLobLsLsmbRgbRsbLoLsmbLgbRsbLsbLiL
sbRjbRcbLcbLsRsbLhRsbLgbLibLsRsbLgbLobLsLsLsmmbLgbLibLgbRsLsbLiRsbLsLs
mbRsbLgbLibLibRgbLgbLsbLibLiLsLsmbRgbLsbLgbLibLcbLsbLsLsmbLobLgbRgbLcL
smbRsRsmbLsbLibRgbLgLsbLsbLgbLsLsRsmbLgbLhbLsLsmbLsbRsLsbLobLhbLgbRgbR
cbRhbLgbLibRibRcbLiLsbLibRsRsLsmbLsbLgLsbLsLsmbLgbLgbRsLsbLgbLgbLsbLib
RsLsbLgbLgLsbLgbLsLsLsmmbLgLsbLgbLgbLgRsbLcRgbLibLgbLgLsbLibRibLobLcbL
ibLgbRibRgbRhRsmbLibLsbRobLgbRcRsLsmbLgbLhbRjbLhbRsbLhbLobLibLsbRcLsLs
mbLgbRibLjbLhbLgbRsRsmbLiLsbLsbLgbLcbLobLhbRjbLobLibLgLsLsmbLibLsLsmbL
sLsmbRobRhbRiLsLsmbRibRiLsbRsbLcbLgbLsLsmbLsbLgbRsbLgbLgRsbLjbLoRsbRob
LobLobLobLgbRibRobLcbLobLibLibLibLcbLobLcbLcbLibLibRibLgbLibLibLibLsbR
iLsbLsbLhbLiRsbRsbLgbLgbLgLsbRgbLcbLibLibLsbLgbLgbRcbRoLsbLibRhbRsbRob
LibRoRsmbRgbLgbRobLsbLcbRcbLsbRibRcbRibLsbLibLoLsmbLsbLcbLgbRsbLobLcbL
sbRibRjbLiLsRsbLgbLgbLibLsbLgbLsbLgbLibLibRsbRsLsbRobRcbLjbLcbLibRobLe
bLobLgbLcRsbLjbLobRhbLsbLobLobRobRgbLsbLibLibLibLsbLobLjbRobLsbLibLsbL
gb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 4; Drug: Control Apo 0.5 然
bLgbLibRiRsmbLsbRsbRgbRjbRgbRsbRgbRsRsRsmmbLebLibLsbLsbRsbRebRibRcbRib
LsbLsLsmbLibRsbLibLsbRgbLcbLobLsbRhbRgbRsbRibRgbLgbRibLsbLcLsmbLobRibL
sbRsbLcbRibRjbRibRgbRebRibLebRsbRgbRjbRibRcbRcbRiRsmbLjbLcbLgLsbRcbRib
RsbRgbRobLhbLibLsbRjbLobRsbRhbRsbRibRibRgbLcbLsbRiRsmbRgbRgbLgbRoRsmbR
cbLsbLgbRibLobRgbLsLsmbRibRibRibLsbLjbRcbRcbRebLsbLobRsbRibRsbLsbRibLs
bLobLhbLgbLsbRgbRsLcbRibRsbRibRibLgbRibLsLsmbLcbRsbRjbLcbRgbRibRibRsbL
gbLgbRebRhb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 5; Drug: Control Apo 0.5 然
bLibRsbLobLgRsbRsbLobLgbRgRsRsmmbLsLgbLsbLobRsbRsbLsLobLibLibLgbRsbLsb
RsbRcbRgbRgRsmbRibRhRsmbLsbLsbRibRibRibRsbRsRsmbLsbRoRsLsmbLgbRsRsmbRs
bRhRsmbRsbRibRhbRibLgbRibLgbLibLoRsbLgbRsbRcRsmbRhRsRsmmbRibRcbReRsmbR
gbRsbRcbRiRsmbRsRsmbLsbLebRibRgbLobLsbLcbLibLibLibLhbRobRobRibRoRsmbLs
bRobRcbRsbRcbRibRgbLobRibRgbRgbLcbsbLsbLgbLobRgbRhbRibRobRjbLcbLcbLgbL
ibLsbLcbRgbRhRsmbRsbRgbLobLibLgbLibLcbLobLibLibRibLibRgbLobRsbLobLgRsb
LsbRcRsmbLsbLjbRhbLsRsbLcbLibLibRibRjRsmbLgbLebRgbLgbLobRobRebLgbRibRc
bRhRsmbRsbsbRibLsbRsRobRcbRhbRibRcbRcbRjbLobLgbLsbRcbRgRsmbRsbRjbRcbRc
bRhbLsbRgbRobRsRsmbLsbRibRcbLsLsmbRsbRcbRibRsRsmbRgbLjbRobRibRcbRebLgb
LibLsbLibLobLobLibRjbLcbLgbRibRhRsmbRibLsbRgbRgbRsbRgbRgbRsbRiLsbRibRg
bLgbRhbRibLsbRgbRsbRsRibLobLcbLsLsmbLhbLibLibLgRsbRgbRobRhbLsbRcbRebRi
bRibRsbLsbLibLsbLhbLobLibRjRsmbRobRsbRibRgbRibLgbRiRsmbLgbRobRobRibLsb
RcbRgbRgbRgbLobLcbRgbLobRhbRgbRobRcbRibLjbLcLsmbLgbLgbLobRibRgbReRsmbR
hbLsbRsbRiRsmbRsRsmbRgbRgbRgbRsbRibRgbLjbRobRhbLsbRcbRibLgbLobLobLgbLs
bRiRsmbRgbRiRsmbRsLsbRcbRsbRcbLsbRobRibRebRcbLgbLcbLcRsbRgbLibRibLoRsb
RebRgRsmbRobLsbRcbRibRsbRobRibRcbRgbRcbLgbLcbRcbLgRsbRgbLjLhbRebRcRsmb
RsRgbRiRsRsmmbRgRsmbRibRgbRibLcbLcbLiRsRsmbRsbRcbReRsmbLgRsbRcbLgbRhRs
mb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 6; Drug: Control Apo 0.5 然
bsbLsbLgbLibRoRsmbRiRsmbLsbRgbRgbRibRgbLsRiRsmbRibRibLsbLgbLgbLibLsbLs
bLsbLibLsbLsLsLombLiRsbLsRsbLcbLibLgbLsLsmbLsbLhbLibLgLsbRsbLsbRibRcLs
LsmbRibLsbLibLhLsbLcbLsbRgRsmbRsbRiRsmbRgRsmbRsbLsbLsRsbRibRcbLgbLibLi
bLiRsbLsLsmbLibLibLsLgLsbRgbRsbRgbRsbRgLsbRcbRsLsbLhLsbLsbLsbsbRobRjbL
gbLibLsbLsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 7; Drug: PCAP931 1 然 Apo 0.5 然
bLsbLoRsbLhbLibRgbRibLsbLsbRibRsbRhbLsbRibRsbRibLsRsbLsbRiRsmbRcbLhbRc
bRcbLcbLcbLcbLsbRcbRsRsRsmmbRsbRsbRgbRcRsmbRiRsmbRhbLgbRsbRsbLjbLoRsbL
ibRcbRcRsmbRobLobLhbLibRgRsRsmmbRgbRgbRsbRsbRgRsmbRsbRibRibLgbRibLgbRi
bLibRsbRsbRsbRgRsmbRsbRibLgbRjbRcbRobRebRobRcbLcbLobLibLjLsmbLjRsbRhbR
jbLobLoRsbLhbRhbLsLobRsbRgbRgbRjbRibRsbRsRsmbRsbRsbRcbLgbRsbRsbRsbRebL
oRsbLjbRhLsbRjbRebRhbLgRsbRcbLibLcbRhbLsbLjbLcbLcbRcbRebRoLsbRjbRebLoL
smbLibRgbLjbLcbLibLobRcbRcbRhbRibRibRgbRcbRhbLibRobRebRcbRobRjbLgbRobL
gbRhbLgbLsRsbRobRhbLgbRibLgbRsbRjbRcLsbRcbRobRcbRcLsLsmbRobLhbLobRsbLc
RsbLobLobRibRsbRibRsbRibRgbRsbRgbLsbRsbRobRsbLsbRgbRgRsmbRsbRsbRgbRsRs
mbRgbLsbRobLcbRibRsbRibRgRsmbRsRsmbLcbLhbLcbLcbLobLjLsmbRcLsbLobRgbRiR
smbLcbRhRsmbLsbLjbLibLobRcbRobRobRcbRsbRobRobRjbRibLsbLobLobLcbLibLcbL
cRsbRjbRobRobRhbLsLsmbRgbRsbRibRgbRsbRsbRgbRgbRsbRjbRcbLgRsbLobLcbLibL
iRsbRgbLgbLiRsbLcbRcbRcLsbRobLobRcbLsLsRsmbLgbRsbLcbRjbLsRobLgbLsbRobR
cbRobLibsbRsbLgbRcbLiRsbLsRsbRcbLgLsbRgbRebLsbLibRobRcbRobRobRcbRobLib
RsbRibRsbRgbRgbRgbRgRsRsLsmmbRgbRgRsmbRcbRsbRsbRsbLsbRjbLjbRcbLgbRobLi
bRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 8; Drug: PCAP931 1 然 Apo 0.5 然
bLhLsbLcbLgbLgbLibLgbRgbLcbLibRsRsmbLcbLsbLgLsbLgbLgbLgLsbRgbLibLsRsRs
mbLgbRhbLiLsLsmbRsbRibRsbRsbRsbRgRsmbLsbLsbsbLsbLsbLobRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 9; Drug: PCAP931 1 然 Apo 0.5 然
bLgLsbLsbLgLsbLgbLgbLsbRsbLibRsbLibLcRsbRibLsbLsbRsbLibLhbLcbRsbLsLsmb
RsbLsbLhbRgbLibRibLibRgbRsbRsLsbRgbRgbRgRsmbLhLsbLsbRgbRgbRsLsbRsLsbRs
bLhbRhbLcbRgLsbLoRsLsbRibLhLsbLsbLgbLsbLgLsbLsbLgbLgbLibRgbLibLiLsbRgb
LgLsbRsbLgbLibLgbLcbLibLibLeLsbRhbLsbLgRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 10; Drug: PCAP931 1 然 Apo 0.5 然
bRcbRibLjbLoRsbLibLgLsbRgbLobRebRiRsmbLsbLhbLgbLibLsbRebLobRebRjbRgbRo
LsRsbLibRibRsbLsbLjbLgbLgbRhbLjbLcbRebLgbLgbLgbLiLsbRjbRsLsbRgLiRsbRsb
RgbLsbRibRsLsbRsbRsbLebLiRsbRibRhbRsbRibRsbRgbRgbRgbRibRgLsbRsbRgbLcbL
sRcRsmbRjbRiRsmbRibLsRsRsmbRsRsmbRgLsbRsbRgLsbRgbRsbRsbRgRsmbRgbRgbRgb
RgbRgRsRsmmbRgbRsbRgLsbRibRsbRibLgbRsbRgbRibLjbLcbRobLgbRgbLsbRgbLjbRo
bLibLsbLibLgbLgbRsbLibLibLibLibLibLibLibRib

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 11; Drug: PCAP931 1 然 Apo 0.5 然
bLgLsRsbLgbRibLsbLibLsbLibLsLibLibLgbLsbLsLsmbLebRiRsmbRsRsmbRgLsbLjbL
cbLiLiLsbLebRhbLiLsbLgbLiLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 12; Drug: PCAP931 1 然 Apo 0.5 然
bLsbLhRsbLgRsbLsbLibLgbRsbLgLsRsbLgbLsbLgbLgLsbLgbLsRsbLgRsbLgbLibLgbL
sbRsbLgbLgbLgbLgLsbLgLsbLsLsmbLsbLsbLgbRgbLsbLsbLsLsmbRsLsbLiRsbLsbLgb
LsRsbLgbLsRsbLgbLgRsbRsRsmbRgbLibLibLsbLibLcRsbLgbLgbRsbLsbLjbLibLibRs
bLgbRsbRcbRcbLjbLhbLibLsbLsbRgbLibLcbLgRsbRsbRgRsmbRsbRibLsRsbLsbRibRs
RsmbRsbLsbRibRsRsmbLsRsbLsRsbRibRgRsmbLgbLjbLsbLjbLhbLgbLgbLsbRsbLcLsm
bLibRgRsmbLsLsmbRsbRgbLjbLhbRsbRgbLsbLgbLgbLibLgbLgbLgbRsbLiRsbLgbLibL
gbLsbLsbLsbRgbRgbRjLsbLsbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 13; Drug: PCAP931 3 然 Apo 0.5 然
bLgbRobLgbRsbRgbRcbLgRsbRcbRcbRgbRgbLcbRcbLjbLobLsbRgbLcbLobRsbRsbLibL
sbRsLibLiRsbLgRsbLgbRgLsbRjbRibRgbLjbRsRobRcbLsLsmbLibLobLgbLobLgbLobL
sbRsbRgbRibLobLsLsmbRcbLobLgbLibLibLibRsbRgbLjbLhbLibRgLgRsbLibLsbRsbR
sbRobRcbRobRcbLjbLobLibLcbRsbLcbLjLsmbLobLgbRgbRsbLebLibRcbLobLobLsbRo
bRobLobRsbLcLsmbLjbLobRjbLcbLcbRjbLcbLobRcbLsbLgbLcbLgbRebRobRcbLcbRob
LcbRcbLjbRobLcLsmbRebRjbRoRsmbRibLoRsbLoRsbLjbLobLjbLibRgbLobRobLjbRjb
LjbRcbLibRibLgbLjbLjbLiLsbRjbRsbLobLobLcbLcLsmbRcbRoLsbLobRcbRobRsbLoL
smbLcbLhbLgbLhLsbLibLhbLoLsmbLobLcbRcRsmbLcbRobLcbRoLsbLjbLobRobRcbLob
LobLobLibRjbRobLoLsmbLobLobLcbRjbRcbRobRobLcLsmbRcbLcbLhLsbLob

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 14; Drug: PCAP931 3 然 Apo 0.5 然
bLgbLcRsbLiLsbRgRsmbLsLsmbRcbRiRiRibRgbRibLjbLibLiLsbLgbLsLsmbLgbLsbLo
bLsbLgbLsbLgbLgbLgbRgbLcbLhbRibLcbRgbRsLsbRibRcbRobRgbLcbLibRsbRgRsmbR
sLsbRgbLgbLibLibRgLsbRjbRibRjbLsLjbRobLgbLibRjbRjbLobRobLcbLobLsLibRib
LibLsbLgbLsbRcbLcbRjbLhbLgbLgbLsbRsbRhbLcbLcbLibRgbRsbLjbLcbRhbLcbRjbL
hbLsbLgbRgRsmbLsbRibLgbLsbLsbLsLsmbLgLsLgLsbLgLsbLgbLsLsmbRgbRibRjbLcb
LobLibLgbLiLsbLsLsmbLcbRobRebLgbRebLobLcbLcbRibRibRjbRjbLsLsmbLjLsmbLc
bRcbRibLobRjbLgbLcbLcbRibLhbLibLibRobLeLsbLhbLiLsbLibLibLsbLgbLjLsRsRs
mmbLgbLibLgLsLsmbLcbLibLjLsmbLjbLhbLhbLsbLhbLsbLcbLhLsbLibLibLgbLsbLgb
sbLsRsbRsLsbLsbLgbLsbLhbLibLibLibLsLsmbRgbRgbLgbRgbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 15; Drug: PCAP931 3 然 Apo 0.5 然
bRcbLgbRcbRibLsbRcbLsbLcLsmbLsRsbRsLsbLsbRsbLobLsbLsLhbLsbRsbLcLsmbLsb
LgbLhRsbLgbRgbLsbRhbRsLibLsbRsbRgbLibLcbRgRsmbLibLibLgbLgbLgbLgbLobRsb
RsbRsLsbLcbLibLsLsmbLgbRsbLgLsLsmbLsbLsLsmbLgLsbLgRsLsbLgbRsbRhbRcbRcb
LsbRcbRgbRcbLcbLhbLgbLsbLgbLgbRsbLsbLgRsbLiRsLsbRsbLsLsmbLjbRcbRcbRcbR
gRsmbsbLsbRcLsbRhbLsLgbRgbRibLgbRgbRcLsbRibRcbRcbLjbRhbLebLcbRgRsmbLsR
sbLobRibLsbLsbRcRsRsmmbLgbLcbRsbRjbLcbRsLsbRcbLibLsbLgbLsbRibLsbRibRgb
RgbRsbRsRsmbRsbLgbLebRcbLibRgbRsLsbLgbLgbLsbLibRsbRjbLsbLebRsbRgbRsLsL
smbRjbRcbLibRcbRebRgbRgbLsRsbLsbLcbRsbLgbRsRsLsmbsbsbsbsbLsbRsbLhbLsbR
gbLibLobLsRsbRibLsbLsbLcbRgbRgbLcbRibLobRsbLcbRgbLgbLgbRsbRhRsmbLjbRib
LsbRsbLhbLibsbLobLcbLcbLgbLgbRgbLibLgbLgbLgbLgRsbLsLsRsmbLiLgbLgLsbLsb
LgbLsLsmbRsbLibRsLsLgLgbLgbRsRsmbRsRsmbRobRcbRhbLibLcbLsbLcbRsbRibLibL
ibLgbRobRibRjbRcbLgbRcbRobLobLibLsbLgLsbLsbLsbRsbLgbLsLsmbLcbLsbLcbLgb
RibRsLsbLsbLsbRhbRgRsRgmbRgbRsRsRgmbRsLsbRsbRsbRgRsmbRgbRsbRibLibRcbLg
bLgbLhbRcbLcbLiLsbLobLsbLobLhbLcbLgbRsbRgbLgbLobLibLsbRsLsbLsbLcbRsbLo
bLsbLhbLsbLibRebRibRcbRgbRhbLsLsmbLsbLsbLcbRsbRcbLcbLobLibRjbRibRsbRsb
LjbLhbRsbLiRsbRibLgbLibRsbLgbLgbLgLsbLgbLgbLgbLsbLgbLsbRsbRjbLjbLsbLcb
LsbRibLibLsbLgbRcLsbLgLsbLobRibLoRsbRsbRgbLcbLibRsRcbLjLoRsbRsbLjbRhbR
gbLcbLoRsbRgbLobLibLsbRibLibRsRsmbLsbRgRgRgRgbRsbRcbLibLsbLobRgbRiRsmb
RobRhbLsbLsbLibRobReLsbRobRgbRgbLsbRgbRgRgbRsLsbRsbRsbRsbRgRsLsmbRsbRg
RsmbRgbRsbLsRsLsbRgbRsLsRsbRsRsmbRsbLgbLcb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 16; Drug: PCAP931 3 然 Apo 0.5 然
bLebRhLsLsmbLsbRsbLibLgLsLsmbLgbLsLsmbLsbLsbLsbRsbRsbLibLsbLeLsbRsRsmb
LeLsbRibRgbRgRsmbRgbRsRsLsmbLiLsbLgbRibLjbLjLibLhbLibLhbRiLsbLgbLibLib
RjbLcbLibLcLsmbRibRibLhbLgbLibLibLhLsbLgbLgbLgbLhbLibLcbLsbLibLibRsbLj
bLebLcLsmbLiLsbLgbRgbRcbRcLsLsmbsbLgLsbRebLcbLsbLcbRebLhb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 17; Drug: PCAP931 3 然 Apo 0.5 然
bRibRcbRebRgbRgbLcbLibLobLgbLoLsmbLhbRibLibLiRsbRgbRgbRsbLsbLobRgbRibL
jbLsbLibLsbLibRsbRjbLhbRibLobLgLsLsmbLsbRsbLibRcRibRiLsbLsbLjbRibRgbLg
bRibRibLobLhbLhbLoRsRsmbLhbLhbLsLsmbLsbLibLsbLgbLsbLgbLibLibLibRgLsbRs
bLhbRcbRgLsbRsbRibRgbRibRsRsmbRjRsmbRsbLgbRibRsbRibRibRib

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 18; Drug: PCAP931 3 然 Apo 0.5 然
bRgbRsbRsRsmbRsbRsbRsbRsbRsbRsbRsRsLsmbRsbLgRsbRiLsbLibRgbLgLsbRiRsmbR
hbLgbRobRcbRibRcbLgbLsbLsbRiRsmbRsbRgRsLsmbRgbRsbRsbRsbRsLsbRsbRgLsbRs
bRsbRsbRsbLsbRsbLgbRibRsbRsRsmbRsbRgbLjbRsRsmbRsbLobLcbRibReRsmbRibRhb
RcbRibRebRibRibRiLsbRgbRcbLgbLgbRibLsLsmbRibRsbRsbLsbRsbLsbLsbRsbLsLsm
bLhbRiRsmbLsbRibRjb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 19; Drug: PCAP931 10 然 Apo 0.5 然
bRibRgRsmbRsbRsbRsbRsbRsbLgbLsbRgbLgbRsLsbRsbRsLsbRsbLsbRgbLsbsbRsbRgb
RgLsbRsbRgbRgbRsRsmbRsbRsbRsbRsbRsbRsbRsbRsbsbRsbRsRsmbLsbRsbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 20; Drug: PCAP931 10 然 Apo 0.5 然
bLsLsLsmmbLgbLsLsLsmmbLsbLsbRcbRgbRsbLsLsmbsbsbsbRsRsmbLgLsbRsRsLsmbLs
LsmbRsLsbRsbLsbRsbLsbLsbLsbsbsbsbLsbRsbLgRsbRsbRsbLsbRsbLsbRsbLsRsbLsL
smbRsLsbLsbLsbLsbLsbLsbRsRsmbRsLsRsbLsbsbRsbLsbLsbLsRsbsbLsbLsRsbLsbRs
LsLsRsLsmbLsbRsbLsbRsLsRsLsLsLsRsmmbRsRsmbRsbRsbLsbLsbLgLsbRsbRsbRsbRs
LsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 21; Drug: PCAP931 10 然 Apo 0.5 然
bRcLsbRgbRobRcbRobRobRjbLsRsbRcbRcLsbRobRibLsbLobLobLobRcbLgbRjbRobLcb
RgbRobRibRibRgbLobRcLsbRobRebLgbRibLiRsbRibRibRsbRgbRibRsbRsbReRsRsRsL
immmbLsbLsbRibRgbRobRobRobRobRoLsbLobRebLsbRgbRhbLibRoLsbRibLoLsmbRcRs
mbRoLsbRobLobRibLhbRsbRsbLcbLcbRobRgbRobRobLibRgbsbRoLsbLsbRobRgbLoRsb
RgbLsbLgbRsbRcbRgRsmbRibLsRsbRibRcbRgbRibLsbRiRsmbLhbRoLsbLsbRibLgbRjb
LhbLsbRjbRgbLibRjbLibRsbRjbRsbLsbRobLgbLgLsbRsbRsbRsbRibRibRsbLcbRjb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 22; Drug: PCAP931 10 然 Apo 0.5 然
bRsbRjRsmbRgLsbRgbRgRsmbRgbRsbRoLsbRgbRgbRgbLoRsbLsbLgbLjbRsbRobLgbRib
LhbLgbLibRhbReRsmbLjbLgbLsbRhbRsbRsbRsbRgRsmbRsbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 23; Drug: PCAP931 10 然 Apo 0.5 然
bRobRibsbRsbRsLsbRsbRhRsmbRgRsmbRsRsmbRsbLgLsbRsLsbRsLsbLsbLsbRsbLsLsm
bLsbLsbLsbLsbLsbLsbRsLsLsmbLsbLsbLsLsmbRsbLsbLsbLsbLsbLsbLsbLsLsLsmmbR
sRsmbLsLsmbLsbLsLsmbRsbRsbRsbRsRsLsmbRsbRsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 24; Drug: PCAP931 10 然 Apo 0.5 然
bLjbRebRgbRgRsLsmbRsbRsbRjbLsbRsbRiRsmbLhRsbRiRsmbRhRsmbRsbRsbLgbLsLsm
bLsbLsbLsbLgbLgbLsbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 25; Drug: Control Apo 0.5 然
bRgbRgbLjbLcLsmbLgbLsbLgbLsbLsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 26; Drug: Control Apo 0.5 然
bLsbReLsbLgbRcbRgbRiLsbLiLsbLgbRjbRibRibLgbRiRsmbLsbRibRgRibLsbRibRiLs
bLibRjbRiLsRsbRibLjbRgbRibRgbRgbLgRsbRibRiRgbRgRsLgLsmbRibRjbRsbLsbRjb
LsRsbRsRsmbRgbLgbRgbRsbRsbRgbRgbRgbRgbRjbRjbRhbRibRhbRiRsLsmbRsLjbLcbL
ibRibRhbRibLsbRgbRsRsmbRgbLsbRsbLgLsbLsbRgbRgbRgbRibRibLsbRgRsmbLgbRib
LibRibLcbLibLsbLiLsbLsLsmbLsbLiLsbLgRsbLsbRiRsmbRhbRsbLsbRgbLgLsbsbLsb
RsbRsbLsLsmbLsbLgbLsbRsbsbRsbRcRsmbLcLsmbRcbRgbRobRcbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 27; Drug: Control Apo 0.5 然
bRsbLgbLgbRgbLcbLiRsbRibLoRsbRgbLibRsbLgLsbLobLiRsRsmbRibLsbRhbRhRsmbR
hRsmbRgbRsbRobRibLiRsbRobRcbRibLgbRoLsbLibRiRsmbRcbLsRgRsmbRobRhbLgbRi
bRobLibRcbLjbRcbLibRoRsLsmbRsbLsbRjbLsRsbLsbRibRgbRcbRsRsmbRiRsmbLsRsb
RsRsmbsbRiRsmbRibRsbRgbLsbLsbRgRsmbRgbRsbRgRsRsmmbRsbRgbLsbLgbLcLsRsmb
LcbLibRobRcLsbLsbLgbRsbRcLsbLgbLebLjbLcbLebLcbLjLsmbLgLsbLcbLcbLibLibR
cbRobRobRobRobRcbLibLsbRobRiRsmbLcbLjbLjbLcbLhbLoRsbsbLcbRcbLcbLibLobL
obRibLsbRjbRcbLobRcbRhbLob

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 28; Drug: Control Apo 0.5 然
bLib

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 29; Drug: Control Apo 0.5 然
bRsLsbRcLsbLsbRgRsmbRgbRgbRsRsmbLibRibLgbRhbRgbRgbLsbLgbLgLsbLcbRgbRsb
RhbRcbRgbRiRsmbRgRsmbRgbLsbRibLcbRcbRcbRgbLgbLibRsbRobRibRgbLsbLgbRgbL
obRibRhbLcbRoLsbLibLibLibLsbLsbRoLsbLibRsbRgLsbLsLsmbLcbRgLsbLibRsbLsb
LgbRobRibRsRsmbLibRoLsbRsbRgbRibLgbLoLsmbLgbRibLsbRibRsbRsbLcbRgbRibRg
bLob

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 30; Drug: Control Apo 0.5 然
bRsbRsbLsbRiRsLsmbLsbLgbRgRsLsmbRgRsmbLhbRibLgbLsbRibRiLsbLibRibLibLsb
RcbLibLgbRobLhbLsbLsLsmbsbLsLsmbsbRsbLsLsmbLgLsbLsbLgRsbLgbLgbLgbLsbLg
bRgbLgbLcLsmbLhbRibLgbLibRsbRgbLgbLibLjbRgbLibLgbLgbLgbLgbRsbLibLiLsbL
ibLsbLiLsbLsLsmbLgbRsbLsbLgRsbRjbRgbRsbLebLcLsmbRsbLgbRsbLiLsbLgbLsbLi
bLiRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 31; Drug: PCAP931 1 然 Apo 0.5 然
bRibLjbLcbRhbLiLsbLobRhbRgbRgbRgbRibRsLsbRgbRgbRgRsmbLcbRoLsbLcbLobRhb
LcbLhbLgbRibLgbLhbLcbLcbLcbLibRibLibRhRsmbRcRsmbLcLsmbRcRsmbRhbRobRibL
ibRibRsbRjbRgbRcbLebLcbLibRgbLsLsmbLgbRibRibRibLcbRcbLcbRoRsmbLcbRibRi
bRobRgRsmbLebRcbRgLsbRgbRgbRsbLgbLjbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 32; Drug: PCAP931 1 然 Apo 0.5 然
bRcbRibRibRsLsbRgRsmbRgbRsbRsRsmbRiRebLcbLibLgbLhbRobRibRsbLgbLobRibLo
RsbLiRsbRgbRsbLcbRgbLibLiRsbRsbLgbLibLoRsbRgbRibLgbLibLibLibLhbRibRgbR
gbRibRibLgbRoRsmbLibLhbLibLsbLiRsbRhbLobRjbLobRibLobRgbLhbRsbLcbLsbRhb
RcbLgbRcbLibLcbLibRibLcbRsbLobRibRibRcbLibRcRsmbRebLobRsbRibLibLibLgbL
gLsbRcbRebLebRhb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 33; Drug: PCAP931 1 然 Apo 0.5 然
bLjbLibLgbRcLsbLcLsmbLgbLsbRcbLibLcbLcRsbLgbLibLiLsbLhRsbLsbRsbLcbRgbL
cbLgbLibRgbRibRsbRobRobRobRibRsbRgbRsbRgbRgbRsbRsRsmbRibLsbLoLsmbLgbLc
bRgbLgbRsbLibLobRgbLoRsbRsbLibLgbLhbRsbRgbLibLsbLhbRsbLibLsbLsbLibLgbL
sLibRsLsbLibLhbRgLsbLsLsmbLsbLhbLsbRsbLibLsbLgbLibRsbRobRibLgbRiLsbLgb
RgbRobRoLsbRobRcbRhbLgbLgbRibRsRsmbRsRiRcbLibLsbLcbLibRsbRsbLibLsbRobR
cbRibRsbLsbLgbLibLibRsbLibRobRhbLsbRobLsbRoLsbLgbLibRsbRcbRhRsmbRgRsmb
LsbRsbRgRsRombRobLibLgbLjbRiRsmbLsbLiLsbRobLsLsmbLcbLibLsLsmbLgbLoLsLs
mmbLsRoLsbRoLsbLibRgbLsbRibRcbLcbLhbRjLsRobLibRobLoLsmbRobLobRsbRgLsbR
sbLoRsbRgbLcbRcbLobRibRgbRgbRibLibLobRgbRsLsbLibRsbLibRsLsbLcRsbLibLib
RsbRobLcbRsbLjbRcbLoRsbLobLobRcbLebRgbRobRsbLoRsbRgbRcbLgbLibLoRsbRobR
ibLgbRjbRobRebLcbLcbRgLsbLjbRoLsbRcbLibRjbRobRoLsbRgbRebLibRsbLibRsbLs
RebLobLhbLobLoRsbRebLeRsbRsbRobLibRhbLjbLebLobLobRcbLibRgbRgbLcbLgbRoL
sbRsbLobRgbLcbRob

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 34; Drug: PCAP931 1 然 Apo 0.5 然
bLobRibRcbLgbLgbLgbLsLsLsmmbLsLsmbRobLibLibRjbLobRcLsbRibRgbLcbLsbLobL
ibLgbLcbLgbLgbLcbLcbRobRibRibLibLcbRobRebRjRsmbRobRgbLgbLibRsbRobLsbLc
bLgbLgbLsLsmbLoLsmbRobLcbLgbLsbRhbLhLsbLsbLhbRsbRcbLibRgbLjb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 35; Drug: PCAP931 1 然 Apo 0.5 然
bLcbRhbRobRibRgbRcRsmbLsbLhbLgbLgbLoRsbRcbRebLsbLhLcLgbRebRhbRibRsbRoL
sLsmbLjbRobRibRobLcbLgbRcLsbRcbRibLgbLcbRiLsbLibLhbRibLibLiLsbRhbRibLo
bLhbRcbLobLibLcbLibRibLhbLibLgbRgbLibLcbRcbLobRjbLobRcbLcbLhRsbRgbRhbR
obRibLibLgbLibRsbLgbRsbRsbRobRobRjbLibRobLjbLgRsbLhbLibLcbRiRsmbLibLcb
RibLgbLsbLsLcbLiLsbLcbRebLgbRobRobLibLiRsbRcbLibLobRibLcbLcRsRsmbRcbRc
bLiRsbRgRsmbRsbRhbRoRsmbLibRgbLgbRhbLsbLgbRcbRibLgbRibRsbRibRgbRibLgbR
gbRsbRibLsbLebLgbLcbRjbRcLsbLobLobLcbLsbRobLjbRobRcbRcbLsLgbRobLhbLibL
gbLjbRobRcbRcRsmbRibLhbRjbLjbLcbLebLhbLiLgbRhbLoRsbRgbsbLcbRob

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 36; Drug: PCAP931 1 然 Apo 0.5 然
bRcbRgbLcbLibRgbRobRibLobLgbLiRsbRibRcbRgLsbRiLsbLibRibLobLibLcbRibRcb
RibLgbLcbRoLsLsmbRgbRgbLcbLhbRgbLibLsbRcbRcbRibLhbLibLibRgbLibRgbRjbRo
bRibLsbRibRgbRhLsRsbLsbRibLibLgbLibLgbLgLsLsmbLgLsbLgLsbLgbLgbLsbLgbRs
bLgbRgbLibLsbRgRsmbLibLobRibLhbRhbLibLcbLhbRjbLobLcbLgbRsbRibRibRgbRob
RcbLsbLibRcbRibRsbRgbLobLibRjbLibLiRsbRcbRcbRibLcbRcbLcbRjbRcbLsbRobRi
bRobLsbRibRibRsbRgbLsbRibRibRgbLobLiRsbRjbLiLsbRhbRibRibLcbLcbLcbRgRsm
bLiLoRsRsmbLsbLebRcbRgbRebLcRsbRibRjbLsbLsbRibLjbLcbRhbRibRibLjbLobRjb
LcbRsbRjbLsLsmbRibRoLsbRibRgLsbRsbRibLjbRiLsbRebLsbRjbLhbLsbLiRsLsbLsb
LsbLobLebLobRgbLgbRibLsbRgbLoRsbLsbRjLsLsRoLsmbRhbRhbLsbRhbLiLsbLgbRjb
LcbRibRjbLobRjbRjbLcbLibLhbRibRsbLjbRebLiLsLsmbLjLcbRgRsmbLcbLibRjRsmb
LhbRobLsbLibLsLsmbRgbLgbLibRsbRjbLcbLgbRjbLobRgbLsbRebLsbLcbLibLsbRiLs
bRibLcbLcbLibRsLsbLobLibLgbLibLgbRcbRobRoLsbRsbLobLjLsmbLgLsbRiLsbLgbL
jbLoRsbRibLobLibLcbLsbRibRsbRibRcbRgbLcbLcbRibLjbRjbLibLgbLgbLsbLgbRjR
smbRobRibLgbRibLjbRobRgbLgLsbLcbLjLsmbRebLhRsbRebLgbLobLibRibRcbLobLeb
RibRebLhb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 37; Drug: PCAP931 3 然 Apo 0.5 然
bRsbRgbRsbRsbRgbRgbRgLsbRgbRsbRgbRibRgbLgbRgbRgbRgbLsbRgRsRsmmbRgbLgbL
sbLibLsbRsbLgLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 38; Drug: PCAP931 3 然 Apo 0.5 然
bRcbRobRibRebRobLsbRsbRsbLhbLcbRcbRgbRibRsbRcRsmbLibRobLhbLibRgbRcbLib
LgbRsRiRsmbRgRsRsmmbRiLsbRgbRgRsmbRiRsmbRsbRgbRsbRsLsbRgbRsbRgbRgbRhRs
mbLhRsbRibRobLsbLsbRcRibRibLsbRcbRgbRibRibRcbRhRsmbLjbLcbRcbLibLibLiLs
bLibRobRhbLgbRhbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 39; Drug: PCAP931 3 然 Apo 0.5 然
bRsLsbRibRsbRgbRibLsbLsbRhbLsbRibLsbRgbRgbRibRgbLsbLsLsmbLhbLsbLgbLsbL
sbLgbLsbRcbRhbRibRgbRsRsmbRgbRgbRsbRobRgbLgLsbLsbRsbLsLibLgLsbLgLsLsmb
LgbLsbRsbLobRgbLgbLsbRjRgbRobRgbRibRjbLcbLibLsbLgbLcbLebLhbRgbLcbLjbRo
LsbRhbLibRibLjbLibRebLsbLgbRsLsbRgRsmbRsbRcbLcLsmbLgbLgbLgbLibLibLibLs
bLgbRibLib

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 40; Drug: PCAP931 3 然 Apo 0.5 然
bLibLcbRgbsbLgbLgbLsLsmbLsLsmbLcbLcbLhbLibLgbLgbLgbLsbLcbLgbRgbLibLhbR
obLhbLoRsbRgbLiRsbLsbRibLcbLjbLibRobLibLjbLgbRcbRibLgLsbLobLjLsLsmmbLi
bLgbLgLsbLibLhbRobLsbLjbRsbRsbRsRsmbRgbLsRsbLjbRgbRgRsmbRibRcbLgbLsRsb
LsbLsbRgbRsRsmbRiRsmbRoLsbLibsbRgbLebRibRjRgbLibLsLsmbLsbLsbRgRsmbRobR
ob

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 41; Drug: PCAP931 3 然 Apo 0.5 然
bsbLobRibLcbRibLobRjbLobRiRsmbLobLsbLcbRsbRgbLobLibReRsmbRhbRibLsbRsbL
sbLjbLcbLcbLibLgbRebRobRhbRoRsmbRibRcbLgbRjbRcRsmbRibRobLsbRibRsLsbRib
RhLsbRibLcRsbRsbRcbRcbRibLibRsbRjbRcbRsRsmbRgbRobLibRgbLcLsmbLcbLiLsbL
sbRibRgbRgRsmbRgbRgbLsbLsRsLsbRgbRsLsbRsLsbRsbRgbLcbLcbRibRibLobLoRsbR
ibRgbLcbRjbLibLgbLjbLobRibLobLcbRibRcbRibRobRcbRobLcbRobLibRhLsbRobRib
RobLcbLsbRgbRhbRgbLsbLibLhRsbLibLcbLsbRsbRibLibLsbLcbLcbRsbRebLibLobLi
bLsbRsbRjbRgbRcbLgbRjbLjbRcbRsbRobRebLibRebRobRgbRsbLsbLcbLcbRobRebRib
RobRgbRjbLsbLibRgbRsRsLsmbLsbRsbLcbLcbLobLgbRsbLibLsbLobLibLobRibRebRh
bLsbLsbRsbLsbLcbRibLoLsmbRsLsbRgbLobLsLsmbRjbRsLsbLgbLibRsbRibRobRobLo
bLsbLobLebRgbRjbRsbRgbRobLibLobLcbLgbLibLobLibLcbLgbLobLsbRcbLgbLgbRgb
RgbRgbRobRobRcbRcbRobRobRoRsmbLsbLsbRsbLcbLobRsbRsbRgbLobLobRsbRoRsLsm
bRgbRgbLibLsbLcbLgbRgbRsbRgbRibRgbLsbRsRsmbLobLgbRsbLobRsbLobRgbRgbRgb
RsbRobRibRgLjbRobLsbRibLhbRobLgbLibLibRjbRibRgLsbLiLgbRsbLgbLgbLgbLiLs
LgbLgbLsbLgLsRsLgbLgbLcbRsbLibLhbRibRgbLsbRibRibLobLoRsbReb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 42; Drug: PCAP931 3 然 Apo 0.5 然
bRcbLibRoRsmbRibRcbLibLibLsbLgbLgbLibLgbLgbLgbRibLibLgbLgbLgbRebLsbRcb
RgbLgbLgbLiLsbLsbLcRsbLobLoRsbLcbRsbLsbLebLobRhbRjbLiLsbLibLgbRebRobLi
bRjbLjbLsbLgbLibRobLibLgbRjbLgbRobRibRcbLcbLebLhbLebLhbLsbLibLibRgbRjb
LhbLibRsbRjbRcbRjbRgbLgbRibRgRsmbRgRsmbRsbLgbLsbLsbLsLhbLsbRjbLgbLsbRg
bLgbRsbLsbRsbLsbRgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 43; Drug: PCAP931 10 然 Apo 0.5 然
bLsbRsbRgbRsbLiLsLsmbLsbRsRsmbLgbLsbRsbRsLsbLsRsbLsbLibLgbRsbRsbLgbLsb
LobRibRsRsmbLsbLobRgRsmbRsbRsbLsbLgbLgbLgbLgbLibRsbLsbLsbLibLgbRsbLgbL
ibLibLibRsbLsbLibLgLsbLibLsbLgbRsRsRsLsmmbLhbLibLsbLsLsRsmbLsbLsbRgRgb
LgbRsRsmbLgbRgRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 44; Drug: PCAP931 10 然 Apo 0.5 然
bLibRsbRsbsbLsbsbRsLsbRsbLjbRhbLcRsbLsLsmbLjbRsbRgRsRsmmbsbsbLsbsbsbsb
RsbRsbLsLsmbLsbRsbRsbRsRsmbLsLsmbRsLsbsbRsbRsLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 45; Drug: PCAP931 10 然 Apo 0.5 然
bLibLgbLgbLgbLgLsbRgRsmbRgRsmbRsbLibRsLsLsmbLsbRoRobRsbLiLsbLgbLsLsmbL
ibLgbLsbLcbLsbRebRsbRgbRsRsmbLsRsbsbRsRsmbRsRsRsmmbRsRsRsmmbLsbLsbRsbR
oLsbRsbRsRsLsmbLgLsbLsbRgbLibLsbLsLsmbLgbLsLsmbLgbLgbLgbRsbRgbLcbRsbLg
bLgbLgbLsbLsLsmbLgbLsLsmbRsLsbLsLsLsmmbRsLsbLsbLsbLgRsLsLsmbLgbLgbRsbL
sbLsbLsbLsbLsLsmbLsbLsLsmbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 46; Drug: PCAP931 10 然 Apo 0.5 然
bLsLsLsmmbLsbRsbLgbLcRsbRsbRgbLoRsbLgbRsbLsbLibRgbRgbsbLjLcLsmbRgbLsbR
sbRgbRgbLsbRgRsmbLsbRsbRgbLgbRsbRsRsmbLsbRsbRsbRsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 47; Drug: PCAP931 10 然 Apo 0.5 然
bLibLibLibLsLsmbLcbLiLebLgbLgbRgbLibLobRhbLgbLgbLgbLgbLgLsbLiLsLsmbLgb
LsbLibLibLgRsbLsLsmbLgbLgbLibLgbLgbLgbLobLcbLhbLcbLsbLiLsbLsbLsbRsbRib
RsbRibLibLsbsbLsbLebLcbRsbLibLcbLsbRgbLsbRsbLjbLcbLcbLgbLsRsbLsLsmbLcb
LsLsmbLgLsbLsRsbLiLsLsmbRsbLsbLsbLibRsRsmbLgLsbLsbLgLsbRsbRibLhbLibLgb
LsbRsLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 114701; End: 115201;
Recording: 1-1; Individual: 48; Drug: PCAP931 10 然 Apo 0.5 然
bLgbLsbLsLsmbLsLsmbRsRsmbRsbRsbLjbRjbRsRsLsmbsbsbRsRsmbRsRsmbLcbRgRsmb
RsbRgbRsRsmbLeLsbLgLsbRsbRsbRjRgbLobRibLibLgRsbLgbLsLsmbLiLsLsmbLgbLgL
sbLgbLgbLgbLcbRobRgbLjLsmbLsbLgbLgLsRsbLgbLiLsbLgLgLsbLibLgbLibRsLgLsb
LgRsLsbLjbRjbLsbLcbLebRgLsbLsbLgbLgbLiLsbLgLsbLgLsbLgbRobRobLcbRsbRibL
cbLibRibLcLsmbLobLcbRsbLcbRsbLgbLsbLgbLgbLgbRobRsbRobRgbLsbLibLibRjbLg
bRobLcbRcbLobRhbRobRoLsbRobLcbRsbLjbLibRjRsmbLibLhbRsbLsbLgLsbRsbLcbRi
bLgbLgbLsbLibLibLgbLibLsRsLgLsLiLgLibLgLsbLgLgbLibLgbLgbLgLsbRsbLcbRgb
RibLsbLibLibLsbRsLcRsbRsbRcbRgbLcbLgbRsbLgbLgbLsLsmbLibLgLsbLiLsLgbLgb
LgLsbLiLsbLgLsbRebRcbRob

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 1; Drug: Control Apo 0.5 然
bRibRsbLibRcbLcbLobRebRebLibLsbRsbRgRsmbRsbLibLgRsbRsLsbLgbRsbLibRjb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 2; Drug: Control Apo 0.5 然
bLcbLsbRcbRsbRobRsRsmbRobRhLsbLibLcRsbRgbLobRgbRoLsbRcLsbRibRcLsbLgbLi
bRibRsLsbRcbRobLgbLibLgbLcbRgbLoRsbRsbLhbRsbLcbLgbLcRsbRsbRibLgLsbRcbR
cbLsbRgbRsbLcbRobRhbRsbRgbRiLsbLibLibLgbLibLsbLcbRgbLcbRgbLcbLcRsbLcbL
sLsmbRsbLcLsmbLgLsbLgbLgbLiLsbRjbLgLsbLcbLibLsbLgbRcbRcbRgbRgbRobRobLg
bLobLibRcbLjbRoLsbLsLsmbRibLjbRobRiLsbRobLibLgLsbLgbRjbRjbRiLsbRibRsbL
sLsmbLcLsRsmbRsbLcbRsbLobRjbRibRsbRobLibLiLsbRobLjbLobRgbLsLsmbLgbRjbR
cbRcbLibRcbLibRibRgbRgLsbLjbRoLsbRhLsbLgbRibLibLcbRsbLobLhbRsbRobLgbRc
bRobLhbLgbRobRiLsbLhbLcbRsbLjbLobRibRgbLsbLobRhbRhbRcbRibRiLsbLgbRgLsb
LibLsbRobRcbRibLsbLibLsbRobRobLgbRibRcLsbRiLsbRgbLsbRobRibLgbLsbLgbLsL
smbLibRsbLibLhbRsbLcbLjbLobRgbRobLibRgbRhbLibLgbLgbLhRsbRgbLgbRsbLcbRs
bRgbLjbLobRcbLgbLgbLsbLgbLcbRgbLobRsbLibRsbLgbLsbRhbLjbLjbLcbRgbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 3; Drug: Control Apo 0.5 然
bLcbLibLcbLibLibLcbLcLsmbLgbLibLobLobLgbRcbRobLhbLobRgbLhbLcbLsbLhbLsb
LcbLsbLibLcbLibRhbRobRsbLgbRobRgRsmbLjbLcbLhbLiLsbLsbLibRgbRiRsmbLsbLo
bLibRgbRcbRoLsbRsbLibLsbLcbRsbRgbLibRsbRobLibLsbRobLsbRgbRsbLgbLibLibL
ibLsbRjbLjbRcbLjbLobLebLcbLibLgbLibLgbLobLobRcbRobLsbLebLcbLsbLhbLibLs
bLcbRgbLsbLgLobLgbLsRsLsbLcbLgbLcbLgbLjbLjbLibLoLsmbRsbLhbRjbRobLcbLib
Lgb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 4; Drug: Control Apo 0.5 然
bLebLsLsmbRibRcbRgbRiRsmbRgbRgbRgbRibLcbRgbRibRsbRibRgbRsLobLebLibRibR
sLsbRjbRibLcbLibLcbRhbRcbRsbLgbRoLsbRiRsmbRgbRsLsbLsbRibLobLsbRibLgLsb
RebRibLsbRjLsbRebRhbLeLsbLibRebRhLsbRebRibRhbRgbLsbRcbRsbLibLibRobRhbR
cbRhb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 5; Drug: Control Apo 0.5 然
bRcbRgbLsbLjbLibRjbRcRsmbRhbLsbRcbRcbRibLgbRsbRsRoRsLsmbRcRsmbRgbRcbRg
bLsbLcbLibRibLhbRjbsbLgbRsbLibRsbLcbLjbRgbLoRsbRhbRoLsbLibLcbLcbRibRcR
gbRcbRjbRcbRibRibRgbLgRsbRsbLibRibRcbRhbRibRsbRcbLsbRcbLsbRsLsbLsbRcRs
RsmmbRcLsbRhbLsbRgbRjbRcbRcbRjbRcbLibLcbLeLsbRsLiLcRsbLgbRiRsmbRoRsmbL
sbLobLgbLhbLsbLcbRcbRgbRgbRibRsbRgRsmbRgbRgbRcbRgbLgbRsbLsbLjbRebRcRsm
bRiRsmbRsbLjbLibRgbLibLibLhbLibLsbRcbRsbRibRcbRhbRiRsmbRsbLobLcbLgbLcb
LibLhLsbRjbRcbLgbLoRsLsbLcbLibLgbLgbRhRsRimbRibLsbLcbRsbLibRgbLgRsbLib
LgbRgbRoRsmbRcbRgbLsbRcbLcbLsbRcbRcbRcbRcbLjbRobRgbRsRsRsmmbRsbRcbRibL
gbRgbRgLsRsbRgbLjbLcbLibRebRcbRcbLsbLsbRibRsbRhbRcbRsbLsbLcbLgbLibRsbR
gbLiRsbRcbLsbLjbLibLeRsbLhbRibLgbRsbRebRgRsRsmmbRgbLsbLsRhbRsbRsRsmbRi
bRsbLjbLobLjbLibLibLgbRgRsmbRcRsmbRibRgbRcbRibRiRsmbRsbLgbLgbRcbRcbLgb
LibRibRgbRibRibLjbLcbLibRcbRcbLgbRobRcbRcbLgbLjLsmbLcbRgbRobRebRcbLobR
gbRcbRgbLcbLcbLgbLcRsbRgbLgbLsbRibLibLibLgbLsbLibRebRcbRebRgbRiRsmbLsb
LoRsbLjbLcRsbLsbLibRgRsmbRoRsmbRiLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 6; Drug: Control Apo 0.5 然
bRobRjbRibRobRgbRgbLsbLobRgbRobLoRsRsmbLsbRiLsbLcbRobLibRcbLobRgbRgbRg
bRcbRoLsbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 7; Drug: PCAP931 1 然 Apo 0.5 然
bLjbLjbRibLoRsbLhbLobLobRsbRcbLhbLsbRcbRobRobLsbRobLobLsbRcbLoRsbRgbRs
bLobRgbLgbLjbLjbLibLoRsbLgbLsLobRibRibLcbRobLjbRobRobRebRsbRcbLgbLcbLo
RsbRgbLibLhbLjbRcLsbLsbLibLcbLibLgbRebRebRebLibRsbLcbRibRsbLsRsbRjbLgR
sbRjbRgbRsLsbLsbRgbRibRgbRobLibRgbRgbRhbRjbLoLsmbLhbRgbRibLsbLgbRjbRob
RoRsmbRcLsbRsRsmbRobLibLcbLcbLcbRhbRjbsbLjbRcLsbLsbRhbRsbRobLsRsbRcbRs
bLcbLsbRcbLsbLebRcbRobRoLsbRjbLjbLjbLcbLhbLcbRibRibLsbLjbLhbRsbLjbRcbL
jbRobRcbLibLoRsbRibLsbLhbRgRsmbRgRsmbLjbRobRsbRsRebLoRsbRebLoRsbLhRsbR
gbRebLibLibLobRiLsbRebLhbLsbLcbLjbLsLjbRcbRibRebLobRobRcbRobLcLsmbRcLs
bLcbLobLobRgbLhbLjb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 8; Drug: PCAP931 1 然 Apo 0.5 然
bRsbLgRsbLgbRobLcbRsbLgbLsbLcbLsbLsbRsbLgbLgLsbLgbLibLgbRibLcbLgbLgbRi
RsmbRiRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 9; Drug: PCAP931 1 然 Apo 0.5 然
bLjbLibLjbRoLsbLibLcbRibRibRgbLcRsbLibLibLibLsLsmbRgbLibRsRsLsmbRgbRsb
RsbRsbLsbRsbLgbRgLsbLcbRjbLhbLjbRcbLsbLjbLjbRcb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 10; Drug: PCAP931 1 然 Apo 0.5 然
bLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 11; Drug: PCAP931 1 然 Apo 0.5 然
bLibRibLgLsLsmbLibLgbRebLebRjbRcbRibLcLsmbLgbLgbLgbLsLsmbRsbLgbRsbLgLs
bLgRsbLgLsbLgbRibLibLgbLsbLgLsbLiLsbLgbLibLsbLibLibRgbLibLgbLibLibLiLs
LsmbLgbLibLgbRgRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 12; Drug: PCAP931 1 然 Apo 0.5 然
bLjbLcRsbLibLjLsmbRgbLgbLgbLsbLgRsbLsbLjRsbLsbLsbRgbLcRsbLibLebLsbsbLg
LsbLcRsbLjRsbLsbLgbsbRgRsRsmmbLsbLsbRsbLgbLsbRgbRsbRsbRgbRsRsmbRgRsLsm
b

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 13; Drug: PCAP931 3 然 Apo 0.5 然
bRcLsbLcbRjbRcbRcbRobLobRobLibLobLobLoRsbRcbLibRobRcbRjRsmbLsRjbLoRsbL
obRjbLibRhRsmbLibRsbLcbRobRcbLobRoRsmbRsbLjbLobRibLobLhbLobLgbLsbLibLc
bRjbRobLobRobLibLsbLjbRjbRobLcbLhbRcRsRsmmbLcbRcbLcbLjbLobRobRobLcbRob
LcbRcbRobRcbLcbRobLgLsbRsbRjbLjbRjbLgLsLsmbRsbRjbLibRhbLjbRjbLjbRcbRjb
Lib

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 14; Drug: PCAP931 3 然 Apo 0.5 然
bLcbLebLibLiLsbLgbRhbLibLibLsLsmbLsbLcbLgbLibLibLsLibLgLsbLsbRsbLhLsbR
cbLsbRsbRsbRsbRsbRcbLibRsLsbRsRsmbLsRsbLcLsmbLiLsbLhbLibLgbLsLsmbLgbLi
bLjLsLsmmbLcbLsbLiLsbLgLsbLibLsbLgbLibRsbLcbLjbLiLsRsbLsbLgLsbLgbLsRsL
sbRsbLgbLsbLsLsmbLjLsmbLsbLsLsmbLgbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 15; Drug: PCAP931 3 然 Apo 0.5 然
bLhbRjRsmbRibLhbLhRsbLibRgRsmbLgbLsRsRsmbLcbLsbRcbLibRgbLsRsbRgbLobLgb
LoRsbRgbRcRsmbLhbLsLsmbRcbLjbLobRobLibRsbLsbLgbRcbLjbRibRoRsmbLgbLsbRh
bRcbLcbLcbLcbLibRgbRsbLsbLgLsbRcbLgbLcbLibRsRibRhbLcbLhbRsbLsbLibLcbLg
bLcbRsbRgbRsbRsbLsbLjbLsLsmbLsbRgbRsbRjbLjbRcRsmbLcbRiRsmbLcbRibRibRsb
sbRibRsbRibRsbLcbLsbLobLgbLibRgRsmbRibRsbRgbLjLsmbRjbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 16; Drug: PCAP931 3 然 Apo 0.5 然
bLsbLgLsbRjbRcbsbRgbRsbRgbLcbLgbLcLsmbLibRcbLibRibLgbsbRsbRjbRsRsmbLjb
LcbLcbLobLhbLcbLjbLcbLibLcbRjRgRsmbLibLgbLibRsbLibLjbLcbLibLibLibLjbLg
LcbLibLibRgbLhRsbLjbLhbLcbRgbLgbLiLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 17; Drug: PCAP931 3 然 Apo 0.5 然
bLgbRgbRgbRsbLsLsmbRgbRgbRgbLebLgbLobRsbRgbLsRgbLgLsbRibRhLsbLgbRcLsbR
cbRjbRjbRibRibRibRibRgbRsbRgLsbRsbRgbRjbLgbRibRsRcbRibRgbRsbRsbRsRcbRg
bRgbRgbRgbRgRsmbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 18; Drug: PCAP931 3 然 Apo 0.5 然
bRjbRebLcbRsbLsRsbRsbRcbRobRiLsbLsbRsRsmbRibRibRibRsbRibRcbLsbLgbLjbLo
bLsbRgbLgbRsbRjbLsbLsLsmbLhLsbLsLsmbLsbLsbRiRsmbLgbRjbRsbRjbRcbRoRsmbR
sbRibRibRhb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 19; Drug: PCAP931 10 然 Apo 0.5 然
bRsbRgbRsbRsbLsbLsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 20; Drug: PCAP931 10 然 Apo 0.5 然
bRsRsRsmmbLsRsLsLsLsmmbRsbLsbLsbLsbRsbRsRsRsmmbRsRsRsmmbRsbRsbRsRsRsmm
bRsbsbLsbLsbRsLsbLsLsmbLsbLsbLsLsmbLsbLsLsLsmmbLgbLsLsLsmmbsbLsLsmbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 21; Drug: PCAP931 10 然 Apo 0.5 然
bLoRsbLsbLgLsbRobLsbRcbRgbLgRsbLgbLsRsbLsbLibRibLsRsbLhbRsbLgbsbRsbLeb
LsbRobLcbLsRsbsbLobRobLsLsmbLgbRsRsmbRobRoLsbRsbRjbLiRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 22; Drug: PCAP931 10 然 Apo 0.5 然
bLgbRsbRgbLsbLgbLcbLebLcbLgbLsLgbRibRcbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 23; Drug: PCAP931 10 然 Apo 0.5 然
bLsRsRsmbRsLsbRsbLsLsmbLsbRsbRsbLsbRsbLsbRsRsmbLsbsbLsbLsLsmbRsbLsbRsL
sbLsbRsbRsbRsbRsbRsRsmbRsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 24; Drug: PCAP931 10 然 Apo 0.5 然
b

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 25; Drug: Control Apo 0.5 然
bLcbLgbLebLcbLebRobLebLsbRjbRhbLebRobLgbRcbLobLgbRobRsbRobLgbLebLobRob
LebLebLibRcbLobRgbLibLobRgbRebLcbRobRobLobLcbLobLebRcbLcbRebLobRobRebR
ibLibLobRhbRcbLebRcbRobRebLsbRebLobLcbRobRebLcbRibRcbLobRobRobLebLibLo
bLebLgbLcbLcbRobLobLgbLebRebLebRebRcbLcbLobLebLobLibRsbRsbRobLobLobLeb
RobRcbRhbLebRibRobRobLobRobLebLcbRobLcbRobRobLebLgbLibLibRobRsbLcbRsbL
sbRebRobLcbRobLibLebLhbLsbLobLebLcbLebLgbLcbLobRobRobLhbRobLobLobRobLj
bRebLsbLebRobLobRebRjbLsbLcbLobLcbLgbLebRobLobRobRobLhbLibLobRobLebLgb
LsbRibRebRebRobRebRobLobLsbLgbRobLgbLhbLobRobRobLibRebLibRebLobRobLebR
hbLebRobRcbLobRebLobLcbLebLcbLobRobLobLobRcbRhbRobLcbLcbLcbRebRebLcbLi
bRebRobRobLobLobRcbRibRcbRgbLobLcbRobRobLcbRobLobRcbLgbLobLcbRcbLebLeb
RobLcbLobRobLcbRobRcbLobLebLobRobLgbLcbLebRobLobRobRcbRebLebLobLibRgbR
ebRobLobRebRobLobRobLebLcbRcbRobRebRobRobLobLsbRgbRobLibLebLobRgbRibRe
bRgbLgbRebRobRobLebLebLebLebLcbLibLobRebRobRebRgbLobRobLobRobRhbLcbLob
RobLobLobRebRobRsbLobRobLobRhbLobRgbRibRobLcbRobRobLcbLobLcbRobRebLgbL
ebLebRobLebRobLobRobLcbLcbRobLobRobRobLibRibLobRobLibRebLobLobRebRsbRe
bLobRobRebLebRobRibLebLebRebLobLgbLobRcbRsbRhbRobRobLsbLobRobLsbLcbRgb
RibRobRcbRobLibLebLebLobRebLebLebRsbLobLobLgbLcbLobRobLebLobLcbRobRebL
gbLgbRcbLsbRcbLsbRebLebRobLjbRobRsbRebRobLobLobRcbRobRebLobLobLobLjbLo
bRcbLebRcbRobLebLobLebRjbRibRsbRebRobLobLebRcbRsbLgbRcbRobLobRibLobRob
LobLcbLobRhbLcbLobLcbLebRebRobLobLobRcbRebRcbLibRobLobRibRobLobLobRebR
obLobRcbRebRobLebRebLobLobLobRobRebLobLgbLobLsbRebRobLebLcbRibRsbLobRo
bRsbLebRebLibLobRobRobRgbLobLcbLobLobLcbRcbLebLobLibRebLgbLebRjbRibLgb
LebLobLobRcbRhbRsbLobLcbRobRgbRebLobLebLobRcbLobRebLobRobLcbLobRobRhbR
ebRebLobRcbLgbRgbLcbRobLebRobRcbLobRobLibLebLobLobRebLebRjbRebLibLcbRg
bLebLobRobRobRibLcbRobRobRobLobLobRgbLobLcbLobLebRobRgbRgbLebLcbLhbRcb
LebRobRebLjbLobLobLobLebRsbRobLobRcbRobLobRobLibLcbRcbLobRibRobRcbLsbL
obLebLgbLgbLebRobRgbLebLibLjbRcbRebLobRgbLobLgbLibLcbLobRebLobLobLobRc
bRobRobLibLsbRjbLobLsbRebRebLobLebRobRhbLobRibRebRibLobLobRgbLsbRcbLob
LsbRibLobRebRcbRebRcbLcbRgbRcbLebRsbLoLobLhbRebLobLobLobLobLjbRebRibLg
bRebLobLebRobRebRebLebRcbRobLobLsbRhbLebLobLgbLobRobRebRobRcbRibLsbRcb
RcbRcbRebRebLobRibRobLobLobLcbRsbRobLebLobLebRhbRobRobLobRebLebLebLobR
ebLobLcbLobRobRobLcbRobLhbLobRobRobRebRebRcbLebLobLobRebRebLobLobLobLe
bRobRebLebRebRibRobLebRobLhbLebLobLobRebRobLobLebLibRobLcbLcbRobRcbRcb
RebLebRebRobLobLobRobRgbLebRobRebLgbLgbLobRcbLebLcbRobRobLjbRibLcbLobR
obRebRcbRgbRcbRcbLobRibRebLebRobLibLibLobRebRobLebLebRcbLobRobLobRibRo
bLobLobLjbLcbRobRobLjbLcbLobLebLobRobRebLobLsbLjbRobLjbRobRsbLcbLobLeb
RebLobLgbRsbLjbRobRobRcbLobLjbRebRebLobLobRcbRsbRebRibLobLibRebRobRebL
obLcbRjbLobRobRebLebLebLebLobLjbRsbRebRsbLebRjbRjbRebRobRobLebLebLebRi
bLcbLobLebRebLobLsbLobRjbRsbRobLibRebLebRobRobLsbRebLsbRgbRcbRsbLsbLgb
LobRobLobLobLebRebLibLobRcbRebRcbLobLobLobLobLobLobRcbRebRcbRsbRobLibL
jbLibRcbLjbLobLsbRebLobLobRsbRjbRebRebLsbLobLsbLobRobLjbRsbRobRobRobLe
bRebRsbRebLebRebLebLjbRobRobLebRobLob

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 26; Drug: Control Apo 0.5 然
bLcbLsbLsRsbLsbLibLgbLhbLibLsbLgbRibLsbLsbLibLsbLibLgbLgbLgbLgbLgbLsbL
ibLgbRsbRsRsmbRgbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 27; Drug: Control Apo 0.5 然
bLcRsbLsbsbRgbLcbLcbLcbLhbLiRsbLobRcRsmbLjbLcbLobLcb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 28; Drug: Control Apo 0.5 然
bLsbsbRjbLcbLcbRhbRibLobLsRsbLgRsbLsbLibLibRibLiLsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 29; Drug: Control Apo 0.5 然
bLgbLsbLcbRiLsbRsbLsbRebRsbLgbLgbLibLibLiLsbLibRibLsbLhbLgbRibLsbLgbLi
bLgbLsbLibLibLsLsmbLibLibLsbLiLsbLsbLibLgbLsbLiLsbLsbLiLsbLgbLsbsbsbsb
RsbLibRcbRcbLsbLibLsbRibRgbRsbRhbRgLsbLgRsbRsbRjbRsbRgRsRsmmbRsLsbLgbR
ibRsbLiRsbRcb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 30; Drug: Control Apo 0.5 然
bLgbLebLsbRcbLsbLcbLgLsbLgLsbLcbRsLsbLhbLgbLibLgbLibRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 31; Drug: PCAP931 1 然 Apo 0.5 然
bLibLcbRcbRgbLsbLobLcbLibLsbLjbLibLgbRgbRsbRgbLsbLgbLibLsbRgbLsbLgbLgb
LgbLiRsbLibLhLsbLibRgbLibLsbLsLsmbLiRsbLgbLgbLsbLibLsbLibLsbRsbRsbRsbR
sbRsbLcb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 32; Drug: PCAP931 1 然 Apo 0.5 然
bRhb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 33; Drug: PCAP931 1 然 Apo 0.5 然
bRjRsmbLcbLebRobLibLcbLjLsLhmbRcbRsbRobLgbRobRcbLgbLcbLsbLibRjbRgbLjbR
ebLcbLobLobRobLgbRjRsmbLobRobLibRoLsbLebLibLcbRibLobLgbLgbRjbRibLgbRib
RobRibRgbRgbRcbLobLhLsbRsLsLsLsmmbLobRibLgbLsbLibLibLgLsbLgbRibRoLsbLc
bRsbLobRhbRebLobRibRibLcbRebRcbLobRgbRjRibLgbRoRsRsmmbLibLiLsbLibLibLi
bLsbLoLsmbRibRobRobRcbRobLebRobLcbRibLoRsbLcLcbLcbRobLeLsbLsLsmbLjLiRs
bRobRhbLcbLibLobRgbRsbLoRsbLcbRsbRcbRsbRsbRjbRebRobLibRjRhLsbLsLsmbRgR
smbLsbLcbLibLiRsbRgbLibRjbRobRcbRoLsbRgLsbLgbRoLsbRjbRobRebLgbLjLoLsmb
RjbRobLeLsbLobLjb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 34; Drug: PCAP931 1 然 Apo 0.5 然
bRibLibRibRgbLibRobRgbLobLiLsbRsbLcbRobLobRgbLcbRcbLcbLobLibLibLgbRgbR
gbRsLsbLcbLibLgbLgbRgbLgbLibLgbLsbLgbRibLhb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 35; Drug: PCAP931 1 然 Apo 0.5 然
bLjbLobLhbLjbLhbLiRsbLobLobLcbLsbLibLcbRcbLhbLsRsbRibRsbLsbLcbLibLoRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 36; Drug: PCAP931 1 然 Apo 0.5 然
bLcbRibRoLsbRobLsbLibLcbRcbLibLsbLjRsbRibLobLcbLhbLibRgbLiLsbLiRsbRcbL
cbLgbLibLsbLcbLcbRcbLebLsbRcbLcbLcbLebLhbRibLcbRcbLobLobLibLibLgbLgbLj
bLiRsbLcbRibLobLibLobLibLgbLsLgbLgLsbRcbLebLgbLibLibLibLcbRobLibRibRoL
sRsbRobLobLcbLibLibLjbRibRibRibRobRobRcRsmbRcbRgbRcLsbLobLobLebLoRsbRc
bRjb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 37; Drug: PCAP931 3 然 Apo 0.5 然
bLsLsmbLibRsbLibsbLjbRsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 38; Drug: PCAP931 3 然 Apo 0.5 然
bRoRsmbRjRsmbLibRobRibRsbRgbRoRsmbLobRsbLgLsbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 39; Drug: PCAP931 3 然 Apo 0.5 然
bLgbLsRsbRiLsbLgbRsbRobRibLibLgLsbLsbRibLsbLgbRgbLgLsbRsbLsbRiRsmbLibR
iRsmbLsbRgbRjbRcRsmbRobLgLsbRibLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 40; Drug: PCAP931 3 然 Apo 0.5 然
bLoLgbLgRsbRgRsmbRobLibLcRsbLgLsbLsLsmbLsbLgbLcbLsLsLsmmbLsLsmbsbLsbRo
bRgbRsRsRsmmbsbsbsbLcbRgbLobLibLsRsbLgbLsLsmbRjbLjbLoRsbRsRsmbRsRsmbRs
bRoLsLsmbLgbLsLsmbRoRsmbRsRsmbRsRsLsmbRsbsbsbRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 41; Drug: PCAP931 3 然 Apo 0.5 然
bLjbRobRibLhbLobLcbLebRcbRobRhbLgbRgRsmbRjbLjbLcbLobRgbLsbLcbLcRsRgbRc
bRsbRgbLibLcRsbRobRibLgbLcbLobRjbLobRsbRibRgbLibLcbRebRsbRgbRsbRsbRjbL
cbLcbLcbRjbRobRsbLgbLsbRsbRsbRsbLcbLobLibRjbLobLsbLhbLjbRcLsbRhbLjbLhb
RjbRebRgbRcbLoLsmbLibRgbLcbRibLibRebRobRobLjbLcbLobLsbRcRsmbRcbRibRibR
cbLcbLsbLcbRsbLibLgRsbLsbLgbLsbLsLsRsLsmbLgbLgbLsbLsbLsLsmbLsbLsbLgbLg
bRsbRgbRobLibLsbRsbRcbLsLcbLsbLsbLoLsmbRcbRobLsLsmbLibLcbLobLibRobLobL
jbRobLsbLcbLobRiRsmbRob

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 42; Drug: PCAP931 3 然 Apo 0.5 然
bLsbRgbLgbLsbLsLsmbRsbLsRsbRgLsbLsbRsbRsbRgbRsbRgbRsbRsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 43; Drug: PCAP931 10 然 Apo 0.5 然
bLsRsRsmbRsRsmbRgbRibRsbLibRgbLgbLsbLsLsmbRgbRiRsmbRsbLgLsbLsbLsbRsbLg
LsbLgRsbLhbRgbLibRgbLgbLcLsLsmmbRgbLsbLiLsbLsbLsbLsbLsLsmbRoRsmbLhbLsb
LsbRgbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 44; Drug: PCAP931 10 然 Apo 0.5 然
bRsbsbRsbLsbLsbLsbRsLsbRsbLsLsRsmbsbLgbRsbLsbLsbLsbLgRsbRoRsmbRjRcbRsb
LsbRgRsmbRsbRgRcbRsbLsbLsbLgbLsbLsLsmbLgbLgbRobRsbRhLsbLibLgbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 45; Drug: PCAP931 10 然 Apo 0.5 然
bLsRsLsbRsLsbLsLsmbLsLsmbLsbRsLsLsmbLsLsmbLsLsmbLgLsbLgbLgLsLgbLgbLsbL
sbLsLsmbRsbLsLsLsmmbLsbLsbLsbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 46; Drug: PCAP931 10 然 Apo 0.5 然
bLsbRsbLsbRsbRsRsmbRsLsbLsRsbsbRsbRsbRgbRgRsmbLsbRsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 47; Drug: PCAP931 10 然 Apo 0.5 然
bRsLgbRsbLgbRsLsRsbLgLsbLsbLsLsmbLsbLgLsbLiLsbLgbLgLsbLgLsbLibLsbLibRs
bLsLsmbRcLsbLsbRsLsbLsbLsbLgbRsbLgbLibLobLiLsbLsbLobLebLibLobRgbRsbLsb
LoLsmbLibLjLsmbLobRibRgbRsLsbRjbLcbLsLibLhbRgbRiLsbLgbRsRsmbRibLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115202; End: 115702;
Recording: 2-1; Individual: 48; Drug: PCAP931 10 然 Apo 0.5 然
bRgRsmbRgbRsbRgbRgbRgbRgbRgbRoLsbRoLsbRhRsmbRsbRgLsbLsbRcbLgLsbLgbRobL
hbRgbRgbLcbLcbRjbLcbLgbRjbLcbLgbLeLsLsRiRgmbRobLgbLgbRobLcbRsbRsbRsRib
RjbLhbRcbLsbLhLsbRiRsmbLsbRebRobLcbLibRebLiLsbLgbRgbLcbLjbRgbRgbRgbRgb
RgbLoLsmbLobRobRhbRibRsbRgbRsbRgbRgbRgbRgRsmbRsbRgbLebLhbLobRcbLhRsbLg
bRgbRoLsbLhLsbRgbRiRsmbLjbLcbLibRcbRgbRcLsRsbLcbLibRobLcbLsLsLimbLiLsb
RsLsbLibRsbLiLsLgbRcbLebLibLsbLiRsbLgbLgLsbLgLsRsbLgbLgLsbRebLobLebRsb
LsbRcbLobRibLgbLgbLibRcbRibLcbRcbLibLsbLibLgLsbLgbLgbLgLsbLibLgbLsLsmb
LgbRjbLoLsmbRgbRibRobRoLsbRjbLhbRcbLhbLgLsLiLsbLsLsmbRsbLgLsbLgbLsRsbL
ibLcbRibLsbRsbRiRgbRgRsmbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 1; Drug: Control Apo 0.5 然
bRsbRgbRsbRgbLgbLgbLgRsbLsbRjbLhbLgbLibLibRsbRibLsbRobRibRsbRsbLibRsbR
oLsbLibLibRsbLibLsbLobLibRibLsbLibLibLiRsbLgbRsRsmbLgbLibLibRgbLibLibR
gbLibRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 2; Drug: Control Apo 0.5 然
bLobRgbLibLsbLibLibLsLsmbLibLjbLgbLsbLsbLgbLibLibLgbRsbLobRgbLhbRsbRgL
sbLgbRhLsbRhbLgbRhLsbRgbRibRoLsbLsbLhbRsbLsbLsbRgLsbLsbLibLgbLibRgbRsb
LobRibRsbLsbLibRsbLobLgbLgbRobLibRsLsRsLsbLsLsmbLobRsbLiRsLsRsbLsLsmbR
sbLgbLsLsmbLsbRjbRobRcLsbRibRgbLsbRibLgbLibLibLsLsmbLobLgbRhbLgLsbRobL
iLsbLhbLibLiLsbLiRsbRsLsRsbLsbRsbLibLibLsbLibLsRsLsLsLsmmbRgbLsbRcbRib
RhLsbLsbRobRoLsbLgbRcbLjbLcbLhbRsbRgbLobRsbLhbRsbRsbLsbLcLsmbLcbLgRsbL
sbLsLsmbLsbRibRsRgbLgLsbRobRhLsLsmbRcbLcbLhRsbLoRsbRsbRibLjbRhbLsbLobR
gbLsbRobLobRjbRobRgbLhbLgbLoLsmbRsbRobLgbRcbRibRhLsLsmbLgbLcbRsbLcbRgb
RgbRjbReLebLgbLoRgbLibLobRgbLsbRibRobRibRgbRsbLcbRgbLibLsbRsbRsbLoRsRs
mbRgbRcbRcLsbLibRoLsbRcbRsbRhbRsbRhbLibRobRhbLibRcbLgbRcbLgLsbRcbRhbLs
bLibRsLsbRcbRcbLgbRhbLgbLcbRsbLobLcbRsbRgbLsbLgbRhbRibRobLgRsbLsLsmbLs
bRcbRobLgbLgLsbRsbLibRhbRhbLobLobLibLcbLcbLebLsbLhbLgbLsbLsbRoLsLsmbRc
bLgbRsLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 3; Drug: Control Apo 0.5 然
bLibLsbLcbLiLsbLsbLobsbRobLibLsbLhbLsbLobLsbLcbLsbRebRgbRibRjbRsbLgbLs
bLobLobLcbLibLsbLsbLgbLgbRsbRjbRcbLibLcbLsbLgbLibLsbLobLhbLcbLebLibLib
LcbRcbRsbLibLgbLhbLgRsbLobRsbLhbLhbLiRsbLsbLgbLsbLobRsbLhbLgbLibLgbLsL
gbLhbLibLibLsbLibRobLjbRobLsbLcbLcbLhLsRsbLgbLibLgbLobLcbLgLsbLibLsbLi
LsbLoLsmbLsbLibLibLgbLsbLsbLcbLibLcbLgbRobLibLsbLgbLhbLgbRsbLobLgbLibL
gbRiRsmbLjbLcbLcbLhb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 4; Drug: Control Apo 0.5 然
bRcbRgbLibLibRibLsbRibRibLobRgbRgbRobRsbRgbLsbRibRsbRsbLgbLoRsLsbLebLj
LgLsbLsbRoRsLsmbLibLibLsbRgbLibRsLsbLhbLjbRcbRibRsbRebRobRjRsmbRjbRcbR
cbRcRsmbRhbRgbRgbLsbRhbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 5; Drug: Control Apo 0.5 然
bLcbLcbLsbLcbRsbLhbLibLibRgbLcbLobLibLibLobLgbRsbRobRgbRgbRiLsbRsbLcRs
bRsbLcRsbLsbLibRjbRobRgbLsbRobRhRsmbRcbRsbRcbRibRgbRsbRsbLcbLiRsbLibLg
bRgbLgbLibLgbLoLsmbRhbRsbRobLgbLibLibLgbLsbRsbLgbRjbRcbRgbRgbRibRgbRgb
LgbRgbRcRsmbRiRsmbRiRsmbRsbLibLibRsbRgbRobRibLsRsbRibLsbRsbRoRsmbRgbLc
bLibLsLibLhbLobLjbRcbLibLhLhLsbLibRjbLcbLcbLibLgbRcbRiRsmbRsbRsbLsbRib
RibRibRsbRcbRsLsbRcbRhRsmbRcbRsRsmbRoLsLsmbRjbLgbLibLgbLibRsbLsLsRsmbR
hLsbRibRsbRsLsbLsbRjbLjbLgbRoRsmbRcbRiRsmbLsbLoRsbLiRsbRibRgbRcbLobLoR
sbLjbRibLgbLsbRcbRibRibRcbRsbRebLjbLcRsLsbRjbLibRjbLobLcRsbRibRgbRibRh
RsmbRibRgbRgbRibRibLsRsbRgRsmbLeLsbLibRgbRsRgbLcbLgLsbRibRcbRobRoRsmbR
cLsbRebRgbLgbRsbRibLibLgbLcbLibLcbRibLibRcbRhbRibRhbRcbRcbRcbRcRsmbRib
RibRgLsbLhbLibLcLsmbRiRsmbRsbRebRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 6; Drug: Control Apo 0.5 然
bLjbRcbLsbLcbLibLgbLsbRgbLgbRgbRibRsbRgbLebLgbRsLsbRgbsbRjbLcbLsbLobRj
bLibRsbLsbLcLsmbRibLibRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 7; Drug: PCAP931 1 然 Apo 0.5 然
bLhRsbRhbLsbLcbRobRjbRobRobLsbRjbLibLobLjbRjLsbLjbLjbRcbLcRsbRiRsRsmmb
RgbRcbLobRjbLebRjbLoRsbRcbLsbRcLsbLobLcbRcbRibLsbLcRsbLjbsbRjbLcRsbLsR
sbRobLhbRjbRgbLgbRsbRsbRjbLjLsRsmbRgbRgbLsbLcbRsbLibLsbLcbLibLcbLgbRcL
sbLsbLoRsbRobLgbRgbRibLgbRibLsbLsbRcLsbLcbLjbRcbRhLsbRcbRobRobLgbRjbRc
bLcbRhbRcbLgbLjbRcbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 8; Drug: PCAP931 1 然 Apo 0.5 然
bRibLsbLsLsmbRsbRcbLsbLgLsbLgbRgbLgLsRsLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 9; Drug: PCAP931 1 然 Apo 0.5 然
bRsbRsLsbRibLsbRgbLgbRsbLgLsbLjbRgbLgbRgbRgbLgbRsbLsbRsbLsRiLsbsbLibLs
bLsLsmbLsbRgbLibRsbLsbRebRgbLjb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 10; Drug: PCAP931 1 然 Apo 0.5 然
bRiRsmbRsbLgbRsRsmbLsLsmbLsLsmbLgbLgbLgLsbLsLsmbLsbLsbLsbLgLsbLibRcRsm
bRcbRibRgRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 11; Drug: PCAP931 1 然 Apo 0.5 然
bRgbRsbRgbRibRibLgbRgbRibLibLibLibRobRcbLjbLob

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 12; Drug: PCAP931 1 然 Apo 0.5 然
bRgbRsbRsbLjbLjbsbRgbLjbLsRsLsbRgbRsRsmbRsbRjbLsbRgbRjbRsbLgbLgbLgbRsb
RjbLjLsmbLsLsLsmmbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 13; Drug: PCAP931 3 然 Apo 0.5 然
bRjbLcbRobLcbRobLcbRcbLjLsmbLcbRcbRhLsbLibRjbLhbRibLhbRjbLjbRcbLiLsbRs
bRhbLcLsmbLjbRobLcLsmbRhbRobLobRobLhbLsbLcLsmbLjbLibRobLibLsbRcbLjLsmb
RsRjbLiLsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 14; Drug: PCAP931 3 然 Apo 0.5 然
bLhLsbLsbLcbLibLibLsLsLsmmbRsLsbRsRsmbLgbLsbsbRcbLiLsbLsbLsbLsbLsbLgbR
sbLgbLgbRsbLsbRcbLebRgbRcbLsbRsbRgbRsbRgbLibRhbLjLsmbLibLsbLhLsbLibLoL
smbsbRsbRsbLsLsLsmmbLgbLiLsbLsbLsbLhbLibLiLsbRsbLibLibLibLsbLsbRsbLibL
hbLgbRibRsbLsRsbLeRsRsRcRsmmbRsbRgbRsLsbLsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 15; Drug: PCAP931 3 然 Apo 0.5 然
bRibLcbLcbRsRsmbRiRsmbLibLjbRjbRcbLoLsmbRgbLgbRsRsmbRsbLibLsbLsbLcbRsR
sLsmbRsbLcRsbRsbLobLsbRibRsRsLsmbLsbRjbRibLibRgbLsbLjLsmbLcbRsbRcbRgbR
sRsmbLgbLgbLibLjLsmbsbRjbLjbLibLcbLibRgbLjLsmbRoRsmbRibRcbLibLgbRgbLsb
LhbRsbLsbLobRjLsbLcbLsbRiRsmbLibLgbLjbLsbLoLsmbLibLcLsmbRsRjbRcbLcbLiR
sbLsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 16; Drug: PCAP931 3 然 Apo 0.5 然
bRjbLjbRibLsbRoLsLsmbRgLsbLobLibLsLsmbLhbLibLgbRsLcbLebLcbRgbRgbLgRsLs
bLhbLobLgbRgbLsbLjLgbLsLsmbLsbRsbLiRsbLibLsbLibLibLcLsmbLcbLjbLjbLibLi
bLiLsRsbLibRgbLibLjbLjLibLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 17; Drug: PCAP931 3 然 Apo 0.5 然
bRgbRibRgbRsbLsbRgbRiRsmbRibRsbRsbRibLsbLgbLibLsbLgbLiRsbRibLgbRsRsmbR
gbLcbReRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 18; Drug: PCAP931 3 然 Apo 0.5 然
bLsbRcbRgbRgbRibRsbRsbLsbRibRibRibRgbRsbRgbLsbRgbRjbRcbRsbRgRsmbLsLsmb
LobRobRibRibRgbLsbRibRibLgbRibLgbRibLsbLgbRsLsbRgbRgbRsRgbRgbRcbRhLsbR
sbRgbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 19; Drug: PCAP931 10 然 Apo 0.5 然
bsbsbRjRsmbLsbRsRgbRsRsmbLsRsbLsbRsbRsbRgbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 20; Drug: PCAP931 10 然 Apo 0.5 然
bLsRsRsmbRsLsLsmbLsLsRsLsmbLsbRsRsmbLsRsLsbRsLsbLsLsmbRsLsbRsLsbLsbRsL
sbRsLsRsbLsbLsbLsbLsLsmbLsbLsbLsLsmbLsbLsLsmbLsbRsLsbLsbsbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 21; Drug: PCAP931 10 然 Apo 0.5 然
bRgbRibRcbRjbRcbRibRgbLsbRsbLgbRibLgbsbRobRobRobRjbLobRobRobsbLgbRsRsm
bRcbLobRob

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 22; Drug: PCAP931 10 然 Apo 0.5 然
bRgbLsRsbsbRgbLsbLsbRsbRgbRobLoRsbRibLobLsbLobRibRibRsRsmbRjbRgbLebRcb
RibRhbRjbLsbRgRsmbRsbRsbRibRebRibLibRjbRibLsLsmbRsbRibRibRgRsmbRibRgbR
sLsbRsbRibRgbRobRgbRjbRsbRsbRgbRgbLcbLgbRsbLgbLgbLgLsbLeb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 23; Drug: PCAP931 10 然 Apo 0.5 然
bRsRsmbRsRsmbRsRsmbRsbLsbRsLsbLsLsmbLsbRsbLsbLsbRsLsbRsbLsRsbLsLsmbRsb
RsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 24; Drug: PCAP931 10 然 Apo 0.5 然
bLsbLibLibLhbLoRsbLgbRsbLibLhbRsbLsbLsLsmbRsbRsbRsLsbLsbRgbRibRgLsbLsb
RgbRsbLiLsbLibLgbRgbLsLsmbRcRsmbRsRsmbLjbLobRsLsbRsbLsbsbLsRsLsRsbRsRs
mbRsLsLsmbRsbRsbRsLsbLsbRsbLsbRsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 25; Drug: Control Apo 0.5 然
bLib

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 26; Drug: Control Apo 0.5 然
bRsbRsbLsbLsbRibLjbRgbLsbLgbLgbRsbRsRsmbLibLgbRsRsmbRsRsmbLibLgbLsbLsb
LsbLgbLsbLsbLgbLsbLgbLsbLsbRsbLsbLsbRgbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 27; Drug: Control Apo 0.5 然
bLcbLobRobLgbLsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 28; Drug: Control Apo 0.5 然
bRsRsmbLibRsbRibLgbLgbLibLsbLgbLsRsbLgbRsRsmbLgbLgbLsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 29; Drug: Control Apo 0.5 然
bLibLgbRgbLoLgbLjbLcRsbLgbRcbLjbLibLibRsLsbRibRgLsbRgbRiRsmbRibLhLsbLi
bLsbRgbLjLgbLcbLibLgbLsbLibRsbLsbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 30; Drug: Control Apo 0.5 然
bLiLsbRsbRcLsbLibRibRsbLgbRibLgbRgbLjLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 31; Drug: PCAP931 1 然 Apo 0.5 然
bLgbLgbLgbLsbLsRsbLsbLibRsbLibLsbLsbLgbLgbLibLiRsbRcbLgLsbLsbLhLsLsmbL
hbLobLibRibLebLibLgbLsLsmbLsbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 32; Drug: PCAP931 1 然 Apo 0.5 然
bRsLsbLsRsLsbRsbLsRsbRsLsbLsbRsLsRsbLsLsLsRsLsRsmmbRsRsmbRsLsbLsbLsbRs
RsRsLjmmbLsRsLsbRsbLsRsbLsLsLsRsLsmmbLsbRsbLsbLsbLsLsLsmmbRsLsbLsbLsLs
LsmmbLsbLsLsLsmmbRsLsRsbLsRsRsLsmbRsbLsbLsLsmbLsbRsbLsLsRsLsRsmbLsbLsL
smbLsRsLsbLsRsLsbLsbsbLoLsmbLsLsmbLsLsRsLsmbRsLsbLsbRgbRsbLsbLsbRsLsbL
sbLsRsbLoLsmbLobRsbRsbLsRsbRoLsbLsbLsRsLsbLsbRsRsRsmmbRsbLsLsRsmbRsRsm
bRsRsmbRsLsbRsLsRsbRoRsmbRsbRsLsRsbRsRsLsmbRsRsLsmbRsbLsLsmbLsbRsRsmbL
sbRsbRsbRsbRjbRsLsbRsbRsbLsLsmbRsbLsRebRcbRsbLsRsbLsbLsbLsLsmbLsbLsbRs
bRsbLsbRsbLsbRebRsLsbLsbLsLsmbLobRsbRebRsbLobRsLsbLebRsbLsbLsbRsbRobRs
bRsRsmbLsbLsbLsbLsbRsbRsRsmbLsbRebLeLsbLsRsbLsbRsbLsbRobRobLsRsbRsbRob
LobRsbRsbRsbLsLsmbRsbRsbRebRsbLsbRsbRsRobLsbRsbLsbRobRsbRsRsmbLsbRsbLs
bLobLobLobRobLsbLsbRsLsbRsbRsbRsbRsbLsbRsbRebLebLsbRsLsbRsbLsRsbLsbLsb
LsRsbRsbLsbRsbLobLobRsbLebRobLjbLsbRsbLsbLsRsbRsbLsbRsbRsbRsbLebLsbLsR
sbRobLobRsbLsbLsbLebRsbRjbRsbRsRsmbRsbRsRsmbRsbRobRjbRjbRjbRsbRsbLsbLs
bRjbRsbRsbLsbLsbRsbRebLsbLjbRobRobLsbRebRebRsbLsbLsbRebLjbLobLsbRsRsmb
RsbRjbLsbLobLsbLsbLsbLobRsbLsbRebLsbRobRsbRjbRebLsbLoRsbLsbRjbLsbRsbLj
bLsbRsbLjbRebLobLsbRobLebRobRsbLjbLjbLebLjbLobLjbRobLobRebRebRjbLebLeb
RsbRebLobRsLebRsbLobLebRsbLsbRebRjbRsbRebRsbLobRsbRobLobLcbRebLobRobLs
bRebLcbLebLsbRjbRcbLsbLobLsRsRsmbRsbLsbLsbLobRcbRebRsbRsbRebLebRobRobR
sbLjbRobRibLobLebLsbLjbLebLebLebRcbRobLobRjbLebRebLobRcbLobLsbRobLgbRo
bRebLobRobLebLobRobRebLjbLebLobRobRcbRebRcbLjbLebRebRjbRebLobRhbRjbLob
LobRobLebLobLjbLebLebLsbRcbRcbRobRobRebRebLobRebLobLobLebLobRobRobLobR
obRobRibLebRebLebLsbLobRobLobLibLobRobRcbRjbRsbLobRcbRobLebLcbRebRebRs
bLhbRobRobLobLobRobRibRobRgbRebRobLobRebLobLgbRsbLebRobRobRobLobRobLeb
RsbLobRcbRibLjbRobRsbLobRobRobLebLebLsbRobLobLobRebLsbLobRobLsbLobLobL
sbLobRcbRebRobLobLjbRebRebRobRsbRebRobRcbRgbLsbRobLebLsbRebLebLobLgbLo
bRobLebLobLsbRobLebRgbRcbLobLebLebRobRebLebLsbLebLobRobLcbLibLobRobLib
LobRibLobLjbRobLebRobLhbLobLebLcbLibRobLibRebRibLebLobRobRebRobRobLcbR
sbRobRobRebLebLgbLebRebLibRebLobLsbLsbLobRcbLcbLobLoRebRebLobLjbRobRcb
LibLgbLcbLcbRcbLobLobLobLjbRobRobRobLobLobLobRebLsbRebRcbRcbRebLebRebR
obLcbLsbRebLebRobLobLibRobLcbLsbRsbLebLobRsbLsbRsbLobLebLebRobRobRsbRc
bRibRebRhbLsbLibLobLjbLobRobRebRobRobLobRobLcbLcbRobRebLobLebRibLobLgb
LgbRebRgbRibLcbLobRibRobRobLebRebLebRgbRcbRebRebRobLobRobLobRibLebLsbR
obLjbRebLsbRebRgbLsbRibRobLobLobLebLobLobLobRhbLobLhbLebLibRobRobLobLo
bRcbLebRobLcbRobRobRobRobRobRobRobRcbRcbLebRebLobRibRibRobRobLobLobRob
RebLebLobLobRobRcbRcbRobRobRobRobRcbLobLebLjbRobLcbRgbLobLobRobLobRebL
obRgbRsbRobLgbRsbRobLobRsbRibRobRgbRobRibRsbLgbLebLibLobRgbRebRobRsbRo
bRcbLobRobRibLobRebRebLobRjbRcbRgbLcbRgbLobLobRobRsbLcbLobRobLsbLebReb
LebLibRobRobRobRobRobRgbLgbRcbRebRobLobRobRcbLibRsbRcbLobRgbRcbLobLobL
obLobLebLebLobRcbLobLcbRebLebLjbLsbLobLibLobLobRobRsbLjbRobLibLhbRobLg
bLcbRobRobRobRebLobLcbRsbRsbLobLsbRobLobLobRebRobLcbLobLebLgbRgbLcbRcb
RobRibLebLobLgbRcbLobLobRebLebRebLgbLebLobLsbRobRcbRobLcbLobRobRgbLobL
ibLebLsbRcbRhbLcbLsbRsbRjbRsbRobRobLobRobLcbRjbRcbLobLobRobLcbLobRobRg
bLebRcbRsbLobRibLsbRobRsbLebRebLobRsbRsbLobRobRebLobRsbRhbRobRobLobRob
RobRobRobRsbLobLcbRsbLsbRebRibRjbRsbRobLobRobLobRsbLebLsbLsbLebLebLobL
ebLobLebRebLebLobLsbLebRebRobRebRebRsbRsbRebRibRobRebLgbRcbLobLobRobRo
bLgbRobLobLobLobLobRcbRobRobRobLobRobLobRjbLobRobRobLsbRsbLobRobLobLjb
RsbLobLebLcbLebRibRjbLobLobRebRobLsbLobRgbLibRebLobRebRebLebLebRebLebR
ebLcbLjbLsbLebRebRobLcbLobLcbLobRsbRsbRebLebLibRebLobRebLobLebLobRebLo
bRebRobLcbLebLobLebRobRsbRobLsbLcbLsbLobLebRebRsbLsbRsbLgbLjbLgbRobLob
LobLjbLebLsbRjbLsbRobLobLjbRobLcbRebRobLjbRsbLobRebLebRcbLsbLebRobRjbR
sbRjbRsbRsbLjbRsbLjbLjb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 33; Drug: PCAP931 1 然 Apo 0.5 然
bRcbLobLjLsmbRsLsbLobRcLsbRibRgbRoLsbRobLgLsbLcbRgbRobRsbRobRobRibLsbL
cRsbRgbRobLibRsbRibLebRobLobRsbRjbRobLoRsbRcRsmbLiRsbRgbRsRsmbRgbRsbRg
bRsRgbRhbRcbLcbLsbRobLhbLsbLibRgbLjLsmbLsRjbRcbLcbLsbRobLcbLobLoRsbRgb
RgbRibLsbLsRgbRgbRgbRgbRsbRgbRgbRgbRobRcbRobRobLobLsbRobLcbLsLsmbLibRs
LsbLsbRjbRsRibRgbLsbRobRobRobRibRhbLcbRsbRibRibRoLsbRcbRobLhbLsLsmbLgb
RibRgbRobRobRgLsbRoRgbRsbLgbRebLobRobLibRgbLoRsbRcbLgbLgRsbRebLsLcbRcb
RgbRobLhbRsbRcbLjbLibRgRsmbLiLsbLgbLibRgbLobLsbRiLsbLgLsbLibLsbLibRobL
obRgRsmbRoLsLsmbLcbRsbRibRobRibRobLgbRibLcbRgbRjbRibRsbRgbRoLsbLoRsbLc
LsmbLhbRobRobLgbLebLgbRgbLeRsRsmbRobLgbRoLsbLgLsbLcbRgbRsbRgbLoRsRsmbR
gbLoRsbLibRsbRsbRjbRgbLcbLcRsRsmbRoLsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 34; Drug: PCAP931 1 然 Apo 0.5 然
bRibLibRsbLgbLibRibLibLgbRibLiRsLsbRgbLibLsbRebRibLcbRcRsRsmmbRibLhbLg
bLibLibLsbRgbLibRibRiRsmbRebRebLhbRibLebLebRcbRibLobLibLgbRob

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 35; Drug: PCAP931 1 然 Apo 0.5 然
bLibRjbLjbRjRsmbRibRsbLjLsRsmbRiRsmbRjbLcbRibRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 36; Drug: PCAP931 1 然 Apo 0.5 然
bLcbRibRgbLgbRobLcbLcbLhbLsbLobRcLsbLobRibLiLsbLobLibRibLcbRobLjbRcbLj
bLhbLgbRgbRibLgbLsbLcbRibLibRjbLcRsbLsbRobRoLsbLjbLsbRibLibRgbLcbRgbRi
b

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 37; Drug: PCAP931 3 然 Apo 0.5 然
bLgbsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 38; Drug: PCAP931 3 然 Apo 0.5 然
bLibRobRsbRsRsmbRcRsmbRibRobRibLibLibRsRsmbLsLsLsmmbRsbRebRgbRhbRiRibL
sbRgbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 39; Drug: PCAP931 3 然 Apo 0.5 然
bRibRibLgLsbLsbLgbLgbRgbLsbRgbLgbLgbLsbRgbLsbLsbRcbLgbLsbRsbLhbLgbRgbR
ibRsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 40; Drug: PCAP931 3 然 Apo 0.5 然
bRoRsRsmmbsbLibLobRsRsmbRcbRgRsmbRsbRgRsmbRsRsmbRibRoRsmbRsbLsbLsbLcbs
bLgbLsbLjbRobRgbRibLebLcbRjbRgbRsbLoRsbsbRsRsRsmmbsbRsbLob

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 41; Drug: PCAP931 3 然 Apo 0.5 然
bRcbRsbRjbRcbRibLibLibLsbLobRjbRobRibLgbRiRsmbRoLsbLgbRsbRcbLgbLgLsbRi
bLsbLobRjbLcbLibLsbLcbRcbRibLgbRgRsmbRgbLjbRibRhbRgbRobRibRgbRsbLsbLsb
RibRoLsbLgbLibRsbRcLsbRgbRgLsRsbRgLsbRgLsLsmbRgbRgbRobLsbLobRobRgbLgbL
gbLibLsbLsbLsbLsLgRsbLgbLgbLsbLgLsbLsLsmbLgbLobRgbRsbLsbRjbLebRobLcbRo
bRgRsmbLcbLcbRsbRsbLhRsbLgbRibLibLcbLobLjbLibLjLgLsbLobLgbLobLgbLgRsbR
sbRobRcbLoRsbLcbRjRsmbLsbLibRoLsbRgbLebLsbRsbLjbRcbRgbLcbLsbLcbLibRsbR
sbRsbLobRibLjbLibLsbLsbLgLsLgbLsbLsRsbLgbLobRgbRjbLoRsbLobLiLsbLgbRcbL
obLcbLsbLobRjbLgbRsbRgbRibRcbLsbLgbRsbRsbLsbRjbLcbLsbRcbLoRsbLobRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 42; Drug: PCAP931 3 然 Apo 0.5 然
bLjLsmbLsbLsbRsbRsbLgbRgbRsRsmbRsbRgbLsbRgbLsbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 43; Drug: PCAP931 10 然 Apo 0.5 然
bLebLiLsbLoLsmbRsbRsRsmbLsbRcbRcbLobLsbLebRcRsmbLsRsbRibLibLsbLibLsbLg
LsLsmbLibLibLibLcbLgbLobLsbLcbLsRsbLibLsbLsbLibLjbLobLcbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 44; Drug: PCAP931 10 然 Apo 0.5 然
bLobLibLcbRcbRibRibRobLgbRobLcbRgbLobLobRobRobLgbRcbLgbRobLoRsbRiRsmbL
obLobLhbLobRcbRcbLibRobLgbRcbRibRibRsLsbRiRsmbRgbRgRsLsmbRiRgRiRgbRgRs
RsRimmbRobLiRsbLobLoRsbRcLsbLgbLibRcbRcLsbRjbLobRcbRsbRsRsmbRgbLsbRgbR
gbLobLhRsbLobRoRsmbRgbRobLibRobLibRhbLgLsbLobRiRsmbRsbLcbRjbRobRgbRhbR
sbLoRsbRibRjbLcRsbLgbRoLsbLibRoLsbLgbRoLsbLibRoLsLsmbRsbRoLsbLgbRibLsb
RibRiLsRsbRiRsRsmmbRsbRoRsmbLcRsbLsRsbRgRsmbLebLobRgbLobRhbRobLebLoRsb
LjbLcbLobRcRsmbLsbLiLsbLcbRgbLibLiRsbRibLibLgLsbRsbLibLsbLgLsbLiLiLgbL
gLsbLgLsLsmbLsbLoRsRgbRgRsmbRobRsbLgbRjbRobRobRcLsbRoLsbRcbRcbRgbRsbRg
bLobLsbLsbLgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 45; Drug: PCAP931 10 然 Apo 0.5 然
bLgbLsbLsbLsLsmbLsLsmbLgbRsRsmbLsLsmbLsRsbLsbLsLsmbLsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 46; Drug: PCAP931 10 然 Apo 0.5 然
bRsbRsLsbRsRsLsmbRgLsLsmbLsbRgbRgbRsRsmbRsbRsRsmbLsbLiLsLsmbLibRgLsbRs
bRsRsmbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 47; Drug: PCAP931 10 然 Apo 0.5 然
bLibRibRsbRgbRsbRibRgbRibRgbRgbRsLsbRgLsbRgbRsbRgLsRsbLsbRibRgbLsbRibR
sbLibLsbLibLsbLgbLgLsLsmbLgbLgbLsbRsbLsbLhbLibRgbLsRsbLibRsbLgbRsbLjbL
ibLgbLibRsbRcRsmbLgLsbRiLsbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 115704; End: 120204;
Recording: 3-1; Individual: 48; Drug: PCAP931 10 然 Apo 0.5 然
bLgbLcbRcRsmbRoLsbRcbLiLsbLgbLgbLiLsLsLgLsmbLsbLgLsbLgbLgbLgbLgbLgbLsL
gbLgbLibRjbRjbLjLsmbLibLsLsmbLcbLcbLgbRhRsmbRcbRsbLibRsbLcbRobRiLsbLib
LcRsRsmbLgbRobRgRsmbRgbLgbRgbLobRcbLcRsbRobLoRsbRgbRjbLhbLsbLsbLgbLgbL
gbRjbLobRgbRgbRsbLobLcbRobLibRcbLcbRsLsbLsLsmbRsbLgbLibLiRsbRsbRsbRcbL
jbRcbLjbRoLsbRobLobRibRjbLibRsRsmbLsbLgbLibRjbLibLsLsmbLgbLiLsbLsbLgLs
bLgbLgbLgLsLsmbLsbLgbLgLsbLsRsbRjbLibLsbRobLobLobLobRgbRjbLibRsRsmbLob
RcbLibRhbRgbRibLgbRgbRsbRsLcbLibRibLhbRsbLgbLgbRsbLhbLsbLgbRoLjbLjbLiR
sbLsRsbLibRsbLiRsRsmbLiLsbLibLobLib

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 1; Drug: Control Apo 0.5 然
bRsbRsbRibLgbLibLsbLsbLcbRhbLgbRgbRsbLjbRjRsmbRibRgbRgbRsbLcbLibLiLsbR
gbLsbRgbLsbLobRgbRibRibRsbLjbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 2; Drug: Control Apo 0.5 然
bsbLgbRcbLibLsbLjbLsbRsbLgbLsbLsLsmbLgbLiRsbLsbLhbLsbLibLsLsmbRgbLsbLh
bRsbRcbLcbLobRgbLhbRsbLibRgbLcbLibLibRhbRsbRobRgbRhbRobRibRsbLobLjbRcL
sbRgbRjbRibLhbLobLcbRibRobLibLibRoLsbRsbLibRsbRibRsRibRobRcbLgbLsbLsbL
hbLsbLibLsbRsbLgbLsbRgLsbLsbLgbLibLsbRgbRobRgbRgbRgLsbRsbRgLsbRcbLibLg
bRcbLiRsbLjbLjbRjbRobRobLjbRibLgbLgbLsbRjbLhbRsbLcbRsbLcbRgbRobLgbLcbL
sLsmbRgbLibRgbLcbLibRgbRsbRsbLob

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 3; Drug: Control Apo 0.5 然
bRjbLibRsbLjbLjbLsbLoLsmbLibLibLibLobLsbLcbLibLibLgbLsbLgbLgLsbLgLsbLs
bLgLsbLsbLgbRcbRgbLsbLcbRsRsmbLibLgbLibLsbLgbLgbLibLibLibRsbLobLgbLibR
sbRibLhbLibLoRsbRsbLobRsbLobRsbLgbLibLhbRsbRgbRgbLcbLhRsbRsbRcbLsbLcLs
mbLsbLiRsbLsbLobRsbLcbRgRsmbRibRcbRebRgbLiLsbLsbLsbLcbLobLgbLsbLgbRhbL
sRsbRobLsbRibLibLsbRobLgbRcbLibRcbLibLcbRgbLoLsmbLibLsbRgLsbLibLibRsbL
gbLiRsbRgbLgbLgbLgbRsbRgbRebRoLsbLsbRibLsRsbLcbLibRiLsbLibLibRsbLcbLhb
RsbLgbLiLsbLgbRgbLhbRgLsbLoLsmbRsbLhbLgbLgbRjbLgbLibRsbLgLsbLsLgLsbLgb
LsbLgbLcLsmbRibLibRsbLsbLibRsbLiLsbLibRgbLoRsbRibRsbRsbLgbLibRsbLgbLib
RsRsmbLgbRsbLiLsbLgbLgbLhbLgbLgbRgbRgbLsbRgLsbLobRjbRsRhbRobRibLsbLcbL
gbLibLgbLibLsLsmbLgbLgbLgbRsbRsbLibRjbLcLsLsmmbLcbRgbLsbLsbLgbLibLgRsb
LsbRjbRjbRhbLsbLcbLgbLiRsbRsbRsbLibLgbLibLgbLgbLgbRsbLsbLiLsbLjbLibLgb
LibLgbLgbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 4; Drug: Control Apo 0.5 然
bRhRsmbRjbRcbRhLsbRsbRgbRhbRibRgbLibLcbsbRcbRgbRsbRgbRibRcRsmbRjbLcbRg
bLjbLibRjbLiLsbRcbLibRcb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 5; Drug: Control Apo 0.5 然
bLgLsRsLsbLgbRjRjbRjbLjbRcbRibRgbRsbRhbRsRoRsmbRibRsbRgbLsbLcbLibRcRsm
bRjbLhbLgbLgbLgbLsbLjbLhbRcbRcbLibLcbLibRcbRibLsbRibRgRsRsmmbRcRsmbRib
RcbRcbRebRgbRibRgbRiLsbRhbRcbRcbRcbRibRibRgbRcbRobRgbLibLibRoRsmbRibRi
bRsbRhbRiRsmbRsbRhbRibLcbLgbLsbRoRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 6; Drug: Control Apo 0.5 然
bLibLsbRcbLhbRhbLibRgRsmbRgbLgbRibLgbRgRsmbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 7; Drug: PCAP931 1 然 Apo 0.5 然
bRibLgbRobLsbLsbRibLsbRibRibLebRcLsbLjLsmbRobRobRcbRcLsbLsbLcbRsbRcbLi
bRjbLcbRjbRibLjbLcRsbRgRsmbRibLsbRibRgbLhbRsRsmbRiLsbRibRibRoLsbLgbRhb
LibRsbLgbRebLibLsbLsbLjbLhLsbLjbLhbRibRsbRgbRobRhRsmbLjbRjbRobRoLsbRgb
RibRsbRgbRsbLsLsmbRgbLsbRoLsbRcbRsbLgbRgbLjbLobLcbRjb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 8; Drug: PCAP931 1 然 Apo 0.5 然
bRjbLsLsmbLsbLhbRsRsmbLgbRjbRgRsmbLsbLsbRsRsRsmmbRgbRsbLcbLhbLsbLsbRib
RhbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 9; Drug: PCAP931 1 然 Apo 0.5 然
bLcbRjbRsbRibLgLsbRsbLsbRcbLgbRgbLgbLsbRsbRgbRsbRsbRcbLsbLibLhLsbRsbLg
bRsbLgbRsRsmbLsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 10; Drug: PCAP931 1 然 Apo 0.5 然
bLgbLsLsLsmmbRgbRgbLsbLgbRjLsbRsbRgbRsbRgbRebRsbLiLsbRsbLgbsbLibRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 11; Drug: PCAP931 1 然 Apo 0.5 然
bLibLsbLgbLibLsbLibLgbLsbLebLebLibLgbLsLsmbLgbRgbLibLgbLsbLgbLgbLgbLgb
LgbLsbLgbLsLsmbLibLgLsbLibLgbRibRgbRsbRibLsbLibLgbLsbLgbLgbRsbLibRgbLg
LsbLgbLsLsLsmmbLgbLgLsbLsbLgbLgLsbLobRgbRsbLibLiLsbLgbLgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 12; Drug: PCAP931 1 然 Apo 0.5 然
bRjbRsbRsbRgbLsbRgbRsLsbRjbRsbRjbLgbLjLsmbLgbRgbRsbLgLsbLsbLgLsLsmbLsb
LsRsbLsbLgbLgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 13; Drug: PCAP931 3 然 Apo 0.5 然
bLibRhbLibRiLsbLhbRobRcbRobRcbLibRcbLjLsmbRibLibRcbLjbRcbLobRibLibRibR
gRsmbLiRsbRgbRcbLjbLeLsbRobLib

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 14; Drug: PCAP931 3 然 Apo 0.5 然
bLjbLhbLobRsbRsLsbLgbLibsbLiLsbLcLsmbRcbLsbLcbLgbLcbLibLsLibLibLcbLiLs
bLibRsbLibLsLsmbRsLsbRsbLsbLebLibLsbRsbLjLsmbLsbLgbLibLgbLcbsbLsbRsRsm
bLgbLsLsmbRsbLibLsbRoLsbLcbLsbLiLsbRsRsmbRsRsmbsbLibLsbLsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 15; Drug: PCAP931 3 然 Apo 0.5 然
bRibLiLsbRjbRibLsLjLsmbLsbLhLsbLsbRibRgbLibLsRsbRoRsmbRiRsmbRgbLcbRjbR
sRsmbLibLibLsbRjbLcbLiLsbRjbRoLsbRibRibLgbRsbRgLsbRgRgRsmbRsbRgbRsRsmb
RsLsbRgbRsbRsbRgbRsRsmbRsRcbRibRcbLjbLibLgbLjLsmbRibLjLsLsLsmmmbRibLib
RgbRgbLjbLsLsmbLsbLsbLgbLcbRsbLsbLsbLgLsbLoLsmbRgbLcbLgbLjb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 16; Drug: PCAP931 3 然 Apo 0.5 然
bLibLibLibLgbLibRsbLgLsbsbRgbLgbLjbLhbRobLhbLibLibRgbLgbLibLsbRsbLgbRs
RsmbLgbRgbRsbLsbRsbRsRsRsmmbRgbRobLgbRsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 17; Drug: PCAP931 3 然 Apo 0.5 然
bsbRgRjbRgbRsbRsbRgbLgbLsLsLsmmbRjRsmbRsbRsbLcRsbLgbRgLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 18; Drug: PCAP931 3 然 Apo 0.5 然
bRgbLsRsbLgbLsbRgRsmbRgbRsbLsbRgbRjbRjRsmbRgbRibRibRgbRibRsbRsRsmbRgbR
gbRsbLiLsbLsbRgbLsLsLsmmbRjbLgbRibRsbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 19; Drug: PCAP931 10 然 Apo 0.5 然
bRsRsmbRsRsmbRsbRsbRsbRgRsmbRsRsmbRsbRsRsLsmbLsbRsRsmbRsRsRsmmbRsbRsbR
sRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 20; Drug: PCAP931 10 然 Apo 0.5 然
bsbLsbRsbLsLsmbLsbRsRsmbsbRsRsmbLsRsbRsbRsRsmbLsbRsRsmbsbRsRsmbRsRsRsm
mbLsLsLsmmbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 21; Drug: PCAP931 10 然 Apo 0.5 然
bLgLsbLcLsmbRjbRhbRibLsbLgRsbRsbRgRsmbRobLgbLsbLobRgbRibRsLsbRgbRibRsb
RgbLhLsbRsbLjbLgbRebLcLsmbRgbRebRcbLsbLgbLgbRsbRsbLgbRgbLsbRhb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 22; Drug: PCAP931 10 然 Apo 0.5 然
bLgbLsLsmbLobRcbRsbLcLsmbLcbLobRebLibRoRsmbLgbRgRsmbRjbRobLjbLgbLsbLhb
RsbRebLcbLgLsbRobLibRjbLjbRibLsbLobLjbRsRsmbLsbRcbRsRsmbLgbRsbLgbRibRi
bLsbLgbLjbRibRsbRibRgRsmbLjbLgbRibRiRsmbRibLgbRibLsbLgbLsbLibLsbLibLgb
LgbLsbRcRsmbRoLsbLgbRgLsRsbLsbLgbRhbLjbRjbRgLsbRsbRcbLgLsbLgbRsbRgbRiR
gRgbRgbRgLsbLcbLsLsLsLsRsmmmbsbLgbRsbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 23; Drug: PCAP931 10 然 Apo 0.5 然
bLsRsbRsRsmbLsbLsbLsbLsbRsRsmbLsLsmbLsbRsbRsRsmbRsRsmbLsbLsLsmbRgbLsbR
sRsmbRsRsLsmbLsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 24; Drug: PCAP931 10 然 Apo 0.5 然
bLeLsbLgbLsbLcLsmbRgRsRsmmbRgRsmbRsbRgRsmbRsLsRsbRsRsmbRgRsRsmmbLibRsb
LgbLgbRsbLgbLsRsbRsbLsbLibRsbLebRsbLhLsLsLsmmbRgLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 25; Drug: Control Apo 0.5 然
bRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 26; Drug: Control Apo 0.5 然
bLsLsmbLgbLsbLsLsmbLibRgbLsbLsbLhbLgbLsbRsbLsbLsbLcbRibLibLsbRsRsmbRsb
LsbLsbLgbLsbLgbLsbRgbLsbLgbLjLgbLsbLgLsbLsbRgbLibLibLgbRgbRsbLjLsmbRsb
RgbRgbLebRgbRsRsmbRjbRibRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 27; Drug: Control Apo 0.5 然
bRsbLgbsbLsbLobRibRsbRgbRgbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 28; Drug: Control Apo 0.5 然
bLcbRcbRebLsLgLsbLgLgLgbRoLsRsbLoRsbLibLhbLibRsbRsLsbRsRsmbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 29; Drug: Control Apo 0.5 然
bLjLsmbRgbRsbLcbLgbLobRobRgbRgbRcbRsbRibRgbRgbLgbLsbLhbLhRsbLsbRhbLsbL
sbLibLsbLsbRobRhbRhbLibLgbRibRgbRiLsRsbRhbRgbRsLsbLsbRgbRibRhbLsbRsbRs
bRgbRsbLiLsbRgbRiRsmbRjRgbRsbRebRgbRsRsmbLsbLibRsbLsbRsLobRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 30; Drug: Control Apo 0.5 然
bLjLsLsmmbLsLsmbLsbLcLsmbRhbLsbLsRsbLsLsmbRsLsbLsbLcbLiLsbLibLsbLsbLgb
LibLsbLibLibLgbLgbLibRsbRsbRsbLsLsmbLsbRgbsbLhLsbLcbRsbRsbLsbRsLhLsbLg
bLgbsbLgbLjLsmbLsbRsbLcbLiRsbLsbRgbLcbLgLsbLibLsbRsbLsLibLcbLibLgbLsbL
gbLibLibRsbRsbLgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 31; Drug: PCAP931 1 然 Apo 0.5 然
bLgbLsbLsbLsbLibLgbLsbRsRsmbRgbLgbLsbLsbLibLibLgbLsbLsbLgbLiRsbLsbLgLs
bLsbRsbRsbLsbLgbLoLsmbLsLsmbLsbLsbLibLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 32; Drug: PCAP931 1 然 Apo 0.5 然
bRiRsmbLobRsbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 33; Drug: PCAP931 1 然 Apo 0.5 然
bRoLsbLcbLcbRsbLgbLsbLgbLibRsLsbLibRsbRsbLgLsbRoRsmbLgbRsbRiLsLgbLcbRg
bLgbRobLcbRobLcbLjbRhbLsbRcbRobRsLoRsbRobLgbLoRsbRibRobLhbRsbRgbRibRsb
LobLibRobLcbRcbLgbRgbLebLibRsbRgbLgbLibRsbLiLsLsRsmbLgbLibRsbLgbLibLsb
RsbLgbLsbLgbLibRsbRgbLsbLgbRebRsRcLsbLobRobLcbRsbRobLibRgbRobRoLsbLgbL
hbRsRsmbRobLibRcbRobRoLsbLibLibLobLcLibRjbRgbLebRobLjbRobLgbRgbLobRibL
gbLgbLgbLcbRgbRjbRcbRsbRcbLibRgRsmbRsbRcbLsLsRsmbLobRsLsbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 34; Drug: PCAP931 1 然 Apo 0.5 然
bLebRcbLhbRhbLhbRcLsbRhbRsbRebLcbRibRcbLhbLibLsbRgbRhbRsbLgRsbLgbLobLc
bLhbLgbLebLibLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 35; Drug: PCAP931 1 然 Apo 0.5 然
bLgbLsbLgbRjRsmbLcbRjbRjRsmbRjbLjbRgbRsbLibRibRsbLjbLiLsRsbRhbLsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 36; Drug: PCAP931 1 然 Apo 0.5 然
bLjbRcbLgbRobRcbRibRcLsbLgbRgLsbLsbLgLsLsmbLgbLsbLeRsbRgbLsbLgbLibRibL
ibLsbLobLibLibRgbLgbLibLgbLjbRhbLjbLibRobRibLgbRibLgbRiLsbRjb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 37; Drug: PCAP931 3 然 Apo 0.5 然
bLgbLgbLgbLsLsRsLsmbLsLsmbRsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 38; Drug: PCAP931 3 然 Apo 0.5 然
bRcbRsbRibRgbRibRsbRgbRsbRsbLgLsbRsbRjbLsLsmbRsbRsbRsbLibLgbRsbRobRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 39; Drug: PCAP931 3 然 Apo 0.5 然
bRgbLgbRiLsbLsLsmbLgbRgbLiLsbRibRgbLjbRibRebRibRobRcbRcbLibLcLsmbLhbRs
bLgbRsbLibLgbRgbLgbRibRcbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 40; Drug: PCAP931 3 然 Apo 0.5 然
bRoLsbRsRsmbRiLsbRsbRsRsmbRsbRsRsmbRgRsmbLcbsbRhbRsbRsRsRsmmbRsbRcLsbR
sRsmbRgbRcLgbLgLsbLsLsLsmmbLsbLgbRibRoRsmbLibLgLsbRebsbRobRsRsmbsbLgbL
gbLsbLsbLjLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 41; Drug: PCAP931 3 然 Apo 0.5 然
bRgbRgbRgbRsbRsbRibRhbRgbLsbLgbRgbLcbRjbRgbLebLcbRgRsmbRjbLhbLoRsbRgbL
obRgbRibRgbRgLsbLgbLgbRsbLcbLcbRgbRebLibLcbRgbRibLcbRibRjbLjbReRsmbRgb
RgbLgbLcbRhbRebRgbRoLsbRgbRobRhbRibLobLibLhbRgbLgLsbLibRcbRgbRjbLebRjb
LobLjbLsbRibRsbLjbRsRjbLibLsbRsbLsbLsbLsbRgbLgbRhbRjbLobRgbRhbLiRsbRcb
LcLsmbRsbRjbLgbLobRsbLobLebLcbRjbRgbRebLibLsbLcbsbLgbLobRgbRgRsmbRebLs
bLobRibRiRsmbRebRcbLjbLgRsbRebLibRibRibLcRsbLibLobRcbRjRsmbRcbLhbLiRsb
LcbLsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 42; Drug: PCAP931 3 然 Apo 0.5 然
bLsLsmbLsLsLsmmbRsRsLsmbLsLsmbLgbLsbLobLobLobLsbLgbLgbLsbLgbLsbLsLsmbL
gbLgRsbLsbLgbLsLsmbLsLsmbRsLsbRsbLsLsmbLgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 43; Drug: PCAP931 10 然 Apo 0.5 然
bLebLcbRgbsbsbLgLsbLcbLibLibRibRiLsbLgbRcbRibRsbLhbRsbLibLcbLhbRobRsbL
ibLhLsbLgbRoLsbLsbRsbLiRsLsbLcLsmbRgbRsLsRsbLibLgbLcbLebLhbRibRgRsmbLs
bRibLiRsbLcbLcLsmbLcbRsbRiRsmbLgbRebLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 44; Drug: PCAP931 10 然 Apo 0.5 然
bLgbRsbLsbLgbLsbRiLsbRsbLibLobLhbRobLobLobLobLsLsmbRsbRsbLsbLsbRsLsLsm
bLsbsbLsbLsLsmbLsbLsLsmbLoRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 45; Drug: PCAP931 10 然 Apo 0.5 然
bLsLsmbRsLsLsLsmmbLgbLsLsRsmbLsLsLsmmbLsbsbLsbLsLsmbLgbLsLsmbLsbLgbRsb
LsLsmbLgLsLsmbLsbLsbLsbLsLsmbLsbLsRsbLsbLsLsLsLsmmmb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 46; Drug: PCAP931 10 然 Apo 0.5 然
bLsbLsbsbRsRsRsLsmmbRgbLsbRsRsmbLiRsbRgbRgbRoLjb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 47; Drug: PCAP931 10 然 Apo 0.5 然
bRsbLiLsbLhbLsbLiLsbRsRsmbLoRsbLgbRibLgbLjbRibRsRsmbLsLsmbLsbLjbLgbRob
LgbRgbLsbRgbRsbLsbRsbRgbRsbRsRgbRibRgLsbRgbLsbLsRiRsmbLsbRgbRgbRsbsbsb
RgbLsbRsLsbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 120205; End: 120705;
Recording: 4-1; Individual: 48; Drug: PCAP931 10 然 Apo 0.5 然
bLibRgbRgbRgbRoLsbLcbRhbLibLibRobLcbLcbRobLobRobRjbLhbRobRobLcbLhbLoLs
LsmmbRgbRgbLgbRjbRsbLjLsmbRjbLhbLsbLiLsbLsbRsbLgLsLgbLgbLcbLobLhLsbLib
RcbRobLiRsbRsbLgLsbRjbRcbRobRgbLgbLebLjLsmbRsRibRibLoLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 1; Drug: Control Apo 0.5 然
bLgLsbLgbLoLsmbLgbLsbLsRsbRgbLoLsmbRibRibsbsbLibRgbRsbLgbRsbRgbLgbLsbL
sbLgbLjb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 2; Drug: Control Apo 0.5 然
bLcbLsbRgbLsbLgbRgbLobRsbLsLsmbLsbLsbLgbLgbLsbLcbRsbLiLsbRsbRibRcLsbRj
RsmbRsbLsRsbLsbRgbLobLcbLgbLsbRsbLoRsbRsbLibRsRibLsbRsRcbRcbLiLsbRgbRi
bRcbLjbRobLibLibLsbLhbLsbRjLsbLgbLcbRsbLibLsbLsbRobRhLsbLsbLsbRobLcLsm
bLobRgLsbLgbLsbLsbLoRsbRhbRgLsbRsbRhbRgbLobRgbLsbLcbRgbRobRobRgbRsbRgb
LobLgbLobRsbRibLsbLgbLgbLhbRsbRgLsbRcbRjbRhbLibRibLsbRobLjbRcbLhbLobRh
bLjbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 3; Drug: Control Apo 0.5 然
bLcbRjbLgbLebRobLjbLcbLobLibRsbLgLsbLcbLobLibLibLsbRcbRobLibRsLsbLsbLi
LsbLibLsbLibLibRsbLibLsbRsbLibLibRsbRgbLsLsmbLibLsLsmbLobLsbRgbLsbRsbL
sbLjbLhbRgbLibLibsbLcbLibLsbRibLgbLobLsbLcbLibLibLjbLobLsLsmbLobRsbLcb
LibLsLsmbLobLcbLgbRobLhb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 4; Drug: Control Apo 0.5 然
bLhbLibLibRcbRibLibLcbLibRiRsmbRhbRhbsbRibRhb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 5; Drug: Control Apo 0.5 然
bRibRgRsmbRcbLibRhbRibRhbLjbLgbRjbLcbLibRcLsbRgbRsLsbLjLsmbRebRcRsmbRg
RsmbRibRiRsmbRgbRsbRcRsmbRhbRgbRsbsbRibRgbRsbRgRsmbRcbRcbRgbRhbLsbRjbR
gRsmbRcbRcbRgbRgRgbLgLsbRgRsmbRgbLgbRsbLjbRjbLibLgbLsbRgbRsbLcbLgbLsbR
gbLgbLibRgbLibLibLibRcbRsbLobRgbRibRjbRibRsbLobRsbRebRjbRcbRgbRcbRhbRo
bRcbRcb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 6; Drug: Control Apo 0.5 然
bRobRsbLobRoRsmbLebRsbRgbRibRcbRsbLobRsLsRsbLgbRiLsbLcRsbRsbRibLsbLibL
sRsbRsRsmbRibRgbRhLsbRobRobRsbLoLsmbRgbRibRgRsmbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 7; Drug: PCAP931 1 然 Apo 0.5 然
bLjbRobLsbLhbLsbLgbRcbLcbRibLgbRsbLjbLcbRhbRibLjbLcbLsbRsbLsbRjb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 8; Drug: PCAP931 1 然 Apo 0.5 然
bRgbRsbRgbRsbLsbRgbRsbRibRgbRgbRsLsbRibLsRsbsbLsLsLsLsLsLsmmmmmbRsbRoR
smbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 9; Drug: PCAP931 1 然 Apo 0.5 然
bRgbRgbLibLobLhbLibLibLibRsbRsbRgbRibLhbRsRgbLgbLgbRgbRsbLgbLgbRsLsbLs
bRoLsRsbLobLgLsRsbLsbLsbLsbLsbLgbRsRsmbLsbRsbLgRsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 10; Drug: PCAP931 1 然 Apo 0.5 然
bLibLibLob

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 11; Drug: PCAP931 1 然 Apo 0.5 然
bLibLibLgbLibLgbRgLgLsbLgbReRibRhbRibRibRgbLgbLgbRgbRibLsbRibLobRgbLib
RsRibLibRjbRibLjbRibLsbLgbLibLgbLhbLhbRibLibLibLsbLebLibLiLsbLgLsbLebR
ibLibRcbRcbLebLibRgbLibRgbLgbRoLsLsmbRibLibLgbLibLgbRgLsbLibRgRsmbLibL
ibLgbRsbLgbLibRoLsbRcb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 12; Drug: PCAP931 1 然 Apo 0.5 然
bLgbLgbLgbLsbLgbsbLgRsbLsbLgbRsbRsbRibRsbLsbLsbRsbRsRsmbLgbRsLsbsbLgbR
sLsbRsbRsbRgbLgbLsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 13; Drug: PCAP931 3 然 Apo 0.5 然
bRobRjbLobRcbLgbRibLcbRjbLjbLcbLobLoLsmbLjbRjbLhbRgbRsbLsbLcbsbRibLcbR
sbLibLsLsmbLsbLebLhbLsbRjRsmbLibRgRsmbRsbLjbLsLjbRobLibRobLhbLcbRjbLjb
RjbLcb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 14; Drug: PCAP931 3 然 Apo 0.5 然
bLgbLiLsbLcRsbLcbRsbLibRsbRsRsmbRsRsmbRsbRgRsmbLjLibRibLjbRhbLgbLsbLhb
LsbRgbRiRsmbLsbRsbRsbReLsbRcbRgbLiLsbRsRsmbLgbLgLsLsmbLsbsbLibLibLcLsm
bRsbLsbsbRsbRsbRhbLjbRsbRsbRgRsmbRsbRibRgbRobRsbLsbLsRsRsmbLsbLsbLjLsm
bsbsbRsbLgLsbRsbRsbRsbLobLibLiRsbLcb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 15; Drug: PCAP931 3 然 Apo 0.5 然
bRcbRsbLcbRjbRjRsmbRcbLjbLcbLiRsbLsbRsbLsbRsbLibLsbLibLiRsbLibLsbLjbLg
LsbRjbRibLhbRjbLgbLibLgbLsbLgbLobLjbLsbLsbLibLsbLsbRsbLsbLcbLsLsmbLsbR
cbLebRcRsmbRgRsmbRsbLjbRibRsbLcLsmbRsbRibRsbLsLsmbLsbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 16; Drug: PCAP931 3 然 Apo 0.5 然
bLibLsbLibRsbLgbLcbRibLibLibRjbRobLibLebLhbLcbRibLibRsLgbLgbLibLgbRgbL
ibLsbLsbRgbLgbRgbRsbLibRgbLsbRsRsmbLgbRsbRsbRjRsmbRgbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 17; Drug: PCAP931 3 然 Apo 0.5 然
bLobRibRsRsmbRgbLsbRsbRsbRcbRibRsbRjbRsRsmbRgbLgbRgbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 18; Drug: PCAP931 3 然 Apo 0.5 然
bRcbRsbRgbLsbRgbLsbRibRsbRsbRsbRibRgbRgbRibRgLsbRsbRsbLgbRsRsmbLsbLgbR
gbRgbRsbLsLsmbLgbLgbRgbRcbLobLsLsmbLgbLob

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 19; Drug: PCAP931 10 然 Apo 0.5 然
bRsRsmbRsbRsRsmbRsbRsbRgbRsRsmbRsbRsbRsbRsbRsbRiRsmbLsbLsbLgbRibRsLsRs
bRibRsbLsbRsbRibRiRsmbRsbRsbRsbsbRgRsmbRsbRsbRsRsmbLsbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 20; Drug: PCAP931 10 然 Apo 0.5 然
bRsLsRsLsbsbRsRsmbRsRsmbLsRsbLsbRsRsmbLsLsmbRsRsmbLsLsmbLsbRsLsLsmbsbR
sLsRsbLsLsmbLsbLsbLsRsRsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 21; Drug: PCAP931 10 然 Apo 0.5 然
bLibLobLsLsmbLcbLgbRsbLgbRcLsbRjbLcbRsRsmbRsbLjbLcRsbLhLsbLsbLgbLsbRgR
smbRsbLsRsbRsbRsLibRibLsbLgbsbLsLsmbsbLgbRsLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 22; Drug: PCAP931 10 然 Apo 0.5 然
bRhbLebRjbRjbRgRsmbLobRgbLgbLsbLcRgbRcbRibRgbRsbRgbRsbRgbRgbRsRsmbRgbR
sbRsRsmbLgbLcbRgbRsRgbRgbLibRsbLcbLobLjbRsRsmbRgbLibLsbRgbLsbLsbLibLcb
RjbRibRgbRsbLgbLiRsbRgbRgbLibLibRjbRhLsbRibLcbRsbLjbRsbRgbRgRsmbLsbRgL
sbLsbRibRebLsLsmbLcb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 23; Drug: PCAP931 10 然 Apo 0.5 然
bRsLsbRsbLsRsRsmbLsLsmbLsRsbLsbRsLsbLsbRsbRsRsmbRsbRsbRsbRsbRsRsmbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 24; Drug: PCAP931 10 然 Apo 0.5 然
bRsbLiLsLsmbsbLsbLsRsbLgbRibLsbLjbLsbRhRsRsRsmmmbLsLsmbLjbLeLsbLsbRsbR
jbLiLcbLiLsbRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 25; Drug: Control Apo 0.5 然
bRsRsRsmmbRiRsmbLobLoLsmbLibLib

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 26; Drug: Control Apo 0.5 然
bLibRgbRsbRsbLsbLsbRjbRsbRsbLgbRebRibLsbRhbRgbRsbLsbLsbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 27; Drug: Control Apo 0.5 然
bLibRgbLsbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 28; Drug: Control Apo 0.5 然
bsbRibLjbLgbRsLib

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 29; Drug: Control Apo 0.5 然
bLjbRcbRhLsbLsbLsbLsbLsLsmbLcbRcbRsRsmbLsRhbRgbLsbLgbRobLgbRiLsbRobLjb
LcRsbLsbLobRsRsmbLgbRsbLsbRcbLibRhbRhbLsbLibLgbLgbRgbLsbRcLsbLsLsmbRcb
RibLsbLsbRgbLgbRsbRhbLcbRibLsbRcbLgLsbLgbLibLgRsbLibLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 30; Drug: Control Apo 0.5 然
bRcbLcLsmbLibLgbLsLsmbLibRjbRsbRjRsmbLibLgbRgbLgbRibRsbLjLsLsmmbRsbRjb
LobLcbLibLibLgRsbLsLsmbLgbLjbLcbLeb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 31; Drug: PCAP931 1 然 Apo 0.5 然
bLsbLsbLsbLgbLsbLsbLeb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 32; Drug: PCAP931 1 然 Apo 0.5 然
bsbsbLsbsbsbsbsbsbRsbsbLsbLsLsmbRsbLsbLsbRsLsbLsbLsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 33; Drug: PCAP931 1 然 Apo 0.5 然
bRobRcbRobRsbRjRcbLcbLibLsLjbLoLsmbRibLibRjbLgbRcbLgbRibLgbRsbRobLibLi
bLsbLiLsbRsbLibLgbLgbLsbLgbLsbLgbLgbLgbLgbLibRsbLsLgLsbLsRsbLiLsbLsbLg
LsbLibLgbRsRsmbLgbLsbLgbRsbRsbLgbLsbLsRsbLibRsbLgbRsbLibLsbLgbRsbLibLg
bLsbLgLsbLsLhbLcbLgbLsbRibRcbRobLgRsbLgbRgbLsbRjbRiRsmbLsbLhbRibLobLsb
RobLcbRobRobRobLcLsmbRsbLgbRcbRsbLcbLsbRhbRobRobRgbLcbLibLobLjLibLibRs
bRcbRcLsbLhRsbLgbLibLibRobRibLsLobRibRobLcbLobRibLsbRobLobRsbRibRobRcb
RobRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 34; Drug: PCAP931 1 然 Apo 0.5 然
bLsbLhbLcbLibRcbRgbLsLsmbLsbLibLibLibRcbLibsbRgbLgbRobRhbLibLsbRibLib

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 35; Drug: PCAP931 1 然 Apo 0.5 然
bRgbRibLcbLjbRjbRsbRjbLgbLjbLobLjbLgbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 36; Drug: PCAP931 1 然 Apo 0.5 然
bLiLsbRgbRibLcbLgbLgbLiLsLsmbLibLsLgbLjb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 37; Drug: PCAP931 3 然 Apo 0.5 然
bLgLsbRgRsRsmmb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 38; Drug: PCAP931 3 然 Apo 0.5 然
bRibRibReRsmbRgbRobRsbRobRcbRibRcRsmbRibRibRsbRibRobRsbRobRibRcbRgbLsb
RibRgRsmbRiRsmbRsRsmbRibRobRsbRibRcbRsbRibRcbRibLgbRsbRcbRcbLsLsLsmmbL
sbRoRsmbRsbRibRsbRsbRsbRgbRcbRibRib

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 39; Drug: PCAP931 3 然 Apo 0.5 然
bRsbRjRsmbRhbRgRsmbLibRoRsmbLgbRsbRgRsLsmbLgbLgbLgbLibLgbLgbLsbLgbLgbL
gbRsbLsbRgbLsbLsbRsRsmbLsLsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 40; Drug: PCAP931 3 然 Apo 0.5 然
bLiRsbRsRsmbRobRsRsRsRsmmmbRoRsmbLgRsbsbsbRobsbRsbRsRgRsmbRobRsbsbLsbR
oLsbLsbsbLsbLobLsbRsbRgbRsRsmbRoLsbRjRsmbRobsbsbLibRsRsmbRsRsmbRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 41; Drug: PCAP931 3 然 Apo 0.5 然
bLoLsmbRhbRibLebLgbRcbLibRibLsbLsbLgbLgbLsbLgbRjbLibLgbRsbRjbLcbRsRhbR
sRsmbRgbRebLoLsmbLobLibLcbRsbRhbRsbRebLibRebLobRcbRobLibRsbRsbRhbLibRj
bLsbLgbLsbLsbRjbLjbLcbRobLobRobRobRobRgRobRibRgbRgLgbLibLibLoRsbLcbRgb
LibRsbRgbRibLsbRibRgbRsbRgRsRsmmbRgbLebLgbRsbRebLebRsbLibLgLsbLgLsbLsb
LgbLgbRsbLiLsbLsRsbLsbLgbLgbLgbLsbLoRsbRgbRibLibLcbLsbsbLgbRebLcbRgbRs
RsmbLibRsbRhbLjbLibLsbLsRsbLgbLobLobRjbLcbLsbRsbLgLsbLobLsbRhRsmbLgbRg
RsmbRgbRgbLsbLjbRcbRcbLobRobLgbLcbRgbLsbRcbLjbLhbRgbLibRjbLobRebLobRhb
RjbRcbRibRebLsbLsbRgRsmbRsRsmbRsbRsbsbRgbRsbRoLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 42; Drug: PCAP931 3 然 Apo 0.5 然
bLsLsmbRgbLsbRsbLsbLsbRgbRsbRgbRsRsmbLsLsmbRsbRsLsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 43; Drug: PCAP931 10 然 Apo 0.5 然
bLiLsbRsbLebLebLoLsmbLsbRsbLibLobLibLcbLiLsbLgLsbRobRgbRjRsRsmmbRebLib
RgbRgbLcLsmbLibLebLobRgbRgbRoRsmbLgLsbLobLgbLgRsbRgbLsLsRsmbRebRsbLcLs
mbRsRgbLsbRsbLgRsbLcbLgbLobRsbLsbRibLeb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 44; Drug: PCAP931 10 然 Apo 0.5 然
bRsbRsbsbRsbRibLgbRsbsbRsbsbRsbRsbsbRsbRibRsbRhbLcbLhbRhRsRhmbLgbRobRi
bLgbLcbLgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 45; Drug: PCAP931 10 然 Apo 0.5 然
bLsbLsbLsbLsbLsLsmbLsbLsLsmbLsLsLsmmbLsbRsRsmbRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 46; Drug: PCAP931 10 然 Apo 0.5 然
b

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 47; Drug: PCAP931 10 然 Apo 0.5 然
bRgbRsbRsbRsbRgbRsRsmbRcbLiLsbLgbRsRobRsbLgbLsbRgbLsbRsbRgbLiRsbLobLcb
LobRibLobRgbLhRsbLsLsmbRgbRsbLsLsmbRgbLsbLjb

>ZF Recording 2016-06-01; tW: 300s; Start: 120707; End: 121207;
Recording: 5-1; Individual: 48; Drug: PCAP931 10 然 Apo 0.5 然
bRobRobRhRsmbLcLsmbRsbRgbRibLibRhbLibRgbRsbRsbRibRsRsmbRgbRgbRgbRsbLeb
LgbLgbLoRgbRgbRsbLsbLibLgbLibRsbLgbLgbRgbLgbLoRsLsRsRgbLsbLhbLsbLobRob
LgbLibLsbRgbRsbLcbLobLobRiRsmbLcbRgbLsbLobRobRgbLsbRgbRgbRsbRiLsbLgbLj
LsmbRibLjLsmbRjbRibLjbRgbLjbRcbLjbLobRibRsbRjbLsbRhbLibRsLsbLsRsbRobRi
bLoLsmbLsbLsbLgbLjbLhbRsbLsRsRsmbLgbLgbLgbLsbLsbLcbLcbRcRsLsmbLgbRsbLi
LsbLjLjb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 1; Drug: Control Apo 0.5 然
bLsbLgbLibLhbLgbRsbLsbsbRsLsbRibRibRgbRibRsbRibLsbLgbRibLcbLsbRgbLcbRc
bLobLoLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 2; Drug: Control Apo 0.5 然
bRcbRiLsbRsbRcbRebLobLhbRgbRgbLgbLgbRobRcbLgbLsbRibLsbLobRsbLhbRibRgbL
gbLjbRsbRobLjbRoLsbRsbRcbLsLsmbLcbRobRgbRgbRsLsbRsRsmbLsRgbRibRiLsbLhb
RibLjbRgbRiLsbLsbRobRgbLsLsmbLsLsmbLcbRgbLhbRsbLibLsLsmbLsbLjbRsbRsbLs
bLgRsbRgLsbLcbRgbLcbRgbLibRsbRgRsmbRoLsbLibRsbLjbLcbRgbLcbRsbRsRsmbLsb
LcbLsbLibRsbRsbLsbLcbLjbRsbLhbLsbRibLgbLibRjbLjLsmbLibRsbLobLsbRgbLsbL
sbRgbLebRjbRobRsbRobLgbRsbLhbRsbRobLibLjbRsRoLsbRgbRsbLibLsbLhbRgbLobR
gbLiLsbLgbRsbRcbRsbRsbRobRgbRsbLsbLcbRgbRcbRibRgbLgLsbRsRsmbRgbRiLsbRg
bRibLibRcbLgbRobRgbRibLsbLiRsbRgbRiLsRsbLibRcbRcbRgbRsbRgbRibLsbRgbRgb
RiLsbLsbRobRsbRibLobRgbRsbLhbRsbRsLsbLjbLcLsmbLcbRsbLcbLobRsbLibLibRsb
RoLsbLgbLsbLsRsbRobRgLsbLibLibLgLsbLgbLgLsbLgRsLsbLsbLcbRsLsbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 3; Drug: Control Apo 0.5 然
bLsbRgbLobLibLsbRjRsmbLjLsmbLibLsbRobLsbLjbLjLsmbLibRsbLobLibLgbLjbLib
LsbLcbLibLsbLgbLgbLjbLebLibLsLsmbLhRsbRsbRobLgbLsLsmbLgbLibRsLsbLobLib
LgbLibLibLebLsbLcbLibLgbLgbLjbLcLsmbLgbLhbLibLsLsmbLsbLcbLgbLibLsLsmbR
gbLjbLibRsRsmbLobRsbRsRsmbRsbLibLhLcbLsbLsbLjLsmbLgbLsLsLsmmbLsbLgbLsR
sbsbLibLsbLgbLsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 4; Drug: Control Apo 0.5 然
bRgbRibRcbLcbLjbRjbReRibRjbRobLsbLsbRobRsLsbRibRcbLobRebRibRibRob

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 5; Drug: Control Apo 0.5 然
bLhbLjbLobLgbLsbLgbLsbLibRsbLibLhbRgbRjbLoLsLsmmbLgbRjbRsbLibRsbLjbLgb
LiLsbLibRcbRoLsbLjbLcbLibRibRsRsmbLhbsbRsbLiLsbLcbLcbLsbRebRgRsRsmmbRs
bRcbRoLsbLsbRsbLibRsbRsLsbLgRsbLsbLcbRsRsmbLcbLibLjbRjbRgbRgRsmbRgbRgb
RsbLgbRebRobRsbRcbRjbRhbLsbRcbLsbRsbRebRhbLsbRcRsRsmmbRsbRcbLgbLjbRebR
jbRjbRgbRsbRibLgbRjbLobRibLgbLobLibRgbLoRsbRgbLobRgbLsbLcbRsbLobLobLgb
LibRibRibRsbLcbLobRhbLsbLgbRjbLjbRebRsbLibRgbRibLsbRibLgbRsbRhbRsbLsbL
ebRcbRcLsbRsbRgbRsbLsbRcbLgbLgLsbRibRibRsbRoRsmbRibRibRhbRcbRgbRibLiLs
bLibRsbLhbRobRibLsLsLsmmbRgRsmbLjbLobRibLsLjLsmbLibRsRsmbRsbLsbRjbLjbL
sbLibRsLibRcbRcbRibRib

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 6; Drug: Control Apo 0.5 然
bRhbRcbRsbRibLiRsbRcbLjbRcbRsbLhbRgbLjbLsbRobRsbRjbRcRsmbLebRcbLsbRcbR
ibRgbLgLsbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 7; Drug: PCAP931 1 然 Apo 0.5 然
bRobLobRgbRibLjbLhbRibLgbRiLsbLibRsbRsRsmbRjbRobLibLcbLcbRsbLjbLsbLoRs
LsbRgbLhbLibRibLcbRgbRhbRsbRsbLibLibRsbRgbLobRsbLcLsmbLgbLgbLsbLgLsbRh
bRgbRibRobLcRsbRsbRibLgbRcbRcbLcLsmbRhbLgbRibRgbLsbLobLobRsRsmbLjRsbLs
bLobRgbRgbRcbLibLsbRcbLgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 8; Drug: PCAP931 1 然 Apo 0.5 然
bRsbRgbRgbRcLsbLsLsRsmbLgbRcRsmbRgbLsbRsRsmbRgRsmbRsbRsbRgbLcbLcRsbRsb
LgbRgbRgbLcbRsbRiRsmbLjLsmbRgbRibLjbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 9; Drug: PCAP931 1 然 Apo 0.5 然
bLgbLibRhbRibLibLjLsmbLsbRsbRsbRoRsmbRsRsmbLiLsbLsbLibLsbLsbRibLsbRgbL
gbRibLsbLibsbLgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 10; Drug: PCAP931 1 然 Apo 0.5 然
bLgbLgbLsLsRsmbLsLsmbLsbLibRgbLgbLgbRsbLgLsbRsbRgRsmbRibRgbRgbRgbRgLsb
RsbRsbRgbRsbLsbRgRsRsmmbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 11; Drug: PCAP931 1 然 Apo 0.5 然
bRgbLibLiLsbLsbRsbRibLsbLebLibLsbLibLibRgbLgbLsbLsbRgbLsbLgbLibLgLsbLs
bLgbLibLgLsbLgbLgbLsbLgbLgbRsbRsbLgbLsbLgbRsbLgbRsbLgbRsbLgbLcbRcbLcLs
mbLibLibLibRgbLgbLgbLgbLsbLgbLgbLsLsmbRgRsLsmbLsbRgbRsbLsRsbRsRsmbRibL
gb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 12; Drug: PCAP931 1 然 Apo 0.5 然
bLgbLsbLsbRsbRgbLcLsmbLgbLibLjbRsbRsRsmbRsRsRsmmbRsbRsbRsRsmbRsbLjbLib
RsRsLsmbLgbLsbLsbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 13; Drug: PCAP931 3 然 Apo 0.5 然
bRcbLibLjLsmbRcbRhbLcbRsbRcbLgbLhbRcbLobLsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 14; Drug: PCAP931 3 然 Apo 0.5 然
bLsbLcRsbRsbLcbLgbLibLgbLibRsbRgbLsLsmbLgbLsbLibLsbLsbLjbLhbsbLibLiLsb
LibLsbRsbRsbLcbLsRsLsbLgbLcbLsbLjbLhLsbLsbLsbLhRsbLgbLobLgbLsbLhLsRsbR
sbLiRsbLsbLiLsbLhRsbLsbLjbLhLsbLsbLhRsLsbLsbLgbLjLsLsmmbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 15; Drug: PCAP931 3 然 Apo 0.5 然
bRsbsbsbLjbRgbsbRgbRgbLibsbRhLsbLsRsRsmbLibLsbLjbRsbRgbLsbRibRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 16; Drug: PCAP931 3 然 Apo 0.5 然
bRgbLibLjbRgbRgbRsRsmbLoLsLsmmbLcLsmbRsbLgRsbLgbRgbLibLgbLcbLibRgbRgbR
gbLsbLibRsbRgbLsbLibRgbLobLgbLsLibRsbLhbRgbLibRsbRgbLsLcbRgbLcbLcLsmbL
ibRibLibLcbLcbLibLgbLiLsbRjRsmbRibRibRsbLob

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 17; Drug: PCAP931 3 然 Apo 0.5 然
bRsLsRsbLgbLgbLobRcbLsbRgRsmbLibRsbLibLibLobRibLibRsbLsLsLiRsmbRiLsbRs
bLgbLsRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 18; Drug: PCAP931 3 然 Apo 0.5 然
bLgbLgRsbLobRsRsmbRgbRgbLsbLsbLsbRgbLibRiLsbLsbRibRsbRgbRibRgbRsbRgbRs
RsmbRsbRsbRsRsmbRsRsRsLsmmbsbRcbRsbRsbLsbRsbLsLsRsmbRiLsbLsbRgLsbsbsbR
ibLsbRsbRgbRsbRgLsbRsRsmbRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 19; Drug: PCAP931 10 然 Apo 0.5 然
bRgbRibRsRsmbRsbRgRsmbRsRsmbRsbLsbLsbsbRgbRsbRsRsmbRhbLsbLsbRsbRibRgbR
gbRsbRsRsmbRiRsRsmmbRsRsRsmmbLsbRgbRsbRsbsbRsRsmbRsbRgbRsRsmbRsbRsRsRs
mmbRsbRgbRgRsmbRsbRgbRsLsbRgRsmbRgbRsbRsbRsbRgRsmbRsRsmbRsRsRsmmbRsbsb
sbRgbRsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 20; Drug: PCAP931 10 然 Apo 0.5 然
bLsLsmbLsLsLsRsmmbLgRsbLsbLsbLsbLsbLsbLsbLsLsmbLsbLsbLsRsbLsbLsbLsRsbs
bLsbLsbLsbLsbLsRsbLsbLsLsRsmbLsbLsbsbLsLsmbLsbLsbLsbLsbLsLsmbLsLsmbLsb
LsbLsbLsbLsLsmbLsbLsbLsLsmbLsbLsbLsbLsbLsbLsLsRsmbLsbLsRsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 21; Drug: PCAP931 10 然 Apo 0.5 然
bLsbLsbLsbLsbLsRsbRsbRcbsbRsbLsbRsLsbRsRsmbRobRgbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 22; Drug: PCAP931 10 然 Apo 0.5 然
bRsbLsLsmbsbRsRsRsmmbLsbLibLsbRsbLsbLsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 23; Drug: PCAP931 10 然 Apo 0.5 然
bRsRsmbLsbRsLsbRsRsmbRsbLsbRsbLsbRsRsmbRsRsmbRsbRsRsmbRsbRsRsmbRsbRsbL
sbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 24; Drug: PCAP931 10 然 Apo 0.5 然
bRsRsmbLsLsmbRgRsmbLsbRiRsmbLsbLsbLgbLsbRsbLibLcbLsbLsbLsbLgbRgRsRsmmb
LsbLiLsLsmbLsLsmbRsRsmbLiLsbLgLsbLhLsbRsRsmbLibLsLsLsLsmmmb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 25; Drug: Control Apo 0.5 然
bRgRsmbLibLjb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 26; Drug: Control Apo 0.5 然
bLgbRsbRsRsmbRsbRsbLsRsbLsRsbLsbRsbRjbReb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 27; Drug: Control Apo 0.5 然
bLibLsbRsbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 28; Drug: Control Apo 0.5 然
bRsLsbLibLibRsLsbRsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 29; Drug: Control Apo 0.5 然
bLgbLsbLsbLgbLiLsLsmbLsbLsbLgbLsbLsLsmbLibRsbRsbRgbRgbLgbLcbLsRsbLgbRg
LsbLgbRsbRcbLibLcbLsbLhLsbRsbRsbLsbLibLsbLsbLgbLsbLcbRsbLsbRsbRgbRhbLc
bRjRsmbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 30; Drug: Control Apo 0.5 然
bLcRsbLgbRsbsbLibRcbRsbRibRgLsbLgbLcbRjbRsbLsbLsbLcbRebLgbRsLsbLsLsmbL
iLsLsRsmbLgbLiLsbLgbLgbLhbsbsbsbRsLsbLsRsbRsbLgbLgbLgbLgRsbRsbLgbRebLi
bLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 31; Drug: PCAP931 1 然 Apo 0.5 然
bRsbLgbLjLsmbLgbRsRsmbLsbLsbLsbLsbLgbLibLsbLgbLcbLjbLibRcbLgbRjLsbLsbL
sbLoLsLsmmbLsbRcLsbRhLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 32; Drug: PCAP931 1 然 Apo 0.5 然
bLgbRsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 33; Drug: PCAP931 1 然 Apo 0.5 然
bRobRibRibLgbLsLsLimbRsbRobLsRgbRgbRsbRobLibLgbLsbLgbRgbRibRiRsmbRsbRs
RsmbRgRsmbRgbRsbRgLsbRgRsLsmbRgbRgbLcbRjbRibRibRoRsmbLibLsbRsbRcbRobLs
bLcbRsbRobLibLsbLsRoLsbLhbLibRibRoRsmbRobRobLsbLoRsbRgbLgbRgRsmbRsbRsb
RgbRsRsmbLobRjbRobLgLsbRibRibLsRsbRgRgbLgbRibRgbRgbRgbLsRgbLsbRiRsmbLg
bRibLsbLcbLcbRgbRcbRcbLgbLibLibLsLsmbLibLsbLgbLibRsbLsbLgLsbLgbLgbLgbL
sbLgbLsLsmbLgbLibRsbRgbRjbLobRsbLgbLibRsbRobRobLhLsRsbRgbRcbLsLsmbRobR
cbRcbLsbLcbRibLoRsbRsbRobRcbRebLibLsbLsbRsbLsLgbRobLhbRibRsbRgLsbRibLg
bRobLgbRibLgbRobLcbLhbRgLsbLibRobLibRibRsbLoRsbRjbRsRjRsmbRjbRsbLcbLib
LjLsmbRgbLsbLgbLsLibRsbLsbLgbLsbLibLgLsbRsbLgLgbLsbLgbLgbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 34; Drug: PCAP931 1 然 Apo 0.5 然
bLsbRsbLibRibRiRsmbLgbRsbLgbRiLsbLgbLjbLibLhbLebRoLsbRibLhbRgbLhLsbLhb
LebRhbLcbRobRgbRibLsbRsRsRsmmbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 35; Drug: PCAP931 1 然 Apo 0.5 然
bLgbLgbLjbLibRgbRibRhbLsbRsbRsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 36; Drug: PCAP931 1 然 Apo 0.5 然
bLsLsLsLsmmmbLsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 37; Drug: PCAP931 3 然 Apo 0.5 然
bLjbLsbLsLsmbLgLsbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 38; Drug: PCAP931 3 然 Apo 0.5 然
bRsbLsbRsbRgbRoRsmbRsbRsbRiRsmbRobRibRebRgbLgLsbLsbLgbLsbLgRsbRjbLsLsm
bLgRsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 39; Drug: PCAP931 3 然 Apo 0.5 然
bLsbRsbRcbRsbRsbLsLsmbLsbRibLobLobLgLsbLibLiLsbRobRgLsbRsbRibLjbLcbLhb
LgbLgbLgbLgbLsbLsbRobRsbRsbRibRgbRsRsmbRgbRgbRgbLhbRcbRhbLgRsbRsbRsLsb
RibLcLsmbRibRcbLcbLcbRgbLgbLsbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 40; Drug: PCAP931 3 然 Apo 0.5 然
bRgRsmbRhbRsRsmbRsRsmbRsbsbsbRobRobLgbLsbsbLsbLsbRgRsmbRobLobRgRgbRsbR
gRsmbLibRgRsmbRobLsbLgbRcbRjbsbRsbRsbRsbsbRibRsbLsbLsLsmbRsbRgRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 41; Drug: PCAP931 3 然 Apo 0.5 然
bsbRsbRobLsbLibLgbRjbRgbLsbsbRhbLobLsbLibRgbRibRibRgbLcbLcbLjbRsbRcbLg
bRobLcbLobLsbLgbRibRgbRgbRibRsLsbRgRgbRgRsRsmmbLsbRibLgbLjbRgbRgbRsbRg
bRgbRsbRsbRsbRsRsmbRsbRsRsmbRgbRgbLobLcbLjbLsbRibLsbLsbRsbRibRgbRibRob
RibLsbLsRsbRsLsbLjbLcbRibRobRsbRebLibRsbRgbRebRgbRgbRgbRgbRsLsbRsbRsbL
cbLebRgbLibLcbLsbRcbRobRebRcbLsbLsbRsbRsbRibLsbRgLsbRgbRsbRgRsmbLcbLeb
RsbRibLgLsbRsbRgbRgbRgbLcLsmbLgbRobRcLsbLsbLibLjbRoLsLsmbLgbLgbRibLcbL
cbLsbRibRib

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 42; Drug: PCAP931 3 然 Apo 0.5 然
bRsRsLsmbRcbLsbLsbLgLsbLgbsbLgbLgbLsbLsbLibLibLsbLsbLsbLgbLgbLsbLsbLsL
sLsmmbLsbRsRsmbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 43; Drug: PCAP931 10 然 Apo 0.5 然
bLcbLsLsLsmmbLibRsRsmbRsRsmbRgRsmbRsbLsbLiLsbLgbLsbLebLcbLebLebLsRsbLc
bLibLcbRgbLsbRsRsmbLgbLobLoLsmbRsRsRsmmbRsbRsbRsbLsbLiRsbLsbLsbRsRsmbR
sbLiLsbLobRgbRsbRsRobLoLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 44; Drug: PCAP931 10 然 Apo 0.5 然
bLgbLgRsRsmbRsbRibRobLsbLoRgbRsbRgbRgbLjLoRsbLgbRobRobLsLsmbLsbLjLsmbL
sbLsLsmbLsbLgRsbLsbLsbRsbRsbLobLobLhbLcRsbRibLgbLcRsbRsbLibRsbLobRiRsm
bLibLsLiRsbLibLgbLgbRsbRsbLiRsRsmbsbRgbLibLgLsbRcbRcbLsbRobRsbLgbLjbRo
bRebLobRsbLsbRhbLjLib

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 45; Drug: PCAP931 10 然 Apo 0.5 然
bsbRsbLsbLsRsbLsLsLsmmbLsLsmbLsLsmbLsbLgbLiLsbLsbRsbLsLsmbLsLsLsLsmmmb
Lgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 46; Drug: PCAP931 10 然 Apo 0.5 然
bLobRgbRhbRibRibRsRsmbRhbLibLsLsmbRcbRhRsmbRibLsbRgbLsLsmbLgbLsbRsLsbR
ib

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 47; Drug: PCAP931 10 然 Apo 0.5 然
bLibLgRsRsmbLsLsmbLsbLgbRsbLibLibLsLsmbLsbLsbLsLgbLgbLsbRsLsbLsbRsLsbL
gLsbLgbLgLsbLsbLcbLsbLibLgbRibLgbLsRsbLoRsbLgLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121209; End: 121709;
Recording: 6-1; Individual: 48; Drug: PCAP931 10 然 Apo 0.5 然
bLhbLebRsbLgLsbLhbLgLsbLgbLgbRibLhbRsbLgbRcbLsbLsbLsLsmbLibRcbLjLsLsmm
bLjbLhbLjbLibLgbsbRibLibRgRsmbLsbLibRsbLsbLibRibLhRsbsbRsbRsRsmbRsbLjL
smbRgbLgbLsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 1; Drug: Control Apo 0.5 然
bRjRsmbLsbLgbLsbLjLsLsmmbRgbRsbLgbRgbLgLsbRsbLgbRsbLgLsbLgLsbLibLibRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 2; Drug: Control Apo 0.5 然
bLibRsLsbLgbRsbLgbRsbLhRsbLibRgbLgbLsbRsbRobRhLsbLgbRobLsbLobLobLgbLib
RsbLsbLibLsbRibRobLgbRgbRibLgbRsbLibRcLsbRgbRobLgbRobRibLibRcbLgbRgbLj
bLcbRgbRsbLgbRsbLibLsbRobRcbLibRcLsbLgbRibLgbLsbLsbLsbRibLcbLgRsbLsLsm
bLgLsbLgbLsbLiRsbRsbRobRibRcbLgLsbLsbLgbLsbLgbLjbRhbRobRhbLgbRcLsbRsbR
ibLsbLjbRcbLibRgbLcbRsbLobRgbRsLsRsbLoRsbRsbLgbRsbLsbLjbLgbLcbLcbRgbRh
bLsbLgbLsbLcbLibRsbLgbLsLsRsmbRjbLibLgbLsLsmbLibLcbLsLsmbRgLsbLsbLsbLg
bRibRibLibRgbLjRsbRibLiLsbLoRsRgbRsbLsRsbLobRsbLoRsbLhbLjbRsbRgbLsbLib
RgLsbLsbLobRsRsmbLobLibLsbRoRsmbLibRobLgbLgbLsbRhbRibRgbRibRhbLsbLibRs
bLibRhbRibRcLsbRgbLsbLgbLgRsbRobLjbRhbRhbRsLsbRsLsRsbRsbRibLsbLgbRsbRh
bRobLjbRibLsbLgbRsbLibLhbRgbLsbRjbRobLobRcbRgbLsbLgbRibRibLgbRobRobLsb
RibLsLsmbLjbLibLhRsbLgbLhbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 3; Drug: Control Apo 0.5 然
bLiRsRsmbRsbRobRibLgbRgbRgbLibLibLsbLgbLsbRobRjbRcbRobRgbLsbLsRsbLoRsb
LhbRsbLoLsmbLgbLgbLibLsbRsRobLobRobsbRibLsLsmbLcbLgbRgbRsbLsbLobLibLgb
LgbLhbLsbLsbLibLgbLhLsbLsLsmbLibLibLiLsbLgbLsbRibRsbRibRibRsbRgLsbLcLs
mbLibLgbLsbLobLcbRibLgbLsbLiLsbLgbLibLgbLcbRgbLibLibLhbLiRsbLsbLjbLobL
sbLhLsbLsbRibLsbLibLibRsbLibLsbLcbLibRgbRsbRsbRsbLcbLsbLgbLsLsLsmmbLsL
smbLgbRsbLsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 4; Drug: Control Apo 0.5 然
bRoLsLsmbLibRobLsbRobRcbLeLsbRsbRgbLibLobRebRibLsbRgbLcbRgRsmbLhbRgbLg
bLibLibLibRjbRebRgbLhbRgbRsRibRjbRcbRobLgbLgbRgbRsbRibRibLsbLgbRibLsbL
sbRsbRibRgbLebRebLebRcbRibLgbLeLsbLebRsRgbRobLibLebLobLsbRhbRgbLjbRibR
gLsbLgbRjbLobRgbRjbLcbLjbLcbLsbRgbRhLsbRsbLsbRjbLgbRibRsbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 5; Drug: Control Apo 0.5 然
bRgbRsbRsbLcbLibLibLgbRiRsmbRgbLhbLjbLibRjbRobLsbRsbRgbRgRsmbRgbRsRsmb
RoLsbRibLibLsLsmbLjbRcbRcbLcbRsbRhbRibRibRsbRibRsRsLsmbRcbLjbLcbLibLib
LhbRibRsbRgRsLsmbLcbLgbLgRsbRgbRcbRgbRsbLsbRhbRsRsmbLibLcbLcbLcbLgbLsb
LgbRoLsbRibLsbLsbLgLsbRcRsmbRhbRsbLjbLcbRjbRcbLsbLsbRobLsbRibRibRgbLsb
RibRiRsmbRsbRsbRsbLcbRjbRcbLgbRsbRgbRibRibRibRsbRiRsmbLsbRhbRgRsmbRcbL
gbRgbRcbRibRebLsLsmbRiRsmbRcbRcbRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 6; Drug: Control Apo 0.5 然
bLebRibRibLibRibRoLsbLsbLhbLhbRibRsbLibLhLsbsbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 7; Drug: PCAP931 1 然 Apo 0.5 然
bLsbLhbLsbLcRsbLgbRiLsRsbLsbRsbRgbRiLsbRsbLjbLcRsbLsRjLsbLjbLcbLibLobL
gbLiRsbRsbRgbsbLgbRsbRjRsmbRibLgbLgbLjbLsbRgbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 8; Drug: PCAP931 1 然 Apo 0.5 然
bLgLsbLsbRobRcRsmbRsLsbRibRsbRhbRibLgLsbLsRsbLgLsbLibLsbRgRsmbRgRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 9; Drug: PCAP931 1 然 Apo 0.5 然
bRgbLgbRibsbLibRgbRgbLjbRgbLsbLgbRsbRgLsbLsbLjbRsbLjbRcbLsbLibLgbLgLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 10; Drug: PCAP931 1 然 Apo 0.5 然
bRsRsmbRgRsRsmmbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 11; Drug: PCAP931 1 然 Apo 0.5 然
bLeLibRiLsbLsbLibLjLibLgLsbLsbRsbLibLibLhbRsbRibLeb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 12; Drug: PCAP931 1 然 Apo 0.5 然
bRgbRsbsbRsRsmbLsRsbRsRsmbRjbRgRsmbRsLsbRgbRgbLsbLgbLsbLsRsbLsRcbRjRsm
bLibRsbLcbLsbLsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 13; Drug: PCAP931 3 然 Apo 0.5 然
bLcbLsbRobLjLsmbRsbRcbLgLgLsbLgbLgbRsbLjLsmbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 14; Drug: PCAP931 3 然 Apo 0.5 然
bLcbRsbLibLobLsLsmbLsbRcbRsbRsLsbLjbLoLsRsmbRjbRoRsmbRibRcLsbLhRsbLobs
bsbLsbsbsbsbRsLsRsRsLsmbsbsbLsbsbRsbRsbsbLsLsmbRsbRsbLsbsbRsbsbLsLsmbR
ibRsbLcbLibRibLibLsbLcRsbLsbLcLsLsmmbLsLsmbLsbLgbLsbLiRsbLcbRsbRsLsbLs
LsmbRsbLcbLhbLsbRsbLsbLgbLcbRsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 15; Drug: PCAP931 3 然 Apo 0.5 然
bRsbRhbRjbRcbLgbsbRiRsmbLsLsmbLibLsRsLsbsbRjRsmbRibLsbLsbLsRsbLgbRgbLj
bRgbRsLsRsbRsbLjLjLhbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 16; Drug: PCAP931 3 然 Apo 0.5 然
bLcbRgbLgbLsLsmbLgbLsbLsLsmbLsbRsbLobLgbRsRgbLgLsbRsbLsbRsbRgbRsbRgbRs
bRgbLgRsLsbRsLsbRsbLobLgbLgbLibLsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 17; Drug: PCAP931 3 然 Apo 0.5 然
bLsbLobLibRsbRsbRsbLoRsbLsbLobLiRsbLibLibRcbRobLsbLhbLhbLgbLgbRibLib

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 18; Drug: PCAP931 3 然 Apo 0.5 然
bRsbsbRgbRoRsRsmmbLgbLsbRsbRgbRcbRgbRsbRibRcbRgbRiLsbLsbLgbLoRsbLibLcb
RsLsbLsbLeLgbLoLsLsmmbLsbLcLsRsmbLgbRobLjbRiLsbRsbRgbRibLgbRibLsbRgbRs
bRjbRsbLgLsbLsbRhbLibRhbRhbLhbLsbRsLsbRgbRiRsmbRhbRsbRhbRsbRgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 19; Drug: PCAP931 10 然 Apo 0.5 然
bRsbRsbRsRsRsmmbLeRgbRobRsbRoLsbLsbLsbLsbRsbRsbLsbRsbLibLsbLsbRsRsmbRs
bRsbRsbRsbRsbRsbRsbsbRsbRsRsmbsbRgbRgbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 20; Drug: PCAP931 10 然 Apo 0.5 然
bLsbLsbLsLsRsmbLsbLsbLsbLsbLsRsbLsLsRsmbLsbLsLsmbLsbLsbLsLsmbLsbLsbLsb
LsbLsbLsbLsLsmbLsLsmbLsbLsbLsLsmbLsbLsbLsLsmbLsLsmbLsbLsLsmbLsbLsbLsLs
RsLsmbLsbLsbLsLsmbRsbLsLsLsmmbLsbLsLsLsRsmmbLsbLsbLsbLsbRsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 21; Drug: PCAP931 10 然 Apo 0.5 然
bRibRsbLsLsmbLjbRibRsRsmbRgbLgbRsbLcbLgbLhbLibLsLsLsmmbLsbLsbLsRsbLsbL
gbLgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 22; Drug: PCAP931 10 然 Apo 0.5 然
bLsLsmbRjbLoRsRsmbRjbRibLsbLhLsbRjRsmbLgbRgRsmbRjLsbLgbLsbRsbRgbRgbRoL
sLsmbLgbReLsbRsRsRsmmbRsbLsbRgbLsbRhbRgbRsRsmbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 23; Drug: PCAP931 10 然 Apo 0.5 然
bLsbLsbLsbLsbRsbLsLsRsmbRsRsmbLsbLsbRsbRsbRsbRsbRsbRsRsmbLsbLsLsmbRsLs
b

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 24; Drug: PCAP931 10 然 Apo 0.5 然
bLjbsbLgLsbRgbLgLsbLsbLsLsmbLsRsLsLsmbLsbsbRsRsmbLgLsbLsLsLsmmbLgbRsRs
RsLsmmbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 25; Drug: Control Apo 0.5 然
bRsbRsbRsRsmbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 26; Drug: Control Apo 0.5 然
bRsbRsbRgLsbRsbRsbRsbLsbRgLsbRsbLsLsmbRsRsmbRgbRsRsmbsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 27; Drug: Control Apo 0.5 然
bRsbRgLsbRsbRsbRsbRsbRoRgbRsbRgbRiLsbLsbRsRsmbRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 28; Drug: Control Apo 0.5 然
bRibLebLgbRibLibLgbLsbLgbLibLsbLibLsbLibLsbLgbLgbLsbLsbLgbLgbLsbLgbRsb
LibLgbLibLgbLgbLgbLgbRhbRgbRibRhRsmbRibLsbRcbLibRsbRsbLiLsbLibLibLibsb
sbLibLsbRsbRsbRgbLsbLibLibRsbLgbLgbRsbRsbLsbLibLsbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 29; Drug: Control Apo 0.5 然
bRibLgbRoRsmbRcbLsbRibLsbLsbRobRibLgbLgbLsbRcRiLsbRcbLsbLsbRcRsmbLgbLs
LsmbLsbRsbRibRibLcRsbRcbRsbRgbRgbRsbRgbLjbRobRgbRgbLsbLibRhbRhLsbRcbRg
bLsbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 30; Drug: Control Apo 0.5 然
bLibLgbLjLsmbLibRgbLsLsmbRoRsmbRsbLgbLgbLhbRcRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 31; Drug: PCAP931 1 然 Apo 0.5 然
bRsbRhbRsbLobRsbLgbLsbLgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 32; Drug: PCAP931 1 然 Apo 0.5 然
bLsbRgbRsbLsbLsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 33; Drug: PCAP931 1 然 Apo 0.5 然
bLobLibRibLsbLcbRjbRjRsmbLcbRcbLsbLjRcbLgbRcbRobLibRgbRjbRebRobLsbRhbL
sbRibRsLsbRibRsbLobLcbRibLebRibLcbLsbRobLjRsRibLibLsRcbLsbLcbLhbRsbRjb
RcbRsbLoRsbRsbRibLiRsbRgbRsbRsbRgbLsLsmbRibRgRhbLsbRsbLsbLobRjbRebLobR
gbRiRsmbLsbRsbLhbRjbRcbLhbRibRobLgbRobRcb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 34; Drug: PCAP931 1 然 Apo 0.5 然
bLibRgbLiLsbLgbLibLibLibLeRsLsbLsbLibLgbRgbsbRcbRebRibRcbLsbLibLobLsLs
mbRibLgbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 35; Drug: PCAP931 1 然 Apo 0.5 然
bRibsbLiLsbRiLsbRsbRjRsmbRhbLsRsbLgbRibRsbsbLsbRibLgbLebRobRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 36; Drug: PCAP931 1 然 Apo 0.5 然
bRgRsmbLsLsLsmmbLgLsbLgbRsbRgbLgbRsbLsbLsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 37; Drug: PCAP931 3 然 Apo 0.5 然
bLsbLjbRebRsbLjbLsbRsbLgbsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 38; Drug: PCAP931 3 然 Apo 0.5 然
bLibRiRsmbRcbLgbLsRsbLgbLsLsmbRjbRsbRsbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 39; Drug: PCAP931 3 然 Apo 0.5 然
bRgbLgbRibLgbRgbLgbRibLgbLsbLsbLgbLgbLsbRgbRgbLgbRgbLgbRgbLsbLgLsbRcLs
bRibRgbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 40; Drug: PCAP931 3 然 Apo 0.5 然
bRiLsLsmbRsbsbRsRsLsRsmbLsbLsbRibLcbLoRsbLsRsbRsbLobLsbLobsbsbRsRsRsRs
mmmbRsbRgbRsRsmbRgbLsbRsbsbRsbRsRsmbRsbRgbRobLsLibLobLsbRgbLcbsbLsRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 41; Drug: PCAP931 3 然 Apo 0.5 然
bLhRsbLibRsRsmbsbLsLibLhbRsbLgbLsbLcbLgbRsbLsbLgbRobRoLsLsLsmmbLibLcbR
sLsbLgbRsbLcbLobLiRsbRsRsmbLcbLibLsbLsbLsbLobLibLcbLgRsbRhRsmbLgLsRsbL
sRibLsbLsbRgbLoRsbRoRsmbLobLgbRgbRgbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 42; Drug: PCAP931 3 然 Apo 0.5 然
bRgbRsbRsbRsbRsRsmbRgbLgbLgbLgbLsbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 43; Drug: PCAP931 10 然 Apo 0.5 然
bRcbLebLcbLgbRgbLhRsbRsLsbRgbLgbRiRsmbRsbRgbRsbLoLsmbLgbRsbLcLsLsmmbLs
RsbRsbLgbLiRsbLcbLgbLcLsmbLgbLsRsbLhbRsbLibLgbLibLcbLcbLcLsLsmmbLcbLgb
LcbLibLobLcbLgbLsbLibLcb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 44; Drug: PCAP931 10 然 Apo 0.5 然
bRgbLsbLobLsbLobRsbRsRsmbsbsbsbRjbLoRsRsmbLibRcbLobRibRsbRsbRobRibLsLh
RsbRobLjbRhbLibLibLsbRsbLsbLibRgbLiLsbsbLibRsbLsbLiRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 45; Drug: PCAP931 10 然 Apo 0.5 然
bLsbLsLsLsmmbRsRsmbLsbLsLsmbLsLsmbLsLsLsmmbLsbLsbLsLsmbLsLsmbRsLsbLsLs
mbLsbRsbRsRsmbRsbRsbLsbReRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 46; Drug: PCAP931 10 然 Apo 0.5 然
bRobRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 47; Drug: PCAP931 10 然 Apo 0.5 然
bRobLcbLoLsRsmbLsbLgbLjbLsbLgbLsbLsbLsbLsbLsLsmbLsbRsbLgLsbRgbLsbLsbRs
bLsbLsbLiRsbRsbRsbLibLeLsbLgbLgbLsbLibLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 121710; End: 122210;
Recording: 7-1; Individual: 48; Drug: PCAP931 10 然 Apo 0.5 然
bRibRgbLsbLiLsbLebRsbLgbLsbRibRcbLsLsmbLcbRsbLsLsmbRsbLsbsbRsbLsRjbLsb
sbLgbsbsbsbRsbLgbLsLsmbLgbRsbRgbLibLhLsbLhbRsbLcbLibRsbLibLgbLhLsbRsbR
sLsbRgbLsbRgbRibLibRgRsmbLsbLjLgbRgbLhbRgbLiLsbLiLsbRsbsbLjLsmbRsRsmbs
bLsbLiLsbRobRobLibLsbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 1; Drug: Control Apo 0.5 然
bRgbLsbLgbRsbLsbRgbLsLsmbRsbRcbLiLsbLiLsbRgbRibRsbRiLsbLcbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 2; Drug: Control Apo 0.5 然
bRgbLgbLibRsbRsbLsbLgbLsLsmbLgbRsbLcbRsbLiLsbLsbRgbRhbRobRgbLsbRsbLcbL
obRgbLibRsbRgbLibLcbLcbLsLsmbRsbRgbLibLhbRjbRhbLobRhLgbRsbRsbRsbRsbRib
RiLsbLobRgbRgbLsbLibRsbLgbLibRgbLibRjbRobRoLsbLgbLsbRsbRgbRibRobRgbLsL
smbRobRgbLsRsbRibLjbRibLcbRjbRibLgbRcbRsLsbLsbRgbRsbRgbRsRsmbRhbLibLib
RsbRobRgbLgbRcLsbRgbLjbRobRgbLsbLgbRgbLobRgbRsbLobLibRsbLsbLgbLibRgbLo
bRgbLhb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 3; Drug: Control Apo 0.5 然
bLebLjLsmbLibRiRsmbLobRgLsRsbLgbLcbLsbLsbRsbLobRibLsbLgLsbLibLobLsbLob
LsbLibLgLsbLiLsRsLsbLsbLsRsbLgLsbLobRibLgLsbLgbLobLsbRoLgLsbLcbRgbLibL
sbLibRsbRgbLobLibLgbRibRgbLsbLjLsmbLibRsRsmbLibLibRsLsbLibLgbLsbLgbLib
LgbLjbLibLsbRjRsmbLiLsbLibLsbRsRsmbLcRsbLgbLsbRibRgbLibLhbLibReRsmbLob
LibLhLsbLibLsbLgbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 4; Drug: Control Apo 0.5 然
bRjbRibLjbRcRsmbReRsmbRibLcLsmbLobLobLsLob

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 5; Drug: Control Apo 0.5 然
bRibRibRhbRjbRcbRcRsmbRhbRgbRobRcbRibRibRsbLjbRcbLjbRobRcbRiRsmbRibRsb
RsRsmbRcbLobRibRsbRibRhbLgbRjRsmbLsbRsbLgbRsbLsbRcbRcbRcbRgbRgbRsbLibR
sbLsbRgbRcbRsRsmbRsLsRsbRsbRcRsmbRiRsmbRibLsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 6; Drug: Control Apo 0.5 然
bRibRgbRjbRcbLoLsmbLhbRsbRgbRcb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 7; Drug: PCAP931 1 然 Apo 0.5 然
bRobLobRsRsRsmmbLsbLsbLsRsbRgRsmbLcbRobLib

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 8; Drug: PCAP931 1 然 Apo 0.5 然
bRibsbLsLsRsmbRhRsmbRobLsRsbRgRsmbRsbLibRobRhbRgbRjLsbRcbLsbRibLgbLsRs
bRsbLsbLsLsmbRgbRsbLsbLgbRsLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 9; Drug: PCAP931 1 然 Apo 0.5 然
bLgbLsbLsbLsbLsbLcbLsbLibLsbLsbLgbLgLsbRsRsmbRsbRsbRsbRjbLobLgRsbLgRsb
LgbRsLsLsmbRsbRgbLsbLsbRsLsbRsbRgbLsbRcRsmbLgbLobLsLsmbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 10; Drug: PCAP931 1 然 Apo 0.5 然
bRsRsmbRsRsmbLgRsbRiRsLsmbRobLobRsbRsbLobLiLsbLsbLibRsRsmbLibRsbLgbLgb
RsbLhbRcbLgbRibRgbRhRsmbLgbRsbRsbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 11; Drug: PCAP931 1 然 Apo 0.5 然
bRsLgbRgbRjbLhbLsbLgbLibLibLobRgbLsbLsbLibLgLsbLgbRsbLjbRibRobRsbLjbRi
b

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 12; Drug: PCAP931 1 然 Apo 0.5 然
bLgbLgRsbLgLsbLgLsbRsLsRsbRsbRsbRsbsbLsLsmbLsbRsbRsbLjLsmbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 13; Drug: PCAP931 3 然 Apo 0.5 然
bRgbRjbRobLcbRjRsmbLibRcbLibLsLsmbLibLcbRhbLsbRsbLibLsRsbLibRibLgbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 14; Drug: PCAP931 3 然 Apo 0.5 然
bLoLsmbLsbLgbLgLsbLiRsbLgbLhRsbLsbLsLsLsmmbLibLcbLgbLiLsbLgbLgbLibLgbL
gbLobRgbRjbRibRcLsbsbRsbRsRsmbRsbLibLibRsbsbLibLgbLhbLibRgbLgbLgbLibLg
b

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 15; Drug: PCAP931 3 然 Apo 0.5 然
bRibRsRsmbLoLsmbRsRsmbRcbRhLsbLibLsbRcbsbsbRsbRobLgbRibLsRsbLsbLiRsbRg
bRibRibLsbLsbRgbRsRsmbRsbRgbLjLsmbRjbRibLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 16; Drug: PCAP931 3 然 Apo 0.5 然
bLsbLsLsLsmmbLgbLsbLsbLsbLsbRcbLibLcbLsbRgRsmbLobLibLsbLgbLsbLgbLgbLiL
sbLgbLcbLsbLsbRgRsRsmmbRgbRgbLgbLsbLsbRsRsmbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 17; Drug: PCAP931 3 然 Apo 0.5 然
bRjbRsLibLibLgbLcLsmbLibsbRgbRjRsmbsbRgbRsbRgbRsbRgbLgLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 18; Drug: PCAP931 3 然 Apo 0.5 然
bLsbRcbRsbLsbLgbLgbLsbLsbLsRsbLsbRsbLgbRgbLgbLgbLgbLsLsmbLsbLsLgLsbRsb
LsLsmbLsLsmbRsbRsbLsLsmbLsbLsLsmbLsbRsbLsbLsbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 19; Drug: PCAP931 10 然 Apo 0.5 然
bRsbRsbsbRsbRsbRsbRgbRsbRsRsmbRibLgbRsbRgbRsRsmbRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 20; Drug: PCAP931 10 然 Apo 0.5 然
bRsbLsLsmbLsLsmbLsLsmbLsbRsbLsRsbLsbsbLsbLsbLsbRsbLsbLgbRsbRsbLsbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 21; Drug: PCAP931 10 然 Apo 0.5 然
bLobLsLsmbLgbLibLsbLgbLsbLsLsmbLgbLsLsmbLsbLebLgLsbRcbLobRsLsbRjb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 22; Drug: PCAP931 10 然 Apo 0.5 然
bLgbLibRsbRgbRgbLibRsbLcRsRsmbLgbRgbRgbRgRsmbLsbLsLsmbLibRiRsLsmbRgbRs
bRcRsmbLsbLjbLsbRjbLjRsbRjbRsLibRjbLsRibRgLsbRsbLgbRgLsbRgbRcbLibLgbRo
RsmbLsRsbLsbLsbRsbLsbLsbRsLsbRjbRgbLjbRjbRcbLsbLgbRsbRgRsmbRsbLibRebRg
bLgbRgbRcbLebRjbRcbLebRjbRhbLgbLgRsbRsbLsbLsLsmbRsbLcRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 23; Drug: PCAP931 10 然 Apo 0.5 然
bRsLsbLsbLsbLsRsbRsbRsbRsbRsbRsbRsbRsRsmbRsbRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 24; Drug: PCAP931 10 然 Apo 0.5 然
bLgbRgbRsbLgLsbLsLsLsmmbLebLgbLobLhbLhRsbLebLsRsRsmbLgbLjbLibLsbLsLsmb
Lgb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 25; Drug: Control Apo 0.5 然
bLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 26; Drug: Control Apo 0.5 然
bRgbRsbLibRoRibLoRsRsmbRsbRsbRhb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 27; Drug: Control Apo 0.5 然
bRiLsbRsbRobRsbRcbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 28; Drug: Control Apo 0.5 然
bLeLsbRebRsbLebRcbRsbRobRebRcbRobRcbRsbLobRobRgbRsbRebLobLcbLebRobLobR
ebLgbLhbRebLobLebRcbRebLebRobRebRobLobLebLibRibLebLobRsbRgbRobLebRebLe
bLebRebLebLobLobRobRebRgbLebRobLobLcbLobRobRcbLebRobLobLebRcbRobRobRob
RsbLcbRgbRobRobLobLibLcbRcbRibLcbLgbRcbLebRobLcbLobLobRcbLobLobLobLhbR
cbRobLobRjbRobLobRobRobLobLobRibRobRobRobLsbLebRobLsbRjbRcbLhbRsbRebRo
bLebLgbRobRebLgbRobRobRcbRebLgbLobRsbRebRibLobLebLobLobRcbLcbLibRcbLcb
RobRobRobLsbRobLebRobRobRibLobRobRebRcbLebLebLebLibRcbLobLebLgbRsbRcbL
ebRobRobRcbRobRgbLgbLsbLgbRcbRebLcbRhbLobRebLobRobLgbRcbLobLcbRobLobLo
bLhbRebLcbLobLcbRobRobRobRobRobLobLgbRobLebRsbLebRobRgbLebLobRhbLobRcb
RhbLebLobRebLebRebRcbLobLebLibRobRobLibLcbLcbLibLobRobRobRebRobRebRibL
cbRobLcbLcbRobRcbRobLebRsbLobLgbLcbRgbLcbLhbRgbRebLobLgbLebRobRcbRobLo
bLhbRcbRobRobRebRobRobRobLobLobRgbRobLobRobRhbLobLobLobLobLobLsbLobReb
LebLobRcbRcbRsbRgbRsbLobRobLobLcbLsbRcbRobRobRebRobRsbRibLgbLcbLobRebL
ibLgbLcbRobRhbRebRobRobLobLobRebLibLcbRcbLibLobLobRobLsbLebRobRebRobLg
bRcbLebLcbRebRobLibRobRibLsbLobRebRebLobRibRgbRcbLobRsbLebLgbRobLobRcb
LobRobRobRobRobLjbLcbRebRibLebRibLibRcbLsbLobRobLobLobLebRobRgbRcbRsbL
ebLcbLcbRcbRebRcbLobLebRsbLobLobRobRobRobLobRobLobLobRobRibLcbLsbRcbRe
bRobLebRobRgbRcbRobRcbLobRcbLcbRobRobLobLobRobLhbLobLobRobRobLebRcbLcb
LebRobRobLebLcbRobRibRebLebLcbRsbLsbRibLsbRcbLobRobLobRhbRibRebRibLobL
gbRobRobLobRsbRibLjbLobRcbRebLobLobRobRebRcbLcbRsbRibLobRobRgbLobRsbLe
bLibLobLebRcbLobRobRcbRobRobLobRebRsbLcbRobLebLebRgbLebLebRsbLobLobLob
LcbLobRcbRobRobRebRobLcbLobLobRobLobLobLebRobRobRobRsbRgbRcbLsbRcbRebL
obRcbLobRobLobRobLcbRobRebRobLebRsbLcbRobRsbRcbLebLobRobRobLobRcbLobLs
bRebLcbRsbLobLebRcbLcbLobRebLcbRebLebRibRcbLsbLsbLobRibRebRobLebRsbReb
RobRobRobLebLobRobLobRsRsmbRobLsbLsbRebLobLobRsbRobLobRobRibRebRgbLebR
sbLebLebRobLcbLobLgbRobRobLsbRcbRobRsbRobRsbRebRebRebRobRcbRibRobRjbRo
bLcbRcbRjbLobLcbRcLebRcbLebLobRsbRobLobLobLebLobLcbLobLsbRobRebRobLgbL
ebRgbRobLobRobLsbLebLsbLsbLcbRobRebLsbRobLebLobRsbLebLebRobRobLcbLcbLj
bLobLjbRobRebRsbLebLebRebLebRcbLsbLobLebLobLjbRobRobRobRcbRibRebRobLsb
RjbRobRgbLobLgbLobLebRebRobRobRibLobLebRsbLobLhbLsbRobRsbRibRobLcbLobL
ibLobRebRebRobLebRsbLcbRsbRsbRebLebLebRhbLsbRebRobRjbRsbRebLebRcbRoLeb
RobRobLobLcbLsbRebRsbRobLebLobRsbRobRebLobRobLebLebLobLobRebRsbLobLobR
cbLobRsbLobRsbRsbRobLebRsbRhbRebRhbRoLgbRobRebLobLgbRebRobRobLebRgbLob
RobRsbLsbRsbRsbRsbLsbLsbLobRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 29; Drug: Control Apo 0.5 然
bRibLsbRcbRgbLsbRibLibRgbLgbRsLsbReLsbLibRgbLibLibLsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 30; Drug: Control Apo 0.5 然
bLibLsbLibLsRsLsbRibLgbRgbLsbRgbLgbLsbRobLibLgbRsbLgbLgbLgLsbRsbLibLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 31; Drug: PCAP931 1 然 Apo 0.5 然
bLjLsmbLgbLsLsmbLgLsbLsbLgbRsbLgbLsbLsbLsLsmbRsLsbLsbLgLsbRgbLgbLsbRgb
RsbLhbLgLsbLibLsbLgbRsbLhbLgbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 32; Drug: PCAP931 1 然 Apo 0.5 然
bLcbLcbRcbRobRgbRobRebLcbLjbRjbRcbLjbRobRsbLebRebLobRcbRgbRebLobLsbLob
LsbLcbRsbRobRobLobLebRgbLobLgbLobRebLsbRobRebLcbRobRobRcbLobRobRobLobR
ebRgbLebLgbRebLcbRcbLobLebRibRobLcbLobRobRsbLobRobLibRsbLebRgbRobRebRo
bLcbRcbLsbRsbRebRgbLebLsbLcbRobLebRobRcbLebLebLcbLcbRebLcbRgbRibLibLob
LobRobRebLobRgbRcbRobRsbLgbLibRobLcbRobRcbLcbLibRobRobLcbLobLhbLobRgbL
obRobLebLgbRobRobLgbRibRsbRebRgbRcbLobLsbLobLobLhbRebLebRebRobRibRcbLo
bRobRobRcbRebRjbRebLebRebLobLgbRebRebRsbRobLebLobRobRobRibRobLobLebReb
LebLcbLibRcbLcbRhbLebLobRgbLcbLebRsbRobLobLsbRobLcbLcbRcbLobLobLobRobL
jbRebRobLcbLgbLgbRobLebRobRgbLebRcbLobRobRjbLcbLsbRcbLobRsbRobLcbLgbLo
bLebRobLobRobLebRcbLobRobRebRcbRibLebLobRsbLibRobRcbRobRobRobRjbRobRsb
LebRebLebRebRobLebLobLobLebLibRobLobRibLibRobRobLcbRjbLobLjbLsbLhbRsbR
cbLobLebLebRobLjbLibLcbLobRobLgbLebRjbRjbRsbLsbRhbRjbLsbLobRobRcbLebLo
bLebRsbLobLobLebRcbRibRhbRcbLgbLebLobLobLobLgbRobRobRobLjbLebRgbLebReb
RcbRebLebLobRebRcbLcbRobRebRjbLcbLebLjbRgbLobRjbLobRobRobRcbRcbLcbLebL
obRebLjbRjbRebRebLobRebRobRobRibRobLebLjbRsbRebLobRjbRhbLsbRebLobLsbLc
bRobRsbRobLobLebLebLgbLobLcbRcbRobRsbRsbLebLobLcbRcbLebRobLobLobLgbLeb
LobRgbLsbRgbLobLcbLjbRsbRobRcbRobLobRcbLobLebRobRcbLobLebRobRobRebRcbL
obLcbRobRsbRcbLsbRgbRobRsbLgbLobRcbLobRobLebRobLcbLhbRebLjbLobLobRibRc
bRobRcbRcbLobLobRebLobRgbRobRobLjbLcbRobLebRobRobRebLobRsbRobLcbRobLcb
LebLcbRebRobRsbLobLsbRebLgbRebLobRebRsbRjbRcbLobLobRebRsbRgbLobRobLobL
oRjbRjbLibLobRebRebLobLobRobLobRebLsbLjbLsbLobLjbLsbLsbRcbRsbRobRobLeb
LebLobRhbRebLsbLebRobRebLobLjbRsRobRibLhbRsbLebLobRobLebRcbLebLobLobRo
bRebRsbRsbLobRsbRobRsbRobRobLobLsbRebLebRebLjbLobRebRjbRcbLebRjbRjbRib
LobRebLobLebRobRsbLebRebRobRsbRsbRobRcbLobLibLcbRibLobRebLcbLcbRsbLibL
obRcbRobRsbLebRibLebLcbLobRobRebRsbLebLsbRsbLobRobRobLobRobRobLibRobLo
bRjbRobRobLebRobRjbLcbLsbRhbLsbRobLobRcbLobRsbLobLobRjbLobRobLebRebReb
LcbLebRibRsbRobLebRobLobRobLsbRsbRobLobLsbRcbLobLsbLobRobRibLebLcbLebL
sbLebRsbRsbLsbLebRobLobRobLobLobRobLobRjbLibLobLebLsbRebLjbLcbLcbLjbLs
bLobLcbLcbRsbLobRcbRsbRibLebLsbRebRobLobLobLobLjbRebRebRibLebRjbLhbRsb
LobRobRobRibLsbRobRebRgbRibRsbRebLsbRebRjbRobLcbLjbLobLobLsbLsbLebLgbL
cbRjbLsbRebRobLsbLobRjbRobLobRcbRebLobRsbLhbRobRobRcbLgbLsbRsbRsbLobRo
bRobLebRobLobRsbLsbLsbLjbRebRobRobRebLobRobLebRobRobLebRsbRobLgbLobLjb
RobLebRjbLobRobRobLobRobLobLebRebLobRobRibRibRobLobRsbRsbRebLobLobRobR
obLibRobLebRebRebLgbRsbRibLobRobLgbRobRsbRcbRobRcbLobRebRcbLcbRcbLjbRc
bLobRcbRcbLcbLobLobLobLobLebRebRgbRobLobRobRhbRebLobRobLobLobRsbRebRob
LcbLcbRsbLebRcbRibRcbRebRebLobRobRobLobLgbLobRgbRebLcbLebLobLibLobLjbL
ebRebRsbRobRsbLgbRcbLcbLobRsbRcbRobLobLobLobLebRebLobRobLsbLobLobRcbRo
bLgbLobRobRobLobLebLobRobRobLsbRebRjbLhbRsbLebRcbLebLsbLobLsbLgbRobLob
LcbLcbRebRcbRsbLcbLibRobRgbRobLgbRobLobLobRgbLcbLebLebRebRjbLobRibRobL
ebRebRobRebLobRobLobLobRebLebRebRobRobRhbLebRobRibRgbLebRebLibRobRcbLo
bRcbRobRebRhbRcbLobRobRobLobLobRhbLobLobRcbLhbLobLebRebRibRibRobLobLob
RebLobRebLcbRebRobRsbLjbRibLobRsbRebRjbLebLobRobRsbLobRsbRobRcbRcbRobL
cbRobRebRibLcbLobRsbRobLebRobLebRobLobRebLcbLobLcbRobRhbRcbLobLobLebRo
bLobRjbLgbRsbRcbRobRobRobLobLobLobRsbLobLcbLobLhbRibLsbLsbRebRgbRobRsb
RhbLobRsbLsbRobLebLobRgbLobRobRcbLibLobRebLobLebLsbLobRcbLobLib

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 33; Drug: PCAP931 1 然 Apo 0.5 然
bLoLsmbRibRibLgbLgbLibLsLsLhmbRibLibRgbLcRsRsmbRgbLibLgbLcRsbRsbLcbRgb
RibLsbLgLsbRgbRiLsRsbRsbRgbRobLibRsbRhbLjbLibLsbRobLgRsLsbLsbRsbRoLsbL
hbLgbLiLsbLsLsmbLgbRsbLgLsbLsLsmbLgLsLsLsmmbLsbLibRsbLibLsbLgbLgbLsbLg
bLgbRsbRcbRgbLsbLsbRiLjbLcbRsLsbLgbRjbRibRjbLobRibRoLsbRobRsbLibLibRsb
RebLjbRsRgbRobRibLgbRobLcbLibLsbRobRcbRcbLgbRsbRobLgbRsLsbRgbRcbRibLsb
LjLsmbLcbLsbRjbLebLgbRgbRsbLiLsbLibRsbLgbLsbLgbLsbLgbLsbLgLsbLsbLgLsbL
sRsbLgbLsbLgbRsbRjbLhbLgbLibRsbLgbLiLsbRsbLgLsbLsbLgbLgbRsbLgbLsbLgbLg
bLcbRgbRgbRgbRhbRoRsmbRob

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 34; Drug: PCAP931 1 然 Apo 0.5 然
bLgbLcbLebRebRcbLibRsbRebLibRcbRgbLibRsbLibLgbLiLsbLgbRgLsbLsbRgbLsbLc
bLgbsbLgbLsbLibLsbLsbLibRsbLgbLcLsmbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 35; Drug: PCAP931 1 然 Apo 0.5 然
bLobLsbRsbRsbRgbRsRobRsbRsbRoLsLsmbRsbRsbRsbRhRsmbRsbRjLsbRsLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 36; Drug: PCAP931 1 然 Apo 0.5 然
bsbRsbRsbRsbLcbLcLsmbLhbLebLibLjbLobRsbLsbLiRsbLobLebLsbLobLsRsbLhbLsb
LgbLiRsbRsLsbRibRibLcbLhbLebLiLsbRgbRibRibRobRsbRibRhbLhbLgbLsbLibLsLs
mbRsRsmbLobRgbLibLibLsbLgbRjbLcbLsbLiRsbLsLsmbLsbLsLgLsbLsbLgbLsRsbLgb
LibLgLsbLgbLgbLgbLsLsmbLgLsbLsbRsbRsbLibLsLsmbLsbLibLcRsbLcbRibLsbRsbL
sbRcLsbRgbRcbRobRibRjRsmbRcbRobRibLjbLibLgbRibRhbRobLibRsbLcbRobRibLgb
RibRsLsbRsRsmbRiRsLsmbLsLsmbRibLsbRobLsbRgbLsbRgbRgbRibLsbLjbLcbLsbLhb
LgLsbRhbRibRhbRcbRibRsbRsbRsbLsbLibRsRsmbLsbLgbRjbLibRjbLibRcbRgbRoRsm
bRibRgbRobRibRsbRgbLgbRgbLjLibLibRjbRjLsbLibLgbLgbLsbLibLsLsmbLibRjbRc
bRibLibRgbLgbRsbLsbLjbLgbLsbLgbRgbRhbLjbRhbLobRebLobLebRibLsbRgbLgbRsL
cbRjb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 37; Drug: PCAP931 3 然 Apo 0.5 然
b

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 38; Drug: PCAP931 3 然 Apo 0.5 然
bRgbRsLsbRsRsmbRsbLiLsbRsbRjbRcbRsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 39; Drug: PCAP931 3 然 Apo 0.5 然
bRobLgbLibRobRcbLsbLgbLcbRebLsbLgbLibLibLgbLgbLsbLgbRgbRsbLgbLgbLgbLib
LgRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 40; Drug: PCAP931 3 然 Apo 0.5 然
bRcbsbRsRsmbRgbRobLsbRsbsbLibRobRsRsmbRgRsmbRsbRsRsmbRsbRsbLsLsmbRobRc
bRsbRsbLibsbLsRsbLsRsbRobRsbRsbLsbRoLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 41; Drug: PCAP931 3 然 Apo 0.5 然
bRoRsmbRsbRoRsmbLcbRsbRcbRcbLibLgbLgbLibRgbLobLsbRcbRcbLcbRsbRcRsRsmmb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 42; Drug: PCAP931 3 然 Apo 0.5 然
bRjb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 43; Drug: PCAP931 10 然 Apo 0.5 然
bRibLgbRebRgbLobLsbLsbRgbLibLgbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 44; Drug: PCAP931 10 然 Apo 0.5 然
bsbLjbRobRiLsbLsbRsbLobLsbRibLcRsbRebLebRobLobLcbLgbLcbLcRsbLcbLobLibR
obRiLsbLhRsRsmbRsbLibRjbLjbRobLsbRcRsmbLgbLjbLibRgbLgbRebRobLjbRcbRobR
ibLgbRgbRobRobLsbRobRibRoLsRsRsRsmmbRgbRgbRgbRibRcLsbRsbRibRsLibLjbRob
RcRsmbRobRjbLibRjbRobLcbRjbLoRsRsmbRjbLcbLcbLcbLgbRsbRsbRsbRiRsmbLsLsm
bRsbRibLsbRgbLsbRgRsRsRgRsmmmbRsbRgRiRsLsmbRsbRgbRsRsmbRgbLibLjbRjbRhb
LjbRcbRibLsbRsbRgbRgbLjbLhbLcbLobLibRibRibLsbRgbRsbRcbRgbLgbRsbRgLgbRs
RibRgbRsbRgRsRsmmbRgRgbLgbRobLibRgbRobRobLebRobLhbRgbRgLsbRoLgLsbRjbLi
bRobLobRebRobRibLjbRobLgbRibRcLsbLcbRgRsmbRgbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 45; Drug: PCAP931 10 然 Apo 0.5 然
bRibLeRsbRsbRsbRsRsmbRsbRsbRsbRsbLcbLgbLcbLsbRsbRsbLsLsmbRsRsRsRsmmmbR
iRsmbLibRsbRsbLsbLcbLgbLsbLiLsbLgbLoLsLsLsmmmbLgbLiLsbLgLsLsmbRsRsmbLg
bLsLsmbLsbLsLsmbLgbLsLsmbLsbLibLsbRsbRsRsRsmmbLsbLgbLsbLgLsbLgbLgLsbLs
RsbLgbLgbRsLsbLgbLgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 46; Drug: PCAP931 10 然 Apo 0.5 然
bRhbLgbLobLsbLsbRsbRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 47; Drug: PCAP931 10 然 Apo 0.5 然
bRsbLsbLsbRsRsmbRgbLsbLobLgbRibRsLsLsmbRsbRsbRsRsLsmbLsbLsLsmbLsbLsbRs
bLsRsbLsLsmbLsRsbRsbRsbRgbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122212; End: 122712;
Recording: 8-1; Individual: 48; Drug: PCAP931 10 然 Apo 0.5 然
bRjbLsbRsbLsbLsbRgbLjLsmbLcLsmbLjbsbsbLsbLsbsbsbLibRjbRsbRsbsbRjbLsRsb
RsbLsLsmbRsbsbLjbsbRsbLcbLgbRibRgbLcbRgbLcbLcbLsbRsbLsLsLsmmbLobLhbsbL
iLsbsbLsbsbRgRsmbRsbRsbLgbLsbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 1; Drug: Control Apo 0.5 然
bLgLsbLgLsbLsbLgbRcbRsbRsbLiLsbRgRsmbRsbLjLgbLibRsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 2; Drug: Control Apo 0.5 然
bRgbLibRsbLoRsbLcbRsbLobRjbRcLsbRibLobLgLsbLsbLgbRobLcbLhLsbRgbRcbRcbL
gbLsRsbLobLibLsbRcbLcbRsbLcbRsRsmbLhbRsbRobLibRcRsmbRgbRsbLsbLcbLobLgb
LsLsmbLgbLgbRiLsbRhbLgbRobRcLsbRobRgbLgbLgbLsbRhbRsLsbRibLsbLsbRoLsbRs
bRcbRibsbRsLsbReRsmbRoRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 3; Drug: Control Apo 0.5 然
bLiLsbLsbRsRsmbRoRsmbLiLsbLsLsmbLobLibLsbLiLsRsbRsbLoRsbRsbLcbLgbRgbRs
bLcLsmbLiLsbLgbLgRsbLgbLsbRoRsmbRgbRiLsbLsbLgLsbLgLsbLcbLibsbRibLgbLgb
LsbLgbRsbLgbLgbRsLsbLgbLgbLsLsLsmmbLgbLgbLsbLibLsbRobLsbLibLjbLsbLjLgb
RsLsbLsbLobRgbRgbLsbLibLgRsbLibLgbLibLsLsmbLsLsmbLgbLsbLgbLgbLgbLsbLgL
sbLsbRobLhbRcRsmbLibLibLsbLgbLcbLcbLibLibLibRsRsmbLiLsbLsbLibLgbLibLgb
LibLgbRsbLgbLgbLsRsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 4; Drug: Control Apo 0.5 然
bRgbRsbRsLobLeRsbRobLcbRgbRcbRsbLgbRibRhLsbRgbRsbLibRsRsmbRgbLsbLibRsb
LobLhbLobLgbLsLsmbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 5; Drug: Control Apo 0.5 然
bRebRcbRobRjbLgLsbLgbRsbLgbRgbLgbRgbLgLsbLgbRsRsmbRcRcbRiRsmbRsbRhbRsR
smbLsLsmbRsLsbRhbRcbRcbRibRsbLgbRibRcLsbRibRhRsRsRimmbRibRhLsbRsbLob

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 6; Drug: Control Apo 0.5 然
bRgLsbRibLsRsbLjbRsbRsbRjRsmbRgbRsbLsLsmbLibLib

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 7; Drug: PCAP931 1 然 Apo 0.5 然
bLgbRgbLsbRsLsbRobLibLjbLhbLcbLobRsbRsRgbsbRsbLsLsmbRgbRcbLiLsbLsRsbRg
bRsbRgbRsbRsbRgRsRsmmbLibLjb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 8; Drug: PCAP931 1 然 Apo 0.5 然
bLsbLsbRsbRsbLsbLobRiRsmbLsRsbLsbRsbRiRsmbLgbLsbRsRsmbLgLsbLgbLsbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 9; Drug: PCAP931 1 然 Apo 0.5 然
bLsbRgLsbLgbRgLsbLgbRgbLsLsmbLsLsLsmmbRgbRsbLibRgbLjbRibLibRhLsbLibLsb
Lhb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 10; Drug: PCAP931 1 然 Apo 0.5 然
bRibLsbRsbLsbRsbLsbLgbLgbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 11; Drug: PCAP931 1 然 Apo 0.5 然
bLsbRibRgbLsLsmbLsbLobLjbLgbLsbRjRsmbRibRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 12; Drug: PCAP931 1 然 Apo 0.5 然
bLsLhbRibLsbRsbRsbRsbLhbsbLjbLsRsbLgLsbRgbRhb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 13; Drug: PCAP931 3 然 Apo 0.5 然
bRcbLjbLibLsbLsLsmbRcbLibLsbRebLsLsmbLcLsmbRcbLobRcRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 14; Drug: PCAP931 3 然 Apo 0.5 然
bLhbRgbLibLsbLgbRiRsmbLibRsbLibLgLsbLsLsmbLebRsbRibRsbLjLsmbLhbLgbLcbL
jbLgbLibLsbLgbLgRsbLgbLiLsbLibRcLsbRoLsbLsbLsbLsbRsbLsLcbLsLsLsmmbLebL
eb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 15; Drug: PCAP931 3 然 Apo 0.5 然
bLjbRibRsRsmbLgbLhbLjbLobRsbRjRsmbLcbLcbRgbRgbLsbLgbLjbRsbRibsbLsLsmbs
bRibLjbRcRsmbLgbRibLibLsbLgbRsbRhbRgRsLsmbLiLsbLsbRgbLibLib

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 16; Drug: PCAP931 3 然 Apo 0.5 然
bRsbRsRsmbRsbRsbLcLsmbLiLsbLsbLsLsmbLcRsbLgbLhbRsbRsRsmbRibLgbRsbLsbRs
RsmbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 17; Drug: PCAP931 3 然 Apo 0.5 然
bsbRgRsmbLsbRgbLsbsbRgbRsRsRsmmbRsbsbRsbLsbLsLsmbLsbLsLsmbRgbRsbRcbLgb
RjbRjRsmbLgbRiLsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 18; Drug: PCAP931 3 然 Apo 0.5 然
bLsbRgbLsLsmbLsbRsbRsLsbsbsbLobLsbLgbLsbLibsbRsbLgbRsLsbRsbLsbLsbLsRsb
RsbLsbRsbLsLsmbLsLgLsbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 19; Drug: PCAP931 10 然 Apo 0.5 然
bRgRsmbRsbRsbRsRsmbRsRsmbRsbRsbRsRsmbRsRsmbRsRsmbLsbRgbRibLsLsLsLsmmmb
LsbsbRibRsRsmbRsbRgbRsbRsbRgbRsRsmbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 20; Drug: PCAP931 10 然 Apo 0.5 然
bsbRsbRsLsbLsbRsRsmbRsbRsbLsLsmbLsLsLsmmbLsLsmbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 21; Drug: PCAP931 10 然 Apo 0.5 然
bRsbRgbRgbRcbLgbLsLsmbLsbLibLsbRobLgbLibRsbLibLsRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 22; Drug: PCAP931 10 然 Apo 0.5 然
bRiLsbRhRsmbRsRsLsmbRsRsmbRsbRsbRgbLsbRiRsmbLgbLsbLsbsbLsbLobLgbLsbLgb
LsbLgbRgbLjbRjbLibRjbRhbLobRibLjbRjbRibRjbLgbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 23; Drug: PCAP931 10 然 Apo 0.5 然
bRsRsmbRsbRsRsmbLgbRsLsbRsLsbLsLsmbLsbRsbLsLsmbRsbRsbRsbRgbRsbRsLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 24; Drug: PCAP931 10 然 Apo 0.5 然
bRsRsRsLsmmbRgbRgbRgRsmbRsbRiLsbLsbsbLsbRsbLsRsbRsbRsbRsbLsbLgLsbsbsbL
gbLcbLibLgbLsbLsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 25; Drug: Control Apo 0.5 然
bRgbLsbRibLibRibLsbLsbLobLsbLjLsmbLsbRsbRsbLsbLsbLgbRgbRsbRgLsbRjRsRsm
mbRjRsmbLgbRsbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 26; Drug: Control Apo 0.5 然
bRsbRgbRsbLsbRsRsmbRsbRsbRsbRgbRibRobRsbRsbLgbLsLsmbRgbLgLsbLsbRoRgbRg
RsmbRgbRsbLsbRsRibRsbLsbLsbLsLsmbLsbLjbLsbLhLsbLsLsmbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 27; Drug: Control Apo 0.5 然
bRibLgbRibsbLsbRsbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 28; Drug: Control Apo 0.5 然
bRsRsRsRgmmbsbLibLjbLjbLibRib

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 29; Drug: Control Apo 0.5 然
bRcbLcb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 30; Drug: Control Apo 0.5 然
bLiLsbLoLsmbLcLsmbLibLgbRgbLgbRgRsLsmbRiLgRsRsRsmmbRgbLebLgbRsbRsbLcRs
bLibLsbLibLibLibLgbLibLsbRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 31; Drug: PCAP931 1 然 Apo 0.5 然
bLgLsbLsbLgRsbLsLsRsmbLsbLsbLsbLsLsLsRsmmbLgbLsLsmbLgbLgbLiRsRsmbLsbRs
bLoLsmbRcbLgbRgbRsRgbRcbLhbLcbRibRcbLjbLibLgbLsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 32; Drug: PCAP931 1 然 Apo 0.5 然
bRebRebRcbRobLebRcbLebRobRcbRobRobLobLebLcbLebLobRobRcbLebRgbRobLebRsb
RibRibLobLcbRebLcbLobLobLsbRcbRobRebRobLcbRobLibLebLebRcbRobRobRibLebR
obRobLebRebRobLobRebRgbRibLobRobRebRobLsbRobLobLobRebLibLobRobLobRcbLi
bLebRcbLibRhbRebRibRobLobRgbLhbLebRebLebLibLsbLobRcbRobRobLobRebRobRob
RobLcbRebRhbLebLcbRgbLobRebLebLcbRgbRcbLobRebLibRgbRobRsbRobLobLebLobR
obLcbLsbRebLhbLebRebRebRgbRobLhbRcbLobRobRcbLobRebLibRebRebLebRebLobLe
bRobRebRobRibRcbRhbRebRcbRcbRcbRebRcbRobLebRcbLebRgbRobRibRcbRobRcbLob
LebRcbRobRobLobLebLcbRcbLebRsbLebRcbRhbLobLcbLcbLobLcbLebLibLcbRobRgbL
ibRobLobRcbRcbRobRobRgbRebLebLibRobRebLobLebRebRsbLebLsbLibLebLobLebRi
bLebLobLhbLibLobRcbRcbLobRobLebRobLhbRebLebLebRcbLibRobRobLhbRobLibLeb
RsbRobLebLebRebRibLcbLebRobRcbRobLobRcbLibRibLobRobLebLobRebRebRobRobR
obRobRobLebRobLobRobRcbRebRcbLobRobRobLobRobLgbLebLcbRobLsbRcbLebLhbRc
bLibRebLcbLcbRobLhbLgbLebLibLobRebLcbRcbLobRobRgbLobRibRebRcbLsbRobLob
LobRobLcbLibRsbRebLcbLibRobRsbLsbRebLobLebLcbLhbRibRibRebLobLobLebRobL
obRhbLsbLobRebLobRobRcbRobRobLobRobRibRcbLsbLebLebRjbRobRgbLebRgbRobLc
bLobRobRibRcbRobRsbLobLebRobLibLcbLobLcbRobRgbLobRobRobLobLcbRsbRcbLeb
LobRobRsbLcbRibRcbLebRobLebRibLcbRobRobLobLebLebLobLobRobRcbLobRobLobL
obLebRobLcbRcbLsbRobLibRobLobRsbLibRebRobLjbLobRcbRebRobLobLebRebRebRo
bRsbRhbRobLobLcbRobRcbLebLebLobRobLibLcbRobRgbLcbRibLhbRcbRcbLcbLebRcb
RgbLebLgbRobLebRebLobLcbRcbRobRobLobRsbLobLebRebRebLebLebRebRobLebRobR
obLebRcbLobRobRobLebLobLobLibRobRobLsbLobRobRobRobLobRobLgbRcbRobRcbRe
bRcbLebRebLobRcbLgbRcbRcbLobLcbRcbRcbRibLibRcbLobRobLobLcbLcbLgbLobLib
LebRobRcbRebLsbLebLgbRcbLhbRebRebLsbRobRobLobLobLhbRibRebLobLobLjbLobL
obLcbLibRcbRcbRobRibLsbLobLobLibLcbRobRebLgbRobRobRobLcbLibRobRobLobLo
bLebRebRebLobRobLobRebRgbLibRobRcbRobRgbLcbLibRebLobRebLobLobLebRcbRcb
RebLobRobRibLobRebLibLobRgbRobRobLobRobRcbRibRobLhbRobRobRcbLsbRobLibR
hbRobRobRobRobRgbLcbLobLobRsbRebRsbLobLcbLobRobLsbLebLobRebLebRobLobRo
bRebLebRobLobRgbRebLgbRobRobRibRcbLobLobRebRobRobRobLibRebRebLcbRobLhb
RgbLhbRsbLebRgbRobRebRobLobRgbRobRobRcbRebRcbLcbRobRebLobRobLibRsbLgbR
ebRebLobRebLcbLebRgbLobLgbLgbRobRobLjbLobLgbLjbRobLsbRcbLebRobRcbLobRo
bLebRsbRobRobLcbLibLobRgbRibLhbLgbLgbLgbLgbLebLgbRobRobLebRobRebLsbReb
LobLibRibRcbRobRebLebRobLobLebRobLhbLcbRebLsbRjbRgbLebRsbLgbLobLobRobR
obRebRobLebRobLibLibLobLcbRgbLobLcbLhbRebLibRebLobLebRebLobRibRobRsbLc
bLobRobRebLobLobRhbRobLobLcbLobRobRobRobRobRobLhbLebRgbRebLcbRobLebRob
LobRobLgbRebLgbRcbLobLcbLebLobRsbLobLhbLebLcbLebRobLobLobRebLebLebRobR
cbRobRobRobLobLibRobRobLobRgbRebLobRibRobLcbLobLgbRobLobLobRjbRcbRibLe
bRebRebRebRcbLebLcbRcbLobLebRjbLhbRibLgbLobRobRibLobLcbRcbRsbLcbRcbLcb
RgbLebLebRobLebLobRebLobLobLcbRgbLebLobRebLgbLibLobRibLobRobLobRebRcbL
obLobLcbRobRobRcbRgbRebRobLebRibRebRobLobRebRobLgbLobLebRebRebLobRgbLo
bRobRebRebLobRcbRobRhbLcbLebRobLsbLebLobLgbLcbRhbRjbRebLebRcbLjbLebRob
RcbLobRjbRgbLjbLebLcbLobLobLobLjbLsbRcbLcbRjbRsbRebRjbLobLibLobLobLobL
ebRobRcbLsbLobRcbRobRobLobLibRjbLebRobLibLsbLobRsbRobLibRibLibRcbRgbLo
bLebLobRcbLobRebRjbRebRebRebRobLgbLsbRebLobRsbLcbRibRebRobLcbRjbRobLob
RobRsbLobRebLeb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 33; Drug: PCAP931 1 然 Apo 0.5 然
bRibLsbLiRsbRsbLcbRsRsmbRhbLjbRcbLsbLjbLsLcbRgbRobLibLobRobLhbLibLibLo
bRibRobLgbLgbLibLgLsbRgbLgbLsbLibLgbLibRgbLibRsbLcbRgRhbLebLoRsbRibLgb
RcRsmbRsbRgbLsbRibRsbRhLsLsmbLsbRebRibRsbLibLgRsbRsbRibLcbLiRsbRcLsbRc
bLcRsbRibRcbLibRibRobRhbLsbReRsmbLjLcb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 34; Drug: PCAP931 1 然 Apo 0.5 然
bRcbRobLsbLjbRcbLobRibLgbLgbRhbRgbLibLgbLeLsbLhbLibLsbReRsmbRgbRobRsbL
gbRsRsRsmmbRiRsmbRibRsbLiLsbRebRcbRsbLcb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 35; Drug: PCAP931 1 然 Apo 0.5 然
bRgbRgLsbLjbLgbRsbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 36; Drug: PCAP931 1 然 Apo 0.5 然
bLiRsbLjLsmbRobLsbLcLsmbRjRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 37; Drug: PCAP931 3 然 Apo 0.5 然
bLsbRjbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 38; Drug: PCAP931 3 然 Apo 0.5 然
bRgbRgbRsbsbRsRsRsmmb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 39; Drug: PCAP931 3 然 Apo 0.5 然
bLobLsbLgbRsbLgbLgbLsLsmbRsbLgbLibRsbLgRsbRsbRsbLgbLgRsbLsbLsbLibRcbLi
RsbRsRsmbLcLsmbRcbLgbRibLsbLgbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 40; Drug: PCAP931 3 然 Apo 0.5 然
bLcbLsbLsbRsbsbRsbRgbsbRsRsmbRsbsbsbRiLsLsmbRsRsmbRsLsbRsbsbsbRsRsmbRs
RsRsmmbRsRsmbRsRsmbRsRsmbRsRsmbRsbRgbRsbLsRgRsRsmmbRsbRsbRsbsbLgLsbLsR
sbRjbRcbRsbRsRsRsmmbRsRsmbRsbRsRsmbRgbRgbRsbLsRsbRsbRsbRsbRgbRgbRsbRsR
smbRsRsmbRsbRsbRsbsbRsbRob

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 41; Drug: PCAP931 3 然 Apo 0.5 然
bLhbLsbLsbRcbRsbLsbLgbLsbRobRoLeLsLsmbLcbLcbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 42; Drug: PCAP931 3 然 Apo 0.5 然
bLjLsRsmbLsbRsbLgbLsbLgRsbLsbLgbLcbRgbRsbRgbRsbRgbRgbLsLhbLsbLgbLsbLgb
LsbLsLsmbLgbLsbLsLsmbLsLsLsmmbLsbLsbLjLsmbLsbRsbLsLsmbLsLgbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 43; Drug: PCAP931 10 然 Apo 0.5 然
bLibLsbRiLsbLcbLgbLibLibLoRgbLsRsbRsRsmbRibLgRsbLgLsbRsRsmbLsLsmbLiLsb
LcbRob

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 44; Drug: PCAP931 10 然 Apo 0.5 然
bRoRsmbLobLgLsbRcbLgRsbLsbRob

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 45; Drug: PCAP931 10 然 Apo 0.5 然
bLsLsLsmmbRsLsbRsRsmbRsbRsbLsLsmbLsLsmbLsbLsbLsbLsLsmbLsLsmbLgbLsbLsbL
sbLsbLsbRsbLsbLsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 46; Drug: PCAP931 10 然 Apo 0.5 然
bRgbRobLibRgbRgbRibRgRsmbLgbRob

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 47; Drug: PCAP931 10 然 Apo 0.5 然
bLibLgLsbLhbLhbLsRsbRsbLcbLobLibRsRsmbRgbLsbRsbLgbLiRsbLgLsbRsbLiLsbLo
LsRsmbRsbLoRsRsmbRgbLgbRsbRsRsmbRsbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 122714; End: 123214;
Recording: 9-1; Individual: 48; Drug: PCAP931 10 然 Apo 0.5 然
bLsLsmbLgRsbLsbLcbRsLgbsbsbRsbsbsbRsbRsRsmbRjbLgbLsLsmbRsbRsRsmbLjbLsb
RiLsRsbRsbRsRsmbRcbRsbLcbRsbRsbsbLsbLibLsbRsRsmbLsLsmbLsbsbLgbLgbsbRgb
RsbRsbRsbLsbLsLsLsLsmmmbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 1; Drug: Control Apo 0.5 然
bRsbRsLsbRobLibLiLsbLibLsbLgbRsbLsLsmbRsbRgbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 2; Drug: Control Apo 0.5 然
bRibRobLjbLobRgLsLsLsmmbLsbLsbLgbRsbLibRsbRiLsbRibLsbRobRsbRibRobLcbLo
bRiLsbRgbRcbRcbLgbLsbLsbLsbsbRobRcbRebRobRgbLsbLcbRgbLcbRsbRsbLoRsbsbL
ibLsbRgLsLsmbRjbReLsRsbRsbRibRibLsbRoLsbLgbRgLsbLibLgbRsbRoLsbLibRsbLi
bLgbLsbLsbLibRsbRsbRjbLibLsbLcbRcbRsbRjbRgbLhbLjbLjbRsbLhbRgRsmbLibRsb
LcbRgbRgbLibRsbRsbLcbRsbRcbRcbLgLsbRsbRobRsbLsbLgLsbLgbLgbLsbLobRgbLib
RsbRsbRgbRcbLjLsmbRobLsbLsbLjbLgbLgLsbLsbLgbRsLsbLsLsmbLgbLgbLsbLgbLcL
gbRobLgbLsbLsbRgbRibRobLsbLsbLsbLsbLcbRgbLobLibLgbLsLsLsmmbLgbLsbRobLc
bLjbLobRjbLobRsbLcbLcbRsLsbLsbLsbLcbRsLsbLsLsmbLobLibLsbLibLgbLcbRgbRo
bRoLsbRibRcbRobLibRobRcRsmbLgbRobRsbRcbRsLsbRhbRsbRibRsbLjbLsbRibRjbLg
bRhbLjbRcbLibLibRoLsbRsLsbLibRsbRsbRobLjbRoLsbRgbLibRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 3; Drug: Control Apo 0.5 然
bLobLibLiLsbRsRsmbRsRjbRcRsmbRibLsbRcRsmbRgbRsbRgbRsbRgRsmbRsbLgbLjbRg
bsbLsbLgLsbLsbRgbLjLsmbLsLsmbRsbRsRcbLibLsbLcbLgbLibLibLiLsbLcbLcLsRsm
bRsLsbRgRsmbRgbLcbLcbLibLsbLgLsRsbLgbLsLsmbLgbLibRsbLsbLsbLiLsbLsbLgbR
sbLsLsmbLgbLibLsbRsRsmbLiLsbLgbLsbLgbLsbLgbLsbLgbLsLsmbLcbLcbLebRibLgb
LcbLibRsbLibLsbLgbLibLgbRsRsmbRsbLsbLibLibLsLsmbLsbLgLsbLsbLibLibLgbLi
bLsbRgbRgLsbLgbLebLob

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 4; Drug: Control Apo 0.5 然
bRibRgbLgbRibRsbLgbLgbRjbLjbLobLobLobLibLsLsmbRsRgbRcbLjbLhbLibLsbLgbR
gbLhbLsbRsLsbRsLsbLcbLibRsRsmbRgbRibLgbRgbLibLgbLgbLsbLsbLsbLjbRobLhbL
sbRibRiRsmbRsbLiLsbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 5; Drug: Control Apo 0.5 然
bRibLhbRcRsmbRibLgbRiRsmbRsbRobRhbRhbRiRsmbLgbRsbRcbRebRcbRibRsRsmbRsb
RibLsbRibRgbLobRibRsbLgbRibRcbLgRsbRgbRibRsbRjbLibRsbRcbLcbLjbRcbRibRg
bRsbRoRsmbRibRibLgbLgbLgbRhb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 6; Drug: Control Apo 0.5 然
bRibLibRgbRcbRgbRoRsmbRjbRjbLibRibLsRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 7; Drug: PCAP931 1 然 Apo 0.5 然
bLsbLcbRsbRiRsmbRiRsmbRsbRgbRsbLibRgbRgbRsbLgbLsbLgbRsbRgbRgRsmbRgRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 8; Drug: PCAP931 1 然 Apo 0.5 然
bLeRsbRjRsmbRgbRiRsmbRgRsmbRiRsmbLsbRcbRibRsbLcbLhbLibRsbLjbLsRsbLsbRg
bRgRsRsmmbLsLsmbLiRsbLgbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 9; Drug: PCAP931 1 然 Apo 0.5 然
bRgLsbLgbRsRsmbLsbLsRsbLebLcLsmbRsbLoLsRsmbRgbLsLsmbLibLsbRsbLcLsmbRsb
RsRsLsmbLgbLsbLoRsbRgbRgRsRgmbRibLcRsbRgbLgbRgbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 10; Drug: PCAP931 1 然 Apo 0.5 然
bRibLgRsbRgbRibRsbLsRcbLsbRsbRsbLsbLsbLsbRsRsmbRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 11; Drug: PCAP931 1 然 Apo 0.5 然
bRgbRjbRgbLgRsbRobRgbRgbRibLsbRibRgRsmbRgbLsbLhbLsbRjbRhb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 12; Drug: PCAP931 1 然 Apo 0.5 然
bRjbLoLgbRgbLsbLsbsbRsLsbRgbRsRsmbRgbLjbRjRsmbRsbRsbRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 13; Drug: PCAP931 3 然 Apo 0.5 然
bRgbLcbRcbRibRsbLcLsmbRjbRgbRobRibRsRsRsmmbsbRgbRsbRgbRsbLebRsbLob

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 14; Drug: PCAP931 3 然 Apo 0.5 然
bLgLsbLgbRsLsbLibLebRsbRobLhbRgRsmbRsbRibRhbRgbLibRsbLgRsbLsbLcbLgbLeb
RsbRobLibsbLsbLsbLsLsmbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 15; Drug: PCAP931 3 然 Apo 0.5 然
bRcRsmbLsLsmbRgbRhbRibRcbLibLgbLgbRsbLibRsbsbLgbLibLsLsmbLsRsbRsbRsbLo
RsLsbLsbRsLsbLgbLsbLgbLsbLsLsmbLsLsmbLsbReRsmbRgRsmbRgbLjbLcbLcbRsbRsR
smbsbLibRsbLibLsbLibLsbRsbLjb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 16; Drug: PCAP931 3 然 Apo 0.5 然
bLsbsbRsbLgbLsLsmbRgbLibLibLibLhbRgbRcRsmbRcRsmbRsRsmbRgbLhbRgRsmbRgbs
bLjbLgbRgbLibRsRsRsmmbRgbLgbLsLsmbRsbLgbLibLsbLcLsmbRgbLibLsbLcbLsbLsb
RjLsbRsbLsbRgbRsbRgbLsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 17; Drug: PCAP931 3 然 Apo 0.5 然
bRsbRjRsRsRsmmmbLsbRsLsbRsbRsbRgbRgLsbRsbLsbRsLsbLobRibRiRsmbRcbLgbRsR
sRsmmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 18; Drug: PCAP931 3 然 Apo 0.5 然
bLsbLsLsmbLgbRibRibLsbRibsbRsbLsbRcRebRgbRgbLsbRgbRgbLsbRcbLsbLsbLsRsb
RhLsbLcbLibLibLsbRobLcLsmbLgbLgbLibLsbLgbLcbLibLsbLsLsmbLgLsbLgbLgbLsb
LgLsbLgbLgLsbLgbLcbLgbLsLsmbLsbLobLsbRsRsmbLgLgbRob

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 19; Drug: PCAP931 10 然 Apo 0.5 然
bRsbRsRsmbRsbRsbRsbRsbRsbRsbRsbRsLsbRsbRgLsRsRsmbRsbRsbRsbRsbLibRsbsbR
sbsbsbsbsbsbsbsbsbLsbRsbRsbsbRsbRsbRgRsmbRsbLsRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 20; Drug: PCAP931 10 然 Apo 0.5 然
bLjbLjbLgRsbLgbLgbLsbsbLsbRsbLsbLgLsLsmbLgLsbsbRsbsbsbRsLsLsmbLsbLsbsb
RsbRsbLsRsLsbLgbLsbLgRsbLsLsmbLsLsmbLsbLgbLsbLsbsbsbLsbLsbLsRsbLsRsbLs
bLsLsRsmbLsbRsLsbLsbLsbLsLsmbLsbLsbLsLsmbLcLsmbRsbLsbLsbRsbRsbRsbRsbLs
RsbRsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 21; Drug: PCAP931 10 然 Apo 0.5 然
bLsbLgbLibLgbLsbLsbLjbRsbLgbLsbLsbLsbLsbLsLsmbRsRobLgbLjbLgbLsbsbRobLs
LsmbLsbLgbLiRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 22; Drug: PCAP931 10 然 Apo 0.5 然
bRgbLjbLobLgbRjbRcLsbRsbRjbRgbRsLsbRsRsmbLoRsbRsbRgRsmbRgbLgbLgbRgbRsb
RobLcbLiLsbLjLsmbRhbLsRsbRgbLsbRgbLgRsbLjbRsbLibRsbLjbRjbLibLsbRibRibR
jbRsbRiRsmbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 23; Drug: PCAP931 10 然 Apo 0.5 然
bRsbRsbRsRsmbRsbLsbRsbLgbLsbRsLsbLsbLsRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 24; Drug: PCAP931 10 然 Apo 0.5 然
bLgLsLsLsmmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 25; Drug: Control Apo 0.5 然
bRiRsmbLcbsbRibLiRsbRcbLsbLgbRcbRsbRobRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 26; Drug: Control Apo 0.5 然
bLsLsmbLsbLsbLgbRsbRsbLsbLsbLgbLsbLgbLsLsmbLgbRgLsbLsbLiRsbRjRsmbLgbRg
bLsbLibLibLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 27; Drug: Control Apo 0.5 然
bsbLjbRgRsmbRgRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 28; Drug: Control Apo 0.5 然
bRsLsbLsbLjbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 29; Drug: Control Apo 0.5 然
bRjbLcbRgbRsbRsbLcbRgRsmbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 30; Drug: Control Apo 0.5 然
bLgLsbLibLcbLcbLsLibLibLgbLgLsbsbLibRgRsmbRgbLgbLsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 31; Drug: PCAP931 1 然 Apo 0.5 然
bLsLsLsmmbLsbLhbLibLgbRsbRsbRibLjbRhbLcbLhbRibRhbRibLebLib

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 32; Drug: PCAP931 1 然 Apo 0.5 然
bLsbLsLsRsmbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 33; Drug: PCAP931 1 然 Apo 0.5 然
bRcRiRsmbRoRsmbRcbLgbLiRsbLsbRebRjbLcRsbRgRsmbRoLsbRjbRhbLsbLsLsmbLsbR
sbRgbRibRgbRibLibRsbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 34; Drug: PCAP931 1 然 Apo 0.5 然
bRibRsbLibLsbRhbLsbLsbLibLgLsbLsRsbLsLsmbRibLsbLgbLsbRsbRsbLgLsbLgbRiR
smbLsbLsbLgbLgbRgbRgbLgbLebLsbRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 35; Drug: PCAP931 1 然 Apo 0.5 然
bLgbRsbRcbRoLsRsLsbRsbRsbRgbRsRsRsmmbRsbRsRsRsmmbRsbRsRsmbRsbLsbRhbRoL
sbRsbLjbsbRjbLsbLsbLibRgRsmbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 36; Drug: PCAP931 1 然 Apo 0.5 然
bRgbRibRibLsLsmbLgbLgbRsbRgbLsbLjbLsbLibLsbLsbRcbRhbLibLibRjbLsLcbRjRs
mbRjRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 37; Drug: PCAP931 3 然 Apo 0.5 然
b

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 38; Drug: PCAP931 3 然 Apo 0.5 然
bLsbRsbRiRsmbRgRsmbRsbRsbRsbRsbLsbLsbRsbRsRsmbRgbRsbRsbRsbRsbLsbLsbLsb
RsbRsbRsbRsbRgbRgLsbRsbLsbRsRsLsmbRsbRsbRsRsRsmmbRsbLsbRsbRgbRgRsmbRsb
RgbLibRgbRibRoRsmbRibRsbRsbRoRsmbRgbLsLsLsmmbLgbLsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 39; Drug: PCAP931 3 然 Apo 0.5 然
bLsbLiLsbRgbRgbRoLsbRsbRsbRobRsbRsRsmbLobLcbRgbRsbLibLgLsbLsbLgbLgbLsb
LgbRibLjbRibRgLgbLgbRibLsbRgbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 40; Drug: PCAP931 3 然 Apo 0.5 然
bRobRsbRsbsbRsRsRsmmbRibRsbsbsbsbsbRsbRoRsmbsbsbLsbLsbRobRsRsmbRsbRsbR
sRsmbsbLsRsbRsbsbRsRsmbRiRsmbRgbRibRgbsbRsbRsbRsbsbLsbRibRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 41; Drug: PCAP931 3 然 Apo 0.5 然
bRobLobRgRsmbRibRsbLsbRhbLoLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 42; Drug: PCAP931 3 然 Apo 0.5 然
bsbLsbLsbLgbLsbRsbLsLsmbRsbLsLsmbsbRobRsbLsLsLsmmbLsLsLsmmbLsbLgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 43; Drug: PCAP931 10 然 Apo 0.5 然
bLgbLoLsmbRsRobRcbRsbLibLoRsLsbLcbLcbLsbLgbLibLobLgbLjbLoLsmbLgbLgbRoL
sbLiLsLsmbRsbLgbRsbRsRsmbLgbLebRoRsmbLgbRsRsmbLsbLibLgbRgRsmbRgRsmbRsb
LgbRgRsmbRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 44; Drug: PCAP931 10 然 Apo 0.5 然
bLsbLsbLsbLsbLgbRsRsmbRsbLsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 45; Drug: PCAP931 10 然 Apo 0.5 然
bLsbLsLsmbLsbLsbRobLgLsbLsLsmbRsLsbLsLsmbLsLgLsbRsLsbLsbLgLsbLsLsLsRsm
mbLgLsbLsbLgbLibLcbRobRcbRibLoLsmbRobRcbLgLsbLcbRsbLiLsbLsLsLsmmbLgLsb
LgbLsLsmbLsLsmbLsLsLsmmbLsbLhbLiLsbLsLsLsmmbLgLsbsbLgbLsLsLsLsmmmbLsLs
mbRsbLgLsbLhbLgbLibLgLsbsbRgbLgbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 46; Drug: PCAP931 10 然 Apo 0.5 然
b

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 47; Drug: PCAP931 10 然 Apo 0.5 然
bLcbLsbLsbLgbLgbLobRgbRsbRsRsmbRsbRsbRsbRgbRsbRsbLsLsmbLjbLoRsbRsLsbLc
LsmbLcbRgRsmbRsbLibLgbRgbRgbRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123215; End: 123715;
Recording: 10-1; Individual: 48; Drug: PCAP931 10 然 Apo 0.5 然
bRsRsmbRsRsmbRsbRsbRsRsmbLiLsbRsbRsRgbLsLsmbsbLsbRcbLsLgLsbLibLsbRsbLs
LsLsRsmmbLsbLcLsmbsbLjbRsbsbRsbsbLibLsLsmbRgbLsbLibRcbLsbRsbRcbsbRsRsm
bLsbLsbRjRsmbRcbLsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 1; Drug: Control Apo 0.5 然
bRgbLgbRjbLgbLobLsbLibLgbLgbLgbLhbsbLgbRsbLgLsRsbRgbLsbRgbLgLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 2; Drug: Control Apo 0.5 然
bLsbLibLgbLgbRsbRgbRgbLcbLcLsmbLibLsbRcbLgbLgbLcbLobLibLsbLsbRsbRsRjbL
ibRibRgbRobLibLsbRgbRsbRhbRcbRsbLsbLsbRgbLsbLibRsbRcbRhbRgbRhbRsbLhbRc
bLsbLhbLhLsbLsbLiLsbLsbRjbRhbsbRcbRiRsmbRsbRsbLibLoLsmbRjbLibLcbLsbLcb
LsLib

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 3; Drug: Control Apo 0.5 然
bLgbLsbLibLsbRsbLibLsbLgbLsbRsbLgbRsbLgRsbLgLsbLsbLgbLsbLgLsbRgbLibRsb
RsbLgLsbLgLsbLgbLsbLgbLsbLgbLsbLsbLgLsRsLsbRsLsbRsLsbLgbLsbLgbLgRsbLgb
LgbLgbLgbLibLiLsbLsLsmbLgbLgLsbLsbLgbLsbLgbLgbLsRsbLibLgbRsbLibLsLsmbL
gLsbLgLsbLgLsbLgbLgbLgbLgbLgbLgLsbLsbLsbLjbLobRhbRgbLgLsbLsbLgbLjbLibL
gbLgbLsbLebLsLsLsmmbLibLsbRebLoLsmbLgbLsbLsbLcbLhbLebLgbLobLibLhbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 4; Drug: Control Apo 0.5 然
bRhbRcRsmbRebRoRsmbLsbRiRsmbLjbRcbRibLibRgbLcbRgbRsLsbRgbRibLiLsbLsbRs
bRhbRgbLsbRibLgbLeLsLsmbLsbLiLsbRsbRsbRebRcbRibRgbRibRsbLgbRsLsbRgbLib
LebLibRjLsbRgbLsRsbLgbRibLjbRibRobRibRsbLjbRibLsbLibLibLgbRsbRebRgbRcb
LeLsbLcLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 5; Drug: Control Apo 0.5 然
bRcbRhbRsbRibLsbRcRsmbRibRsbRhbLsbRibRsbRsbRcbLcbRibLibRsbLsbLjLgbLgbL
gbRsRsmbRibLsRsbRgbLjbLobLibRibRibRibLibLsRhbRcbLgbLgbRibRcLsbRcbLsbRs
bLgbLgbRobLibRcbLgbRhbRibRsbRgbRgbRsRsmbRibRgRsmbLsbRcbLgbRibRsbRgbRgb
LobLcbRibRcbRcbRcbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 6; Drug: Control Apo 0.5 然
bLibRibRcbLgRsbLcbRhbRsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 7; Drug: PCAP931 1 然 Apo 0.5 然
bRgbRgLsbRgbRibRibRsbRgbRibRobLiLsbLsbLibLibLsbReLcbRcRsmbRcbLibRobRhb
LsRsbLibLsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 8; Drug: PCAP931 1 然 Apo 0.5 然
bLgbRobRgRsmbLsbRgRsmbLsbLsbRgbLiLsLsmbLsLsmbLsLsmbLgbLsLsmbRsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 9; Drug: PCAP931 1 然 Apo 0.5 然
bLgbLcLsmbRsbRgbRsbLsbRcbRibRsbRgbRsbRsbRcbLsbLjbLebRjbLibLsbLgLsbRgbL
gLsbRgbLsbLgbRsbLgLsbRjRsmbLsLsmbLgbLgbLsbLgLsbLgbLsbRsLsbLgbLibRsbLib
RsLsbLgbLhbLjb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 10; Drug: PCAP931 1 然 Apo 0.5 然
bRsbRsbRsRsmbRsRsRsRsmmmbRsbRsbRgbRsbRgbRibLsLsmbLgbRsbRsbRsbLsbLgbLgb
LcbRjRgbLsLsmbRsbRibRsbRgbRsbRsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 11; Drug: PCAP931 1 然 Apo 0.5 然
bLsbRgbRgbRgLgbLcbRgRsmbLgbLsLsmbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 12; Drug: PCAP931 1 然 Apo 0.5 然
bLgbLsbLgbLsbLsbLsLsmbLsbLsbLsRsbLsbsbLsRsbLgbLoLsmbLgbRgbRgbLgbLjLsLs
mmbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 13; Drug: PCAP931 3 然 Apo 0.5 然
bRibRsbLhbRsbRcbRhLsbLgLsbLsbRhbLobLcbRibLsbRsRsmbRgbRiRsmbLsbRibRgLsb
RsbRgbLsbRibRsbLsbLsbRibRsbRsbRsbRibRsbRgbRsbRgbLsRsbRsbRgRsmbLsRsbLsb
RgRsmbRsbsbRsbLgbsbsbRgbRsRsmbRgbRhbLcbRcbRgbRsbRgbRgbRgbLgbRcbRjRgbRs
bRjbLibRsbRsbRsbRgLsbRsRsmbLoLsmbLobLjbLoRsbLob

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 14; Drug: PCAP931 3 然 Apo 0.5 然
bRobRsbRibRobLhbRsbLgLsbLjLsmbLiLsbLsbRsbLjLsmbRjbLsLsmbLgbLcbRsRjbRsb
LjbLjbLsLjLibLsbLgbLgRsbRcbRcbLsbLcbLgbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 15; Drug: PCAP931 3 然 Apo 0.5 然
bLgLsbRgbLsbLiRsbLsbLgbsbLjLsmbLsbLjbRibLibLgbRsbRiRsmbRsbRjbRhb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 16; Drug: PCAP931 3 然 Apo 0.5 然
bLsbRhbRsbRsbRsbRsRsmbLjbLjLjbRjRsmbRgbRsbRsbRgbLcbLsLsLsmmbLsLsmbLsLg
bLsbRsbRsRsmbLibRgRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 17; Drug: PCAP931 3 然 Apo 0.5 然
bLsbLgLsbLgbRsLsbLgbRgbLhbRgbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 18; Drug: PCAP931 3 然 Apo 0.5 然
bRcLsRsbLgbLsbLoLsmbRgbRobRcbRoRsmbLgLsbLsRobRobsbsbsbsbRsbLsbLsLsmbRs
bRgbRsbRsbLsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 19; Drug: PCAP931 10 然 Apo 0.5 然
bRsbRsRsmbRsRsmbRsLsbRsbRsLsbRsbRjLsbRsbRiRsmbLsbRibRgRsmbRsbRibRsbRsR
smbLsbRsbLibRsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 20; Drug: PCAP931 10 然 Apo 0.5 然
bLsLsRsmbRsbRsRsmbRsbRsbLsRsbRsbRsRsmbRsbRsbRsbLsbLsLsmbLgRsbLsbsbLsLs
mbLsbLsbRsLsbLsbLsbLsbLsbLsbLsLsmbLsbLsbLsbLsbLsLsLsmmbLsRsbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 21; Drug: PCAP931 10 然 Apo 0.5 然
bLcRsLsLsmbRhbRsbLsLsmbsbLsbRobLsbLibLibLsbRsRsmbLgbRjbRsRsmbRgbRgLsbL
gbRgbLeLsbLsLgbLibLsRsbLsRsbsbLibLsbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 22; Drug: PCAP931 10 然 Apo 0.5 然
bRibLsbLobLgbRgbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 23; Drug: PCAP931 10 然 Apo 0.5 然
bLgRsbRsbLgbRsbLgbLsbsbRsRsLsmbLsLsmbLgbRebRcbRibRsbRsbRhLsbRebRsbRgbR
gbRsbLsLsRsmbLibRibLgbRsbRsbRibRhbLcbRhbLgRsbRjbLcbRgbLsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 24; Drug: PCAP931 10 然 Apo 0.5 然
bRsbLsbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 25; Drug: Control Apo 0.5 然
bLibRgRsmbRjbRgRsmbLgbRgRsmbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 26; Drug: Control Apo 0.5 然
bLgbLsbLiRsbLsbLsbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 27; Drug: Control Apo 0.5 然
bsbsbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 28; Drug: Control Apo 0.5 然
bRgbRgbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 29; Drug: Control Apo 0.5 然
bLjbRhbRcbRgbLsbRhLsbRibLhbLsbLsLibLsbRsLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 30; Drug: Control Apo 0.5 然
bLgbRibRcbRoRsmbRgbRsbRsbLibLgLsLsmbLgbLgLsbLiRsbRsRsmbLibLgLsbLcbRcRg
bRcbLgbRgbLgbRibLgbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 31; Drug: PCAP931 1 然 Apo 0.5 然
bLsbsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 32; Drug: PCAP931 1 然 Apo 0.5 然
bLsLsmbLsLsmbLsLsLsmmbRsRsmbRgRsmbRgRsmbLsbRgbRsbRsbRsbRgbRsRsmbRhbRgb
Rsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 33; Drug: PCAP931 1 然 Apo 0.5 然
bRiRsLsmbRobRjbRibRobRcbRoRsmbRibLsLsmbLhbRhbLibRsbLibRgLsbRsRobRsbRhb
Rsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 34; Drug: PCAP931 1 然 Apo 0.5 然
bLcLsmbLgbLgbLsLsRsmbLsbLsbLgbLsbLibLsLsmbLgbRhbRcbLcbLcbLgbLsbLsbLsbL
sbLhLsbRgbRsbRsbLgbLgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 35; Drug: PCAP931 1 然 Apo 0.5 然
bRgbRsbRoRsLsmbRsRsmbRjbRibRgbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 36; Drug: PCAP931 1 然 Apo 0.5 然
bRcbLcbLebLjbRibLebRiRsmbLobLobLibLgLsbLgbLsbRsbLsbRgbLhbRjbLhbRhbLibL
ibLsbLgLsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 37; Drug: PCAP931 3 然 Apo 0.5 然
bLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 38; Drug: PCAP931 3 然 Apo 0.5 然
bRsbLgbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 39; Drug: PCAP931 3 然 Apo 0.5 然
bLsbLgbRsbLgbLibLgbLsbRgbRgbRebRcbLjbLibRsbRibRibRsbRobRgRsmbRsbLgbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 40; Drug: PCAP931 3 然 Apo 0.5 然
bRsbRcRsmbLgbLsbLsbLcbLgbRsbRgbRiRsmbRsRsmbLsRsbRcbRsRsRsmmbRsRsmbRgRs
mbRsbsbRibRsRgbRsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 41; Drug: PCAP931 3 然 Apo 0.5 然
bRebsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 42; Drug: PCAP931 3 然 Apo 0.5 然
bLsbLsbLgbLsbLsbLsbLsbLsbLsbLsbLsbLsbLsbLgRsbLsLsmbLsbLgbLsbLsbLsbLsbL
sbLsLsLsmmbLsbLgRsbLsbLsbLsbLsbLsbLsbLjb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 43; Drug: PCAP931 10 然 Apo 0.5 然
bLgLsbLibRoRsmbRebLjLsmbLoLsmbRsbRsbRsRgRsmbLsbLsbLibLibLcbLobRsRsmbLc
bLsbLibLgbLgbLoLsmbRjbLcbLibLsbLsbLsbRgRsmbRibLgbsbRsbLsbLsbLsbRiRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 44; Drug: PCAP931 10 然 Apo 0.5 然
bLsbLsbLsRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 45; Drug: PCAP931 10 然 Apo 0.5 然
bLsbLsLsLsmmbRsLsbLsbLgbLsbRsbLsbLgbRsbRsbLsbLsRsbLebLcbLiLsLsmbLgbLsb
LsbLgLsbLgbLsbRsRsmbLibRsbRsRsmbLsbLibRgLsRsbLsbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 46; Drug: PCAP931 10 然 Apo 0.5 然
bLgbRiLsbLgbLsbLsbRibRebLcbRjbLebLjb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 47; Drug: PCAP931 10 然 Apo 0.5 然
bRgRsmbLsbRsbLsbLsbLjRsbRsbRsbRsbRsLsbRsRsmbRsRsRsmmbLsbLobLiLsbRsbLob
LibRgRsmbRsRsmbRgbRgbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 123717; End: 124217;
Recording: 11-1; Individual: 48; Drug: PCAP931 10 然 Apo 0.5 然
bRgbLjbRcbLibLsbLgbLsLsmbRsbRoRsmbLiLsRsbRsbLibRibLgbLsbLsbRgRsmbLgbsb
sbLsbRsRsmbLsbsbLjbLjLsmbRjbRcRsmbLhLsbLgLsLsmbsbLsbRcb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 1; Drug: Control Apo 0.5 然
bRsRsmbLgLsbRsbLobLgbLsbLgbLgbRgbLsbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 2; Drug: Control Apo 0.5 然
bLibRsbRgbLibRsbRgbLsbRgbRibRhLsbRoLsbLsbLobRgbRsbRcbLgbRsbRhbRibLcbLi
bLhbRgRsmbLgLsbRsRsmbRgbLsbRcbRcbRhbLgbLiLsbLhRsbRsbRcbLjbRobRsbLiLsbR
sbLibLobRgbRjbRoLsbRobLgbLsbRcbRobLibRgbRcRsmbLibLhbRobRibRsbLibRgbLsb
LcbsbLcbRgbLgLsbLiRsbRcbRhbLhbsbRhbRcbLgbLibLibRobRobRsbLsbLsbRsbLhLsb
RgbLobRgbRsbLsbLgbLsbLgbLsbLgbRsbLoLsmbRgbLsbLsbLsbLibLgbLiRsbRsbRjbRh
bRibLgbRhbRgbLsbLjbRgbLob

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 3; Drug: Control Apo 0.5 然
bLcbLsbRcbLjbLibRobLsbLobsbLhbRobLgbRsbRjbsbLsLsmbRjRsmbLhbRjRsmbRgbRs
bRcbRsbRobRgbLhbLcbLibLgbLgLgLsbLoLsmbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 4; Drug: Control Apo 0.5 然
bRhbLobRcbRgbRsLsbLcbRjRsmbRibRcbRjbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 5; Drug: Control Apo 0.5 然
bRhbRoRsmbRobRgRsmbRsbLhbRsbLhbRobRsbLcbRebLgbLsbRibRobRhbRibRcbRgbLgb
RgbLsbRcbLgbRhbRibRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 6; Drug: Control Apo 0.5 然
bRcbRhbRsRgbRgbLsbLsbRiLsbRibRibRjRsmbRsbLsbLgbLgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 7; Drug: PCAP931 1 然 Apo 0.5 然
bRhbLjbLcbRsbsbRsbRsbRcbLgbLgLsbLsbRsbRgbRcLsRsbRibLgbLibRsbLhRsbRgbRs
LsbLiRsbsbsbsbsbsbsbRsbsbsbRjLsbsbLgbLsLsLsmmbLsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 8; Drug: PCAP931 1 然 Apo 0.5 然
bRjLsbLibLgbLgbLiLsbRgbRsRsmbRhbLcbLgbLcbLobRsRsmbRobRhbLsbRiRsmbRsbLs
bRgbLgbRoRsmbRsbsbRibRjbRibRcbRsRsmbLsbRgbRibLsbLsbRsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 9; Drug: PCAP931 1 然 Apo 0.5 然
bRgLsbRsbRsbRsRsmbRsbLibLsbRgbRcbLjLsmbRsbLsbLgbLgbLibLsbRgbRsbLiLsbLs
bLgbLsLsmbLibLcLsmbLsbLsbLibRsbLsLsRsmbLgbLcbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 10; Drug: PCAP931 1 然 Apo 0.5 然
bLcbLebLiLsbRgbRobRebLsbRgbRgbRsbRibRgbRgbRebRibRsbRsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 11; Drug: PCAP931 1 然 Apo 0.5 然
bsbLibRoRsRsmmbsbLebLgbRgRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 12; Drug: PCAP931 1 然 Apo 0.5 然
bLsbLsLsmbRjbRgLsbRgbRsbRsRsmbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 13; Drug: PCAP931 3 然 Apo 0.5 然
bsbsbLcbLcbRobRibLsRsbLsbRsLsbRhbLoLsmbLhbLgbLsRsbRjRjRsmbLsbLebLhbLhb
LgLsbRobsbsbsbsbsbsbsbsbsbsbLjLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 14; Drug: PCAP931 3 然 Apo 0.5 然
bLgbLibRjRsmbLiLsbLebRcbLsbLsbLibRsRsmbLsbLsbLsLsLsmmbLcbRsbRobsbLgbLs
bLsbLhbLhbsbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 15; Drug: PCAP931 3 然 Apo 0.5 然
bLgbLgLsLsmbLgbLsbLgLsbLsbRgRsmbLjbLibLsbLsbRgbsbRsRsmbRsbLsLsmbsbLibL
sbLsbLcbLibLsbLsbLibLsbLcbLsLsLsmmbsbLcLsmbLsbsbRsbRcRsmbLsLsmbLgbRsbR
ibLsbLjbLobRsbLsbRsLgRsLsbRsbLsLsmbLsRsLsbRsbRsbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 16; Drug: PCAP931 3 然 Apo 0.5 然
bRcbRsbsbRsbRsbRibRgbRcRsmbsbLgLsbRsbLjbLsbRsRsmbRgbsbRgbRsbRhbLgbLjLg
bLiLsbLsLsmbLgbLgbLsLsmbLgbLgbRsbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 17; Drug: PCAP931 3 然 Apo 0.5 然
bLgbRcbRibRhbLsbRcbRhbLjbsbRgbLiRsbLibLsbsbRebRobsbLgbLsLobRgbRsbRsRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 18; Drug: PCAP931 3 然 Apo 0.5 然
bLsbRsbRcbRsbRcbRobLsbRsbRgbRhLsbsbRibsbRgbRcbLsbLgLsbsbLsbLsbLsLsLsmm
bRsbLsbLsbLsLsmbLsLsmbLsbLsbLsLibLoLsmbLsbLsbRhLsbLsbLgbLcLsmbRsbRgbRg
bRgbRsbRsbRsbRgbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 19; Drug: PCAP931 10 然 Apo 0.5 然
bLsRsbRsRsmbRsbRgbRsRsmbRsbRsbRsRsmbLsLsmbRsbsbRgbRsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 20; Drug: PCAP931 10 然 Apo 0.5 然
bLgLsbLsLsmbLsLsmbRsbLsRsbLsbLsbLsLsmbsbLsbLsbLgbLsbLgbLsbLsLsLsmmbLsb
LsbLsbsbLsLsLsmmbLsbLsLsmbLsLsmbLsbsbLsRsbLsbLsLsmbLsbLsbLsLsmbLsbLsRs
bLsbLsbLsbLsbLsbLsRsbRsbLsRsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 21; Drug: PCAP931 10 然 Apo 0.5 然
bLsbLsLsLsmmbLsbsbRsbRsbLsbLsLsRsmbLsLsmbRsbsbRsbLsbLsbRhbsbsbsbLsRsbR
sbRsbRsbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 22; Drug: PCAP931 10 然 Apo 0.5 然
bLsbLoLsmbRsLsbRsbLsbRibLsbLsLsmbLhbLgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 23; Drug: PCAP931 10 然 Apo 0.5 然
bRsbRgLsbRsRsmbsbRsbRsbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 24; Drug: PCAP931 10 然 Apo 0.5 然
bLsbLsLsmbRsbLsbRsbLsLsmbsbRsLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 25; Drug: Control Apo 0.5 然
bLjbRcbLjbRgRsmbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 26; Drug: Control Apo 0.5 然
bsbLibLibRsbRgbsbRsbRsbLsLgbLjbRgbRjRsmbLsbLsLsmbLsbRsbRsbRsLsbLgLsbLs
bLsbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 27; Drug: Control Apo 0.5 然
bRebLsbRjbLebRjbLjbRjbRjbRsbRsbRjbRjbLsLjRsbLjbRjbLsbRsbLsbsbsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 28; Drug: Control Apo 0.5 然
bRibLibLibLsbLgbRsbLiLsbRsbLgbRgbRsbRsbRibLgbLsbLcbLibLgbLgbLcbLgbLgbL
ibLiLsbLgbLibLibLibLgbLsbLgbLibLgbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 29; Drug: Control Apo 0.5 然
bRoLsRsbLcLsmbLsbLibLsbRsbLsbLgbLgbLsLgbLgbLsbLiRsbLsLsmbLgbLsbLgbLsbL
gRsbLsbLgbRsbLsbLgbLsbLgbLgbLibRgbLsbLsbLibRsbLgbLsbLgbLgLsbLibLsbLgbL
ibLiLsbLibRsbLsbLibLibRsRcRsmbRcbRsbRcbLgbsbRiLsbLgbRgbLsbRjRsmbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 30; Drug: Control Apo 0.5 然
bLibRoLsbLhbRgbRsbLhbLgLsbLgbRgbLiLsbsbsbLgLsbRiLsbLibLibLibLcbLcLsLsL
smmmbRsLsbLibLsbRgbLibLsbLsbLiLsbLsbRgRsmbLsbRsbsbsbsbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 31; Drug: PCAP931 1 然 Apo 0.5 然
bLsbLgbRobRibsbLibLsbLsbLsbLgbLgbsbLgbLgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 32; Drug: PCAP931 1 然 Apo 0.5 然
bRsRgbRebRsRsmbLsbLgbRgbLsbRgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 33; Drug: PCAP931 1 然 Apo 0.5 然
bRibRsbRgbRjRsmbLjbRjbRoRsmbRgbLsbRhbLsbRibLgbLsLsmbRibLebRoLsbLsbLgbR
jRhbLcbRhbLebRcbRibRobRsbsbsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 34; Drug: PCAP931 1 然 Apo 0.5 然
bLibLsbRcbRibLibRsbLibLgbLcLsmbRsbLgbLcbRcbRsbRsbLibRobLsbLcRsbLhbLsLs
mbsbRcbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 35; Drug: PCAP931 1 然 Apo 0.5 然
bLsbLibRibRgbRjRsmbLsLsmbLgbRsRsLsmbLsbLsbLsbRsbRsbLsbRsbRcbRsRsmbRgbR
ibRibRhbLsbRcb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 36; Drug: PCAP931 1 然 Apo 0.5 然
bLebRgbLcbRjbLcbRibRjbRcbLibLibLibLsLibRgbRebLjbLcbRgbLibLibLcbLibRsbR
sbRsbLsbRibLjLhbRjRibLcbLibLsbLsbLgbRgbLgLsRsbLibLgLsbRgbLcbLjbLibLibL
sbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 37; Drug: PCAP931 3 然 Apo 0.5 然
bLob

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 38; Drug: PCAP931 3 然 Apo 0.5 然
bLgbLsbRsbLgbLsbRgbLiRsbRsbsbRgbRsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 39; Drug: PCAP931 3 然 Apo 0.5 然
bRibLgbRsbRgbLsLsmbRgLsbLjbRhbRsbRibRgRsmbRibRsbRiLsbLgRsbLsbLibLsbLsR
sbLsbRoLsbRgbRsbRcbLgbLibRibRsbLgbLebRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 40; Drug: PCAP931 3 然 Apo 0.5 然
bRobRsLsbRsbRsbLsRsbRsRsmbLibLiRsbLsbRsbRgRsRsmmbLibLsbRsbRsbLgbLsRsbL
cRsbRsbLsbRobRoRsRsmmbRsRsmbRsRsRsmmbRobRsbRsbRsbLsbLgLsbLoLsmbRsbsbLs
bLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 41; Drug: PCAP931 3 然 Apo 0.5 然
bRobRsbLobLobRebRobRobRebLcbLjbRebLcbRobRjbLebLsbLebLobRcbLcbLcbRobRob
LebLobLsbLobLebLsbRsbRebLobLsbLebRobRjbLobLsbRjbLobRebRjbRebRsbRjbLebL
obLebLobRebRjbLebRcbLjbRebLobLebRcbRcbLcbLcbLobRjbRebRjbRobRsbLobRebLc
bRobRobRjbLjbRebRjbLjbLsbRebRjbLjbRobLibLebLebLobRebRjbLcbLsbRobRobRob
RcbLobLebLjbLebLobLobLsbRobLobRcbLgbRebRobRcbLcbLebLjbLsbRobRobRebLcbR
sbRebRobLobRjbRobLobRebLebLsbLobRsbRebLjbLjbRsbLobLjbLjbLjbRobLobLobRo
bLobRgbLebLobRcbRobLobRcbLebRobRobRjbRobLobLobRcbRjbRobLjbLebRsbLjbLob
LjbRcbRjbRjbLobLcbLebRobRobRsbLobRebLebLjbLobLobLebLjbRobRcbLebRcbLebR
jbRobRjbRobRjbRsbLhbLebLobRcbLobLobRobRobLobLobRjbLobRjbRobRjbLsbLjbRo
bLobRjbRobRjbRjbLjbLjbLob

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 42; Drug: PCAP931 3 然 Apo 0.5 然
bLgbLsbLsbLibLsbLsLsmbLsbLsbLsbLsbLgbsbLsbLgbLsLsmbLsbLsLsmbLsbRsbRcbR
sRsmbRsRsmbRsLsbRobRgbLsbLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 43; Drug: PCAP931 10 然 Apo 0.5 然
bLsbLgLsbLsbRibLsbRsbRsbRsRsmbRsbRsbLgbLsbRsbRsbLgbRgbRgRsmbLsbLjbRsbR
sbLsbRgbLcLsmbsbsbLsbsbRgRsmbRsLsbRsRsmbRsbRibLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 44; Drug: PCAP931 10 然 Apo 0.5 然
bLsbLsbLoRsbLibLsbLsbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 45; Drug: PCAP931 10 然 Apo 0.5 然
bLibLsbLibLcbLgLsLsmbLgbRsRsLsmbLcLsmbRgbLsbLibLiLgbLgbLgLsbLsbLgbLsLs
mbLsbLsbLsLsmbLgLsbLhbRsbLgbLsbsbLcLsmbRgRsmbLsbLgLsbLgLsbLgRsbRsbLgLs
bLsbLgbLgbLgLsbLsbLgLsbLcLsmbRsbRsbLebLebRsbLgbLsbLibLsbsbLibLobRibRsb
RgbLgbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 46; Drug: PCAP931 10 然 Apo 0.5 然
bLsbRjbLhbRsbRsbRsbLjRsbRsbRjbRsbRsbRsbRgbRsbRgbLsbRsbRjbRsbRebLjbLgbR
gbRsbLjbLsbLjbLsbRsbRsbRjbRsbRjbLsbRsbRjbRsbRsbRsbLsbLsbRjbLsbLsbLsbRj
bLjbRgbLcbRgbLgbRjbLsbRsbRsbLsbRsbLsbLsbRjbRsbRjbRsbRgbRsbLsbRsbLsbLsb
RsbRsbLsbRsbRjbRsbLsbRsbLsbLjbRsbRsbLsbLjbRsbLsbLsbRsbLsbLjbRsbRsbRsbR
obLgbRsbRjbRjbRsbRsbLsbLjbRjbLsbRsbRsbRsbLsbRsbRsbRsbRjbRjbLsbLebLsbRs
RsmbRsbRsbLsbRcbLcbRsbRsbRebLeb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 47; Drug: PCAP931 10 然 Apo 0.5 然
bsbLgbLcLsmbLgbLcbLsbRsRgRsmbLsbRsLsbsbLobLoRsbLiLsbRgbLiRsbRsRsmbsbRg
bLgbRgbLsRsbRcbRsbLibLibLsLsmbLgbRsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 124219; End: 124719;
Recording: 12-1; Individual: 48; Drug: PCAP931 10 然 Apo 0.5 然
bRcRsmbsbRsRsRsmmbLsLsmbsbsbRsbRsbLsbsbsbsbsbsbsbLsbsbsbLsbsbLgbsbLjLs
LsmmbLsLsLsmmbLsLsmbLgbsbLsLsmbLibLcRsbRhbLsbLhbLsbLsbRgbLsLgbLsRsbLsL
smbRsbRsLsbsbsbsbsbRjbLibLsbsbRgbRcRsmbLsbLgLsbLibLsLsmbLsLsmbsbRibsbL
gbLsLsmbLibLhbLsbsbLsLsLsmmbLob

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 1; Drug: Control Apo 0.5 然
bLiLsbRgbRibRgRsmbRsbRibLibLsbLjbLibsbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 2; Drug: Control Apo 0.5 然
bRgbLsbLjbLgbLibLsbRcbRobRhbLjbRsbLibRcbLibLibRsbRcbRhbLibLsbRgbRiLsbR
obRobLgbLsbLjbRgbRcbRgbRibRiLsbRgbRgbLsbLibRcbRcbLgbLjbRhLsbRsbRoLsbLi
bLgbLibLjbRjbLsbLhbRgbRobLsbRcbLgbRgbRjbRobRjbLsbLgbLgbRsbsbsbLsbLsbLg
bRsbLhbLsbLibLgLsbLgbLibLsbRobRsbRobLgbsbLsbRobRgLsbRsbLgbRsbRcLsbLgbL
sbRcbLibRhbsbLjbLsbLcLsmbRsRsmbRsbLgbLobRsbLibLibLsbRsbsbsbsbLibLsbLgL
sbLsbLgRsbLgbRgbLgbRsbLibLgbLibRsbRgbRhbLhbLcbRsbRcbRobRibRibLsbRgbLsb
LgbRhbLjbRobRjRsmbRsbRobsbLibRibLsbRgbRobRgbLsbRibRibRobLgbLgbLsLsmbLs
bLibRsLsbLgbLsbRsbRobLjbLobLcLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 3; Drug: Control Apo 0.5 然
bLibLsbRsRobRsbLebRsRoRsmbLgbRobLibLibLsbLebsbRgbLhbRgLsbLgbLibRsbRsbL
ibLsbLibRsbLgbLsbLsbLibLsbRsbLgbLsbLsbLgbLgbLgbLgbLgbLgbLgbLsbLsbLibLs
LsmbLsbLiRsbLgbLibLsbLgbLgbRgbLibLibLjLsmbLibLibLiLsbLiLsLsmbRgbLsLsmb
LhLsbLsbLcbRsbRgbLobLibLibsbRibLsbLsbLsbRsbLobRjbLibLgbRsbLsbLhbLgbLgb
LsRsbLsbLgbLsbLibRsbLibRsbLgbRsbLiLsbLgRsbLsbLgbLsbRoLsbRgbRhbRgbLgbLs
bLibLibLibLgbLiLsbLsbLgbRgbLcbLgbLibLibLgbLsbLgbLgbLsbLgbLsLsmbRsbLgLs
bLsbLcLsmbRibRsLsbLgbLibRjbRibLjbLcbLgbLsbLibLiLsbLcbRsbRsLsbLgbLjLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 4; Drug: Control Apo 0.5 然
bLjLgbLsLsmbLsbRoRsmbLcbsbRibRib

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 5; Drug: Control Apo 0.5 然
bRibRgbLcLsmbRsRsmbLoRsbRiRsmbRgRsmbRsbRibRgbRsRsmbLjbRgRsmbRhbRsbLibL
sbLsbRibRsbLhbRgLsbLibLcbRibRibLcbLcbRibLibLobRibLsbLsRsbLsbRibRsLsbRi
bRsRsmbRsRsRsmmbRibRgbRsbRibRgbLibRibRjRgbRsbLgbRsbRibRibLsbRibRsbRhbR
sbRgbRiRsmbRsbRibRsbRcbRcRsmbRiLsbRgbLobRibLibRibsbRjbLcbRgbLgbRjbReLs
bRsbLsbLcbRjbRcbRcbRibLgbRsbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 6; Drug: Control Apo 0.5 然
bLgbsbRjbLsLsmbRjRsmbLgbLsbRibLoLsRsmbLcLsmbLcbLsbLibRsbRobLsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 7; Drug: PCAP931 1 然 Apo 0.5 然
bLobLgbRsbRsbRcbRobRcbRgbRibLsbRsbRhbRibRibRgRsmbRgRsmbLgbRcbLgRsbRibR
obLjLsmbRiRsmbLgbLjbRcbLgbReRsmbRiLsRsbLibRibRsbLibLhbRiLsbLsRsbRibLjb
LibsbRjbRcb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 8; Drug: PCAP931 1 然 Apo 0.5 然
bRsbRsbRgRsmbsbLsbRgbLsLsmbRgRsRsLsmmbsbLibRsbsbRsbLsbLsLsmbLgLsRsbLgb
LoLsmbRsbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 9; Drug: PCAP931 1 然 Apo 0.5 然
bLoLsRsmbRcbRobLgbLibsbLgbLiLsbRgbLhbsbRgbRsbLgLsbRsbLgbLsbRgbRobLhbRg
bLsLsmbLgLsbLsbLsbLsbLgbLibLsbLgbsbLhbLsbLsbLibLsbLgLsbRsbLgbRgbsbsbLi
RsbRgbRsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 10; Drug: PCAP931 1 然 Apo 0.5 然
bRsRsRsmmbLsbRsRsRsmmb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 11; Drug: PCAP931 1 然 Apo 0.5 然
bRsbRgbRgbLsbRcbRibLgbLsbLibLsbLgbRsbRcLsbRgbLibLjbRobRibLsbLgbLcbsbRs
RsmbsbsbLibLsbsbRgRsRsmmbRsbLsbRsbRsbRgbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 12; Drug: PCAP931 1 然 Apo 0.5 然
bRsRsLsmbLsRsbRsbRgbRsbRsbsbRgLsbRgbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 13; Drug: PCAP931 3 然 Apo 0.5 然
bLgbRibRsLhbRobRsbRobRsRsmbRjbLgbLjbRjbsbRsbRibRcbRcbLobLcbRgRsmbLsRsb
LsLsmbLcb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 14; Drug: PCAP931 3 然 Apo 0.5 然
bsbRsbsbRsbRcbLsbLsbRoLsbLiLsbLcbRsbLiLsbLjbLsLcbLsbLsbLsbLibLcLsmbLsb
RibRsbRsbRjb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 15; Drug: PCAP931 3 然 Apo 0.5 然
bsbLibLibLgbsbLibLsLsmbRgbLibLsbRcbRsbLgbsbLiLsbLsLsmbsbRsRsmbLsbLsbLg
bLgLsbLsLsmbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 16; Drug: PCAP931 3 然 Apo 0.5 然
bRsRsmbRsbRgbRsbsbRgbsbsbLcLsLsmmbLsbLjLcbLcbRsbLsbLibLsbLsbLsbLibLgbR
ibRsLsbLhbLsbLcbRsRsmbLsbLibLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 17; Drug: PCAP931 3 然 Apo 0.5 然
bRsbLsbRibLjLsmbRgbRiRsmbRsLsbRsbLiRsbLibRcbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 18; Drug: PCAP931 3 然 Apo 0.5 然
bRsbRgbsbLsbRobLiLsbLsRsLsbLoLsLsmmbsbLgLsLsmbRibRobLgbRgbRibLsLsmbsbL
sLsmbRsbRgbRgbRsbRibRibLsbsbRgbRgbRsbRsbRsbRsbRibLsbLgbRsbsbRgbRsbLsbR
gbRgbLsLsmbLsbRibLsbRibRsLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 19; Drug: PCAP931 10 然 Apo 0.5 然
bRsRsmbRsbRsRsmbRsbLcbRsLobLgbLsbRgRsmbRhbLgbRgbRibLsbLsLsmbsbRsbRsLsb
sbRsRsmbRobLsbRgbLobLhbLgbLcLsmbLsbRoLsbLsbLsbLsbsbRsbRsbRsbsbLsbRjbRi
bRsRsmbRsbRgb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 20; Drug: PCAP931 10 然 Apo 0.5 然
bLsbLsbLsLsmbsbRsLsbLsbsbRsbLsbLsbLsRsLsbLsbLsbLsbLsbsbRsLsbLsbLsbsbLg
bLsbLsbLsbLgbLsRsbsbRsRsmbLsLsmbLsbLsbsbLsbLsbLgLsbRsbsbsbRsLsbLsbsbLs
bLgbLsbLsLsmbLsLsmbsbLsbLsLsmbRsRsmbLsbRsbLgLsbLsbLsLsmbsbLsbLsbLsbLsb
LsLsmbRsRsmbLsLsLsmmbLsbLsbLsbLsLsmbLsLsRsmbLsbLsLsmbLsLsmbsbsbsbLsLsm
bLgbLsbLsRsbLsbLsbLsLsmbLjLsRsmbLsbLsbLsbLsbLsLsmbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 21; Drug: PCAP931 10 然 Apo 0.5 然
bRobRjRsmbRsRsmbRsRsmbLsbRsLsbLsRsbsbsbRsRsmbRsbsbsbRgLsbRsRsLsmbsbRsb
RsbRoRsmbLgbRgbRsbRhbRiRsmbLsbRgRsmbRsbRsbRsbRsbRgbLebLgbLibLsbRsbRsbL
obRsbLiLsbsbsbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 22; Drug: PCAP931 10 然 Apo 0.5 然
bLsbRebLsbLibRibRsbLgbRcRsmbRibLgbLsbRjRsRsmmbRgbLsbRjbsbLsLsmbLsbRsbL
sRibLsLsmbLsbRgbLoRsbLsbLjbLsbRsLsLsmbLsbRoLsbLsRsbLgbLgRsbRgbLgbRebRs
RsmbRsbLsbsbLsbRsbRsbLsbLsRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 23; Drug: PCAP931 10 然 Apo 0.5 然
bRgbsbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 24; Drug: PCAP931 10 然 Apo 0.5 然
bRgRsRsmmbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 25; Drug: Control Apo 0.5 然
bRsbLjbRgRsRsmmb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 26; Drug: Control Apo 0.5 然
bsbsbRsbRsbRsbRsbLsLibLcLsmbLibRsLsbsbLcbLibRgbRsbLgbLsbLgbRsbRgbLsbLs
bLsLgbLsbRsbLsbsbLsbLgLsbLsbRebRibRgbRsbLsbLsbRibRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 27; Drug: Control Apo 0.5 然
bRsRsRsmmbRsbLsbLsbRsbLibRcbRcbRcb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 28; Drug: Control Apo 0.5 然
bsbsbsbsbsbsbsbsbsbRsbsbsbsbLsbLgbRgRsmbLsLibRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 29; Drug: Control Apo 0.5 然
bLsRsRsmbRsbsbRsbsbsbLcbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 30; Drug: Control Apo 0.5 然
bRjbLebRsbLgbsbLcbLgRsbLeLsbLibLcbLgbLibLgLsbLgbLgbLgLsbsbLgLsbLgLsbsb
LgbsbLgbLgbLjLsmbLsbLsbLsLjbLebRcLsbLgbLgRsbLsLsmbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 31; Drug: PCAP931 1 然 Apo 0.5 然
bLsbLibRgLsbLsbLsLsmbLhbRsbRsbRcRsmbRsRsmbRsbRgbRsbRsbRsRiRsmbLcbLgbRo
RsmbLsLsRsmbLebLcbRgbRcbRsLsbRsbRjbRsLsRsbRsbLsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 32; Drug: PCAP931 1 然 Apo 0.5 然
bRjbLsbLsbRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 33; Drug: PCAP931 1 然 Apo 0.5 然
bRcbRsbRsLsbLsLsmbRibRsRsmbRgbLsbLsbRibsbRiLsbRcbRjRsmbLsbRsbRsbLsRsbR
hbRgLsbRgRsmbRobRhbLgLsbLgbLeLsbRobRsLcbRcbLsbLcbRibsbRsLsbRcRjRsmbRcb
LsbsbRgbRsbRibsbRsbRsbLsbRcLsbLsbLsbRgbRib

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 34; Drug: PCAP931 1 然 Apo 0.5 然
bLgLsLsmbLibRcbLsbLibRsbRsbRcbRhbRcbLibLgbRsbRhbRcbLibLcbLgbRobLcLsmbL
sbLsbRibRsbsbLgbLsbLsbRcbRibRgbLib

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 35; Drug: PCAP931 1 然 Apo 0.5 然
bLjbRcbRsbRsRsmbLsbLsRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 36; Drug: PCAP931 1 然 Apo 0.5 然
bLsbLiLsbsbsbLgbLsLsmbLobLcbLibLsLibLgbLibLiLsbLgbLgbRgbLibLibRjRsmbLo
bLibRgbRoLsbRsLsbRgbLsbLibLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 37; Drug: PCAP931 3 然 Apo 0.5 然
b

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 38; Drug: PCAP931 3 然 Apo 0.5 然
bRgbRsbRibRsbLsbLsbRsbRsbRsRsmbRsbRsRsmbRsbRsRsRsmmbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 39; Drug: PCAP931 3 然 Apo 0.5 然
bRcbRibRsbRiRsmbLsbLgbLsbLjbLgbsbRsRsmbRsbLibLcbLobsbLgbRibLsRsbLgbRgb
RhbRibRgbRsbLibLgbRsbRibRgbLgbRcbLgbLsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 40; Drug: PCAP931 3 然 Apo 0.5 然
bRcLsbRsbLsbLsLsmbLsLsmbLsLsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 41; Drug: PCAP931 3 然 Apo 0.5 然
bLsbsbLiRsbRgbLsbsbRsbRsbRsbRibLsbsbsbRobRgbRsRsmb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 42; Drug: PCAP931 3 然 Apo 0.5 然
bRgbRgbLsbRsbRsbRsbsbRsRsmbRsbRsRsmbRjRsmbsbLsRsbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 43; Drug: PCAP931 10 然 Apo 0.5 然
bRoLsbLiLsbLobRsbRgRsmbRsbLcbRibLsbLsRsbRsbLsLsmbLibLsRsbLibsbRgbRsbRg
bLibRibRgbLsRsLsbRsbsbRgbRobLoRsbRsbRsbRibLebLibLibRibLsbLibRhbLsbLsbL
gbRsbRsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 44; Drug: PCAP931 10 然 Apo 0.5 然
bLgbLsbsbRsbsbsbsbLgbRsbRsbLebLibLoRsRsmbRobRibLsRsbRiRsLsmbLobLhbRhbR
gbRcbRsbRobRcbsbRcbsbsbRsbLsbsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 45; Drug: PCAP931 10 然 Apo 0.5 然
bRsRsmbLsLsmbRsRsmbRsRsmbLsLsmbLsbLgbLsLsmbLsbRsLsbLobLsLsmbLcbLgbLgbR
sRsmbLsLgbLgLsbLhbRgbLibLcbLgLsbLgLsbLsLsmbRsbLiLsbLebLgbRsbLsLgLsLsLs
mmbLsbLgLsbRsbLsLgbRsRsmbLsb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 46; Drug: PCAP931 10 然 Apo 0.5 然
bRsbRebRsbLsbRsbLsbRobRsbRsbLsbLsbLsbLsbRsbLsbRobRsbLsbRsbLsbLsbRsbLob
LsbLsbRsbRobRjbLsbRjb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 47; Drug: PCAP931 10 然 Apo 0.5 然
bLgbLjbLhLsbLcbRsbLobRsbLcRsbLebLsbLsbLgbLgbLibLgLsbLgbRsbRsbRsbLibLsb
RsbLjbLcLsmbLoRsbLgb

>ZF Recording 2016-06-01; tW: 300s; Start: 124721; End: 125221;
Recording: 13-1; Individual: 48; Drug: PCAP931 10 然 Apo 0.5 然
bLcbLgLsbsbLsbRgbRgbRgRsmbRgbRsRgRsmbRebRjbsbLgbLsbRsLsbLgLsbRgbRsbLsb
LgbLsLgbRsRsmbLsbsbRgRsmbsbLcbLcbLsbsbRsbLsbLgbRsRsmbLsbLsbsbRsbRsbLib
LsbLsLsmbsbRsRsmbLgbLiLsbLibsbRsRsmbLsbRsRsRsmmbRsbsb

